Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame

Information

  • Patent Grant
  • 11185405
  • Patent Number
    11,185,405
  • Date Filed
    Tuesday, August 27, 2019
    5 years ago
  • Date Issued
    Tuesday, November 30, 2021
    3 years ago
Abstract
The present invention relates to a radially collapsible frame (1) for a prosthetic valve, the frame (1) comprising an outflow end region (3) at a proximal end of the frame (1) and an inflow end region (2) at a distal end of the frame (1), opposite to the outflow end region (3). The frame (1) further includes at least two radially spaced commissure attachment regions (10, 10′, 10″) and a cell structure (30), composed of a plurality of lattice cells being arranged radially around a flow axis of the frame (1) and connecting the at least two commissure attachment regions (10, 10′, 10″). Finally, at least one anchoring/positioning arch (20, 20′, 20″) is provided, wherein said at least one anchoring/positioning arch (20, 20′, 20″) radially overlaps the cell structure (30) at least partially. In order to form the inventive frame from as a single piece, the invention further relates to a method comprising bending the at least one anchoring/positioning arch (20, 20′, 20″) towards the cell structure (30) of the frame (1).
Description

The present invention relates to a radially collapsible frame for a prosthetic heart valve and a method for manufacturing such a frame. Specifically, the present invention relates to a radially collapsible frame for a prosthetic valve used in the treatment of a stenosis (narrowing) of a cardiac valve and/or a cardiac valve insufficiency. In addition, the present invention relates to an endoprosthesis comprising the inventive radially collapsible frame.


The expression “narrowing (stenosis) of a cardiac valve and/or cardiac valve insufficiency” is intended to include a functional defect of one or more cardiac valves which is either genetic or has developed. A cardiac defect of this type might affect each of the four heart valves, although the valves in the left ventricle (aortic and mitral valves) are affected much more often than the right sided part of the heart (pulmonary and tricuspid valves). The functional defect can result in narrowing (stenosis), inability to close (insufficiency) or a combination of the two (combined vitium).


Radially collapsible frames for prosthetic heart valves are known in the state of the art. In particular, minimally-invasive forms of treatment of cardiac valves have been developed recently which are characterized by allowing the procedure to be performed under local anesthesia. One approach provides for the use of a catheter system to implant a self-expandable frame, which is connected to a collapsible valvular prosthesis. Such a self-expandable endoprosthesis can be guided via a catheter system to the implantation site within the heart through an inguinal artery or vein. After reaching the implantation site, the radially collapsible frame can be unfolded so as to anchor the endoprosthesis in the vicinity of a native valve annulus.


To this end, it is known that the radially collapsible frame may be comprised of, for example, a plurality of self-expanding substantially longitudinal arches, the arches being configured to hold a valvular prosthesis in place at the desired implantation site. The prior art document EP 1 980 220 A1, for instance, discloses a self-expandable stent having three retaining arms (20) which form the base for an anchoring segment for accommodating a valvular prosthesis (40). In order to automatically position and orientate the common frame described by the EP 1 980 220 A1, a total of three positioning arches (10) are provided. The positioning arches (10) have a rounded head portion (12) which engages the pockets of an insufficient heart valve, which shall be replaced by the known endoprosthesis. These three positioning arches (10) ensure that the requisite positioning accuracy can be obtained in the direction of rotation and provide for additional radial clamping forces in order to support the implantation of the stent at the desired implantation side.


Additionally, when the known frame (1) is in its expanded state, the respective positioning arms of the positioning arches (10) are located in the pockets of the diseased heart valve and thus essentially guarantee secure and error-free positioning of the medical device. The pocket flaps of the diseased heart valve are then clamped between the positioning arches (10) and the retaining arches (20), in a manner similar to a paper-clip, due to the expansion of the endoprosthesis 1. This further assists in achieving an optimum positioning and anchoring of the known heart valve frame.


As a consequence of the clamping effect between the positioning arches (10) and the retaining arches (20), the radially collapsible frames known from the prior art tend to allow for a frictional contact between the valvular prosthesis and the diseased native heart valves, as the valvular prosthesis is frequently directly connected to the retaining arches of the collapsible frame. Such a frictional contact between the diseased heart valve and the valvular prosthesis can result in increased wear of the valvular prosthesis, due to undesired friction with the diseased heart valve. Furthermore, due to the common frame configuration, the diseased heart valve may impede the motion of the valvular prosthesis, especially during the opening movement of the prosthetic valve leaflet. In some circumstances, this may mean that the prosthetic heart valve leaflets may not be able to open fully, as a consequence of the presence of the diseased heart valve leaflets. Moreover, the common stent structures often fail to provide for sufficient radial forces in order to anchor the stent structure at the desired implantation side. As a consequence, inadvertent relocation of the stent after implantation may occur.


On the basis of the problems outlined above, certain embodiments of the present invention address the issue of providing a radially collapsible frame for a prosthetic valve, which guarantees perfect positioning of the heart valve prosthesis and, at the same time, protects the prosthetic valvular leaflets effectively from external stresses due to a frictional contact with the native heart valve leaflets. In addition, the inventive frame should provide for a treatment of the narrowed cardiac valve or cardiac valve insufficiency by way of a simple and reliable procedure to enable a routine treatment without major stress to the patient.


In this regard, and as it will be described in more detail below, the invention provides a radially collapsible frame for a prosthetic heart valve comprising an outflow region at a proximal end of the frame and an inflow end region at a distal end of the frame, opposite to the outflow end region. The radially collapsible frame further includes at least two radially spaced commissure attachment regions located at the outflow end of the frame and being configured to receive commissures of the prosthetic valve leaflets. A cell structure composed of a plurality of lattice cells is being arranged radially around a flow axis of the frame and connects the at least two commissure attachment regions. Finally, the radially collapsible frame further comprises at least one anchoring/positioning arch, wherein said at least one anchoring/positioning arch radially overlaps the cell structure, at least partially.


In medical terms, the commissure of a heart valve is a point or line of union or junction between the respective leaflets of a heart valve. In the closed state of a heart valve, the commissures can be described as the points or lines of a leaflet, contacting another leaflet in order to close the particular blood vessel. Naturally, the leaflets of a heart valve are continuously in contact with each other at two or more commissure edges which are radially distributed about the flow axis of a prosthetic heart valve. In this connection, the expression “commissure attachment region” describes an arrangement of struts located at the outflow end of the inventive stent, which is configured to receive the at least two commissure edges of the leaflets. Normally, the number of commissure attachment regions complies with the number of commissure edges formed by the leaflets.


Furthermore, the term “radially overlapping” expresses that the at least one anchoring/positioning arch is located along the same section of the frames flow axis as the cell structure. The anchoring/or positioning arch is, however, not part of the cell structure but radially distanced therefrom. In particular, the at least one anchoring/positioning arch may extend radially outwardly from the circumference of the cell structure, and hence, overlap the latter at least partly.


Accordingly, the inventive frame has the advantage that a cell structure, which is composed of a plurality of lattice cells, prevents any undesired contact between the native heart valve leaflets and the valvular prosthesis. In particular, the cell structure is disposed between the valvular prosthesis and the leaflets of the native valve. Therefore, the cell structure forms a separation wall in between and, additionally, provides for an improved clamping effect of the native heart valve leaflets together with the at least one anchoring/positioning arch. Moreover, the inventive collapsible frame does not necessarily have to provide for retaining arches, as it is conceivable to attach the valvular prosthesis directly to the plurality of lattice cells of the cell structure, by means of threads for example. Finally, it should be noted that the cell structure provides for an additional support of the inventive frame at the desired implantation side.


According to another embodiment of the present invention, the at least one anchoring/positioning arch of the collapsible frame may be rigidly attached to the at least two radially spaced commissure attachment regions. In particular, it is preferred to form the at least anchoring/positioning arch integrally with the at least two radially spaced commissure attachment regions as a single piece. In this way, the inventive radially collapsible frame is particularly robust and provides for a stable support of the valvular prosthesis within a patient's blood vessel. As it will be described in more detail below, all of the parts of the inventive frame may be cut out of a single hollow tube of shape memory material. Consequently, the radially overlapping at least one anchoring/positioning arch does not need to be fixed to the collapsible frame, by means of sutures, welding or adhesive, after the radially spaced commissure attachment regions and the cell structure have been cut out of the hollow metal tube. Instead, the at least one anchoring/positioning arch is cut out of the same hollow tube as the rest of the radially collapsible frame, wherein the at least one anchoring/positioning arch is formed proximally of the outflow end region of the frame and bend in a distal direction (towards the inflow end), so as to radially overlap the cell structure, after a laser cutting has been performed.


Of course, it is also feasible to apply other means of attaching the anchoring/positioning arch rigidly to the frame, such as welding, sewing, gluing or riveting for instance. According to this alternative, the at least one anchoring/positioning arch is formed as separate piece and attached to the frame structure subsequently, after the frame has been cut out of the hollow metal tube. In more detail, the at least one separate anchoring/positioning arch may be welded to the commissure attachment regions in such a way that the at least one anchoring/positioning arch radially overlaps the cell structure at least partially and extends in a direction towards the in flow end of the frame. As a consequence, it is not necessary to bend the at least one anchoring/position arch during a shape-setting process of the frame.


In accordance with another aspect of the present invention, the inventive frame further comprises a plurality of circumferentially arranged retaining arches, each including first and second arms joined to one another at a distal end of the retaining arches. The two arms of each respective retaining arch are joined by a rounded structure. The provision of circumferentially arranged retaining arches provides for various advantages effects. In particular, the retaining arches, which substantially range from the outflow end to the inflow end of the inventive frame, protrude radially in the expanded state of the frame to press against the wall of a patient's blood vessel in which the frame is deployed with a radially-acting contact force. The shape of the retaining arches may be configured to be positioned below the native valve annulus or to be positioned at least on the native valve annulus, thereby providing additional anchoring for the inventive stent together with a valvular prosthesis affixed thereto. As an alternative or in addition to the cell structure of the frame, the retaining arches may be used in order to attach the valvular prosthesis to the collapsible frame. In particular, a cusp edge of the valvular prosthesis may be sutured to the retaining arches, at an opposite and of the free commissure edges of the leaflets. In this connection, the first and second arms of each retaining arch may be shaped in such a way as to imitate the natural arcuate shape of the cusp edges of a native heart valve.


To this end, the two arms of each retaining arch are joined to one another at a connection, preferably having a substantially U- or V-shaped structure. As mentioned before, this particular shape of the retaining arches may particularly imitate the natural shape of a heart valve cusp region. The U- or V-shaped retaining arches may be located in such a way that the closed portion of the U- or V-shape forms the connection of the two arms in a distal direction, towards the inflow end of the frame. The open ends of the U- or V-shaped structure, on the contrary, may be attached to the at least two commissure attachment regions. Therefore, the retaining arches preferably have an open end directed towards the outflow end of the radially collapsible frame.


According to another embodiment, an entirety of three anchoring/positioning arches and an entirety of three retaining arches are provided at the inventive frame. Consequently, it is preferable to further provide for an entirety of three radially spaced commissure attachment regions, which are connected to the three anchoring/positioning arches and the three retaining arches respectively. In this regard, each first arm of the three anchoring/positioning arches or retaining arches respectively may be connected with a first commissure attachment region, whereas each second arm may be attached to a second neighboring commissure attachment region. In this way, each anchoring position arch and each retaining arch is connected with at least two of the radially spaced commissure attachments of the frame. The provision of three retaining arches is particularly useful when accommodating a valvular prosthesis having three flexible leaflets such as an aortic valve, for example. The same applies to the number of anchoring/positioning arches, which should comply with the number of leaflets of the valvular prosthesis so as to guarantee a suitable orientation of each leaflet at the desired implantation site.


As already indicated, the adjacent arms of two neighboring retaining arches preferably merge at one of the commissure attachment regions, near the outflow end region of the frame. Accordingly, each of the retaining arches is connected to a neighboring retaining arch at one of the commissure attachment regions, forming a circumferentially aligned attachment region for the cusp edges of the valvular prosthesis.


In another embodiment, the cell structure of the frame comprises a first cell region composed of a plurality of first cells, the first cells being arranged between the respective first and second arms of each retaining arch. Additionally, the cell structure may comprise a second cell region composed of a plurality of second cells, the second cells being arranged between adjacent arms of two neighboring retaining arches. In other words, the cell structure is preferably composed of at least two different cell types, which are arranged in an alternating manner radially around a flow axis of the frame. The first and second cell regions are intersected by the respective arms of the retaining arches. Preferably, the first and second cells of the first and second cell regions are constructed with a similar pattern and size. However, it is also conceivable to construct the first and second cells with differently. In particular, it may be desirable to implement a denser cell structure in the second cell region compared to the density of the cell structure in the first cell region. This is because the mainly second cell region provides for the stability of the inventive frame, whereas the first cell region is mainly provided in order to protect the valvular prosthesis from any direct contact with the native heart valves. Of course, however, the first cell region being arranged between the respective first and second arms of each retaining arch, also adds to the stability of the present frame.


In a particularly preferred embodiment, the at least one anchoring/positioning arch particularly radially overlaps the first cell region of the cell structure. In other words, the at least one anchoring/positioning arch is preferably arranged in between the respective first and second arms of each retaining arch, and thus, circumferentially aligned with the retaining arches.


According to another embodiment, each of the first cells or second cells is formed by a plurality of struts. Accordingly, each of the struts is either connected with one of the neighboring cells of the respective cell regions or with one of the arms of the retaining arches respectively. As already indicated above, each of the struts of the first and second cells is preferably formed by a laser cutting of a hollow shaped memory metal tube, providing for integrally connected first and second cells of the frame structure.


As already indicated above, each of the positioning arches and each of the retaining arches include a closed end directed towards the inflow end of the frame, wherein the closed end of a respective anchoring/positioning arch is substantially circumferentially aligned with respect to the closed end of an associated retaining arch. In other words, the positioning arches are configured symmetrically to the retaining arches although preferably disposed somewhat further towards the outflow region of the frame. Moreover, the upper end of the positioning arches may be connected to the upper ends of the associated retaining arches by means of the at least two radially space commissure attachment regions in the outflow region of the frame. In the expanded state of the frame, both, the commissure attachment region and the respective upper end of the positioning and retaining arches spread out so that a radially-acting force is exerted on a blood vessel wall, thereby enabling secure anchoring of the stent at the site of implantation. The circumferentially aligned lower end of the anchoring/positioning arch, on the other hand, spreads out even further than the retaining arches and the cell structure, so as to be able to engage the pockets of the native heart valve, thereby clamping the native heart valve leaflets between the lower of the anchoring/position arch and the lower end of the respective retaining arch.


In another embodiment, the present radially collapsible frame comprises at least one fastening portion by means of which a valvular prosthesis is connected to the frame. The at least one fastening portion preferably extends along the longitudinal axis of the frame and comprises a plurality of fastening holes distributed in a longitudinal direction at a discrete position along the length of the at least one fastening portion. A thread of thin wire may be guided through each fastening hole to secure the valvular prosthesis to the stent. The advantage of this feature is that longitudinal displacement of the valvular relative to the frame is a substantially minimized once implanted and so the prosthesis is not unduly disturbed or weakened as a result of the hearts peristaltic motion.


In addition to fastening holes, the fastening portion may include one or more notches to assist the seating and retaining of suture material. The notches also assist with an even attachment of the prosthesis to the frame and similarly to the fastening holes, minimizing longitudinal displacement of the prosthesis. The fastening portions are preferably formed as an integral part of the retaining arches. Nevertheless, it is also conceivable to implement fastening portions along any of the remaining structures of the inventive frame, such as the commissure attachment regions.


According to another embodiment, the retaining arches have a shape that matches the leaflets of a prosthetic valve attached to the frame, in the expanding state of the frame. This specific design of the respective arms of the retaining arches is unique for catheter delivered valves as it provides for heart valve durability advantages. The so formed arms of the retaining arches for supporting the cusp edge of the leaflets of the valvular prosthesis are attached to the frame across a gap behind the positioning arches and the cell structure respectively.


In order to further increase the support of the frame at the implantation site, the inventive frame may comprise at least one annular collar which is connected to a part of the rounded structure at a distal end section of the respective arms of the retaining arches. That is, the lower end section of each arm of the retaining arches may merge into an annular collar, which provides an additional anchoring measure for the frame. Furthermore, the annular collar may also be connected to the lower end of the second cell region. The annular collar may exhibit a plurality of supporting webs which run parallel to the longitudinal axis of the fame in its collapsed state and are inter-connected by transversal webs. In the expanded state of the frame, however, the supporting webs and the transversal webs of the annular collar may form a rhomboid or serpentine-like annular collar which abuts against the vascular wall of the patient. Therefore, the annular collar serves a supporting body through which the radial forces developing due to the self-expansion are transmitted to the vascular wall. Since a relatively large contact area of the frame interacts with the vascular wall, because of the structure of the annular collar, there may be a decreased risk of injury to artery or the tissue despite the increased radial forces. Moreover, the annular collar may be used to attach a skirt portion of the valvular prosthesis to the inventive frame. In this way, the risk for paravalvular leakage can be substantially reduced.


Each of the supporting webs of the annular collar may further provide for an eyelet as an additional fastening means. In this regard, the eyelets are uniformly distributed around the inflow end section of the frame, thereby providing a more uniform fixation of a valvular prosthesis to the frame. Hence, the risk of an actual displacement of the valvular prosthesis relative to the frame may be reduced.


According to another aspect of the present invention, the lower end section of the annular collar constitute at least one flared or tapered section, in the expanded state of the frame, thereby providing for an improved fixation for the frame in the position of the native cardiac valve and for preventing antegrade migration of the frame having a valvular prosthesis affixed thereto.


Preferably, the annular collar has a flared or tapered section with a radial shape. However, it is also conceivable that the flared or tapered section is not uniform along the circumference of the frame. For example, the annular collar may have a flare only near the location of the positioning arches, wherein no flares are provided near the commissure attachment regions, i.e. the regions in between the two arms of two neighboring position arches.


According to a most advantages embodiment, the annular collar may comprise a flared and a tapered section at the same time. In particular, the upper end of the annular collar, which is connected to the lower end of the retaining arches and to the lower end of the second cell region respectively, may be flared, whereas the lower end of the annular collar, which is located at the inflow end of the frame, may be tapered. In simple terms, the annular collar may have a substantially pear-shaped configuration, which effectively prevents damage to the patient's heart vessel caused by contact with the annular collar. If the present frame is used in order to support the implantation of a prosthetic aortic heart valve, for example, this specific configuration of the annular collar is particularly advantageous. This is because the pear-shaped annular collar prevents the frame from irritating the heart conduction system by stimulating the bundle of his which is located below the natural heart valve annulus, i.e. at the position where the annular collar is supposed to be arranged. By forming the annular collar in a pear-shape, it is possible to exclusively contact the lower region of the native heart valve annulus so as to support the inventive frame at the implantation site. Any region further into the heart chamber, on the other hand, is not affected by the annular collar, as the lower end section is tapered and hence does not contact the walls of the heart chamber at whole.


In another embodiment, the inventive frame has a scalloped inflow edge designed at its distal end when the frame is in its expanded state. Hence, the inflow edge of the frame does not lie entirely in the plane perpendicular to the longitudinal direction of the frame. Rather, the edge of the frame at its inflow end region may have a scalloped shape. In addition, the scalloped inflow edge may also be flared or tapered around its circumference or only at the selected location. For example, one embodiment may include a flare at the inflow edge only near the location of the positioning arches and transition to a none-flared straight cylindrical shape in the area between two neighboring positioning arches. In particular, the location of the respective flares and the respective straight cylindrical shape may be determined by the location of the arms of the respective retaining arches to which the tissue component (s) of the valvular prosthesis is attached. The scalloped shape generally follows the native valve annulus and does not compromise the ability of the valve to seal against leakage.


As will be described in more detail below, when manufacturing the inventive frame, it is conceivable for the frame to exhibit a structure integrally cut from a portion of a hollow tube, in particular from a small metal tube, which incorporates all of the structures of the frame at the same time. Specifically, it is conceivable to use a laser beam to cut the stent structure from the small metal tube.


The small metal tube is most preferably a shape memory material such that the frame exhibits an integrally-formed structure which can transform from a first pre-definable shape into a second pre-definable shape. Therefore, the frame exhibits a first pre-definable shape (collapsed shape) during insertion into the patient's body and a second pre-definable shape (expanded shape) once it is implanted. Because of the frames design, during the transition of the frame from the first pre-definable shape into the second pre-definable shape, the positioning arches and the cell structure radially expand as a function of the cross-sectional expansion of the frame. The frames second shape is preferably selected such that when the frame is expanded, the cell structure abuts against the wall of the blood vessel in which the frame is deployed. In addition, the lower ends of the cell structure which are positioned beneath the native valve annulus, provide additional anchoring of the stent.


When the frame consists of shaped memory material, the material is preferably being designed such that the frame can transform from a temporary shape into a permanent shape under the influence of an external stimulus. In this regard, the temporary shape is the frames first shape (i.e. the collapsed state of the frame) while the permanent shape is assumed in the frames second shape (i.e. in the second state of the frame). In particular, the use of a shape memory material such as Nitinol, i.e. an equiatomic alloy of nickel and titanium, allows for a particularly gentle implantation procedure when implanting the frame. When manufacturing the frame from a shape memory material, the frame structure is preferably shaped after it has been cut into a stent pattern from a hollow tube. As will be described in more detail below, once the desired shape has been formed by bending the structures of the frame, this shape is “fixed”. This process is known as “programming”. Programming may be affected by heating the frame structure, forming the frame into the desired shape and then cooling the frame. Programming may also be affected by forming and shaping the frame structure at low temperatures, this being known as “cold stretching”. The permanent shape is thus saved, enabling the frame to be stored and implanted in a temporary, non-formed shape. If an external stimulus then acts on the stents structure, the shape memory effect is activated and the saved permanent shape is restored.


A particularly preferred embodiment provides for the external stimulus to be a definable switching temperature. It is thus conceivable that the stent material needs to be heated to a higher temperature than the switching temperature in order to activate the shape memory effect and thus regenerate the saved permanent shape of the stent. A specific switching temperature can be preset by the relevant selection of the chemical composition of the shape memory material and the heating time during programming.


It is particularly preferred to set the switching temperature to be in the range of between room temperature and the patient's body temperature. Doing so is of advantage, especially with regard to the medical device being used as an implant in a patient's body. Accordingly, all that needs to be ensured when implanting the frame is that the frame is warmed up to the patient's body temperature (37° C.) at the site of implementation so as to activate the shape memory effect of the frame material.


By means of the inventive frame, a diseased native heart valve may be treated. In this connection a prosthetic valve (valvular prosthesis) is supported on the inventive radially collapsible frame. Thereafter, the at least one anchoring/positioning arch is positioned within a pocket of the native heart valve. Subsequently, at least a portion of the native heart valve is positioned between the at least one anchoring/positioning arch and the plurality of cells of the cell structure. Finally, a radial force is applied against a portion of the vascular wall, by means of the commissure attachment region and the cell structure, for example, so as to fix the frame and the prosthetic valve to the desired implantation site.


As already indicated before, the present invention further relates to an endoprosthesis comprising the inventive radially collapsible frame. The endoprosthesis further includes a valvular prosthesis which is attached to an inner surface of the frame, preferably by means of sutures. The endoprosthesis may be used to treat any deficient heart valve, most preferably a deficient aortic heart valve. Due to the inventive structure of the radially collapsible frame, the endoprosthesis can be fixed securely to the native heart valve annulus and exhibits a particularly high wear resistance.


For the majority of patients undergoing treatment, it is preferable for the endoprosthesis to have an outer diameter of approximately 7.0 mm to approximately 5.0 mm in its first shape so that the valvular prosthesis can be introduced with a 23F delivery system (given an external diameter of 7.0 mm) or with a 17F delivery system (given an external diameter of 5.0 mm).


Due to the new frame design, the inventive endoprosthesis can achieve an outer diameter between approximately 4.0 mm to approximately 8.0 mm in its first shape. Accordingly, the new endoprosthesis may be introduced with a 20F delivery system, preferably an 18F delivery system, more preferably a 16F delivery system and most preferably a 14F delivery system. Therefore, the endoprosthesis according to the present invention can be introduced into a patient's blood vessel easier and causes less damage.


After the endoprosthesis has been released from the catheter tip, in the implanted state respectively, the endoprosthesis exhibits a second predefined shape in which the stent and the valve assembly affixed thereto is in an expanded state (expanded condition). Depending on the patient being treated, it is preferable for the frame to exhibit a diameter of between 19.0 mm and 27.0 mm in its second shape and implanted state.


The present invention further relates to a method for manufacturing a radially collapsible frame according to the present invention. In particular, the inventive method comprises a step for providing a hollow tube made of shaped memory material, followed by a step for scanning a beam of laser radiation over a desired region of the hollow tube, such that a desired pattern is cut into the tube, thereby cutting a stent pattern. In particular, the laser scanning step is configured in such a way that the stent pattern comprises a basic frame cell structure defining a mash, composed of a plurality of cells, each cell being formed by a plurality of struts, and at least one anchoring/positioning arch extending away from the plurality of cells of the cell structure. In other words, by scanning the hollow tube with a beam of laser radiation, a stent pattern is cut out comprising a cell structure and at least one anchoring/positioning arch located above the latter cell structure.


Subsequently, in a shape setting process, the final structure of the radially collapsible frame is defined by bending the at least one anchoring/positioning arch into the direction of the cell structure in such a way that the at least one anchoring/positioning arch extends in substantially the same direction as the plurality of cells of the cell structure. Accordingly, the so bent at least one anchoring/positioning arch radially overlaps the plurality of cells of the cells structure at least partially. As a consequence, the at least one anchoring/positioning arch is radially distanced from the cell structure of the frame. That is, the at least one anchoring/positioning arch is positioned in a radial distance from a flow axis of the frame, which is further than the cell structure.


In order to prevent the beam of laser radiation from cutting two opposite ends of the hollow tube made of shaped memory material at the same time, the step for scanning the metal tube with a beam of laser radiation may include a step for placing the hollow tube on a mandrel. Thus, after cutting one surface of the hollow tube, the beam of laser radiation hits the surface of the mandrel and hence does not affect another opposite part of the hollow tube. In this connection, it should be noted that the cut out stent pattern is removed from the mandrel before the aforementioned shape-setting process of the inventive method is performed.


According to another embodiment of the present method, the shape setting process may apply a heat treatment process to the stent pattern. In more detail, the heat treatment process can be used in order to set the permanent shape of the frame to a shape with an at least partly radially overlapping anchoring/positioning arch. Of course, the permanent shape is configured to be the expanded shape of the inventive collapsible frame. That is, in the temporary shape the frame is flexible and hence can be collapsed in order to be introduced by an insertion device.





The following will make reference to the included drawings and describe preferred embodiments of the frame according to the present invention in greater detail.


Shown are:



FIG. 1 a perspective side view of a first embodiment of the radially collapsible frame according to the present invention, capable of supporting and anchoring a valvular prosthesis, shown in its expanded state;



FIG. 2 a second perspective side view of the frame according to the first embodiment shown in FIG. 1; and



FIG. 3 a flat roll-out view of a preferred embodiment of the cut out stent pattern, which can be used to manufacture a radially collapsible frame in accordance with the present invention.



FIG. 4a a flat roll-out view of a cut out stent pattern without anchoring positioning arches, which can be used to manufacture a radially collapsible frame according to a second embodiment;



FIG. 4b a flat roll-out view of anchoring/positioning arches, which can be used to manufacture a radially collapsible frame according to a second embodiment;



FIG. 4c a flat roll-out view of a second embodiment of the inventive frame, comprising the cut out stent pattern of FIG. 4a and the anchoring/positioning arches of FIG. 4a;



FIG. 5 a flat roll-out view of a third embodiment of the inventive radially collapsible frame.






FIGS. 1 and 2 show a first and second perspective view of a first embodiment of a radially collapsible frame 1 in accordance with the present invention. In this connection, it should be noted that FIGS. 1 and 2 respectively only show the depicted front half of the frame embodiment. In detail, the back half of the depicted frame which includes further commissure attachment regions and cell structures is not depicted in order to ease the understanding of the present invention.


The first embodiment of the inventive radially collapsible frame 1 depicted in FIGS. 1 and 2 comprises an outflow end region 3 at a proximal end of the frame and an inflow end region 2 at a distal end of the frame, opposite the outflow end region 3. If the present collapsible frame 1 is used as a supporting structure for an aortic heart valve replacement, for example, the outflow end region 3 is positioned towards the descending aorta, whereas the inflow end region 2 is located below the native valve annulus, that is, inside the left ventricle of the patient's heart.


As can further be seen from FIGS. 1 and 2, the radially collapsible frame further comprises at least two radially spaced commissure regions 10, 10′, 10″ located at the outflow region 3 of the frame 1. In the depicted embodiment the frame 1 comprises three radially spaced commissure regions, only two of which are depicted due to the fact that the back half is omitted from the respective side views. The commissure attachment regions 10 comprise a commissure attachment portion 12 which is configured to receive commissure edges of prosthetic valve leaflets of a valvular prosthesis. It should be noted that the valvular prosthesis is not shown in FIGS. 1 and 2 in order to improve the visibility of the structures of the inventive collapsible frame. In connection with the attachment of the commissure edges of the prosthetic valve leaflets, the attention is drawn to U.S. Pat. No. 6,460,382 B1, which shows various options for attaching a leaflet to the respective commissure attachment regions.


At the proximal end of the commissure attachment regions 10, 10′, 10″, retaining portions 11, 11′, 11″ are provided. The retaining portions 11, 11′, 11″ may comprise eyelets (not shown) which can be used in order to temporarily attach the inventive frame to a medical insertion device. Alternatively, the retaining portions could be received by grooves of a retaining element attached to the insertion device. The retaining portions 11, 11′, 11″ may comprise the depicted round shape. However, it is also conceivable to form the retaining portions 11, 11′, 11″ in any other shape, such as rectangular or polygonal shapes.


The radially spaced commissure attachment regions 10, 10′, 10″ are connected with each other by means of a cell structure 30 composed of a plurality of lattice cells 31, 31′, 31″, 32, 32′, 32″ which are arranged radially around a flow axis (not shown) of the frame 1. The flow axis of the inventive frame is basically defined by the longitudinal axis of the frame, around which all of the depicted frame structures are disposed circumferentially. As shown, the cell structure 30 is located beneath the radially spaced commissure attachment regions 10, 10′, 10″ and attached with the lower end of the commissure attachment portions 12, 12′, 12″. The commissure attachment portions 12, 12′, 12″ are designed so as to receive commissure edges of the leaflets of a valvular prosthesis. For this reason, the commissure attachment portions 12, 12′, 12″ comprise a plurality of fastening holes (FIG. 3), providing a means for suturing the valvular prosthesis to the frame 1.


The cell structure 30 may be used in order to attach the cusp edges of a valvular prosthesis to the frame. In the depicted embodiment, however, the cell structure 30 functions in order to protect the leaflets of the valvular prosthesis from any contact with the natural heart valve leaflets. In other words, the cell structure 30 may be used as a leaflet guard as will be described in more detail below.


Further to the cell structure 30 and the radially spaced commissure attachment regions 10, 10′, 10″, the inventive frame comprises at least one, in particular three, anchoring/positioning arches 20, 20′, 20″. The anchoring/positioning arches 20, 20′, 20″ radially overlap the cell structure 30 at least partially. In other words, the anchoring/positioning arches 20, 20′, 20″ are positioned at a radial distance from the flow axis, which is further than the radial distance of the cell structure 30 from the flow axis. That is, the anchoring/positioning arches 20, 20′, 20″ extend radially outwards relative to the cell structure 30.


Moreover, each of the positioning arches 20, 20′, 20″ comprises an eyelet 21, 21′, 21″ at a distal end thereof. The eyelets 21, 21′, 21″ may be used in order to carry radiopaque markers (not shown) that help with introducing the inventive frame into a patient's blood vessel.


Each of the at least one anchoring/positioning arches 20, 20′, 20″ is rigidly attached to two neighboring commissure attachment regions 10, 10′, 10″. According to the embodiment shown in FIGS. 1 and 2, the anchoring/positioning arches 20, 20′, 20″ are each formed integrally with two of the radially spaced commissure attachment regions 10, 10′, 10″ so as to form a single piece frame 1.


The first embodiment described by FIGS. 1 and 2 further comprises a plurality of circumferentially arranged retaining arches 40, 40′, 40″. Each of the retaining arches 40, 40′, 40″ comprises a first arm 40a, 40a′, 40a″ joined to a second arm 40b, 40b′, 40b″ at a distal end of the retaining arches 40, 40′, 40″. The two arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ are joined by a rounded structure at the distal end, that is the direction of the inflow section 2 of the frame 1. It should be noted, however, that the retaining arches are completely optional and may be replaced by the cell structure 30 in further embodiments of the present invention. The retaining arches 40, 40′, 40″ provide for a better support of the inventive frame 1 at the desired implantation site and provide for an attachment region for the cusp edge of the leaflets of the valvular prosthesis. In more detail, the cusp edge of a valvular prosthesis can be sutured to the respective arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ of the retaining arches 40, 40′, 40″ by means of threads or wires. In order to improve the attachment of the valvular prosthesis with the arms 40a, 40a′, 40″, 40b, 40b′, 40b″ of the retaining arches 40, 40′, 40″ each of the arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ may comprise a plurality of notches which are arranged substantially along substantially the hole range of the retaining arches 40, 40′, 40″. The notches 41 may further assist the flexibility of the retaining arches 40, 40′, 40″ and hence the retaining arches 40, 40′, 40″ can easily be adapted to the cusp edge of the prosthetic leaflets. In addition or as an alternative to the notches, the retaining arches 40, 40′, 40″ may be provided with a plurality of fastening holes, distributed along the retaining arms 40a, 40a′, 40a″, 40b, 40b′, 40b″.


Particularly shown in FIG. 1 is that the retaining arches 40, 40′, 40″ are circumferentially aligned with the positioning arches 20, 20′, 20″. This is because the native valve leaflets are preferably clamped between the positioning arches 20, 20′, 20″ and the retaining arches 40, 40′, 40″ respectively. For the same reason, the retaining arches 40, 40′, 40″ and the anchoring/positioning arches 20, 20′, 20″ have substantially the same shape, preferably a substantially U- or V-shaped structure.


Adjacent arms of two neighboring retaining arches 40, 40′, 40″ or positioning arches 20, 20′, 20″ merge at one of the commissure attachment regions 10, 10′, 10″, near the outflow end region 3 of the frame. Therefore, the retaining arches 40, 40′, 40″ and the positioning arches 20, 20′, 20″ are connected to each other near the outflow end region 3, particularly via the commissure attachment portions 12, 12′, 12″ of the commissure attachment regions 10, 10′, 10″.


As already mentioned above, the first and second arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ of the retaining arches 40, 40′, 40″ intersect the cell structure 30 of the frame 1 according to the first embodiment. Due to this, the cell structure 30 comprises a first cell region 31 composed of a plurality of first cells, arranged between the respective first and second arms 40a, 40b, 40a′, 40b′, 40a″, 40b″ of each retaining arch 40, 40′, 40″ and a second cell region 32, composed of a plurality of second cells. In contrast to the first cells of the first cell region 31, the second cells of the second cell region 32 are arranged between adjacent arms of two neighboring retaining arches 40, 40′, 40″. One example of the second cells 32, 32′, 32″ can be derived from the perspective side view of FIG. 2. In this regard, the second cell region 32 is located between the first arm 40a of the first retaining arch 40 and the second arm 40b″ of the third retaining arch 40″.


Each of the first cells and/or second cells of the first and second cell region 31, 31′, 31″, 32, 32′, 32″ is formed by a plurality of struts 311, 321 which are connected with retaining arches 40, 40′, 40″ or each other respectively such that an onion-shaped cell structure is formed. The density of the first cell region 31, 31′, 31″ is substantially equal to the density of the second cell region 32, 32′, 32″. Alternatively, it is also feasible to manufacture the frame 1 with first and second cell regions 31, 31′, 31″, 32, 32′, 32″ having different cell densities. In this regard, it is most preferable to construct the cell regions 31, 31′, 31″ in such a way that the density of the second cell region 32, 32′, 32″ is denser than the density of the first cell region 31, 31′, 31″.


The first and second cell regions 31, 31′, 31″ and 32, 32′, 32″ respectively have different functions in the depicted embodiment. The second cell region 32, 32′, 32″, on the one hand, provides for the requisite annular stability of the frame 1. The first cell region 31, 31′, 31″, which is arranged between the two arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ of each respective retaining arm 40, 40′, 40″, on the other hand, is configured as a leaflet guard. That is, the first cell 31, 31′, 31″ region mainly stops the native heart valve leaflets from contacting the leaflets of the valvular prosthesis which can be attached to the inside of the frame 1. Of course, the first cell regions 31, 31′, 31″ also provides for some stability of the inventive frame 1.



FIGS. 1 to 3 further show that the inventive frame 1 may have at least one annular collar 50, which is connected to a lower part of the rounded structure, at the distal end section of each of the retaining arches 40, 40′, 40″. The annular collar 50 provides for an additional support of the frame 1 at the desired implantation site. In addition to the connection with the retaining arms 40, 40′, 40″ the annular collar 50 is connected to each or a few of the lower cells of the second cell region 32, 32′, 32″, which are arranged between adjacent arms 40a, 40a′, 40a″, 40b, 40b′, 40b″ of two neighboring retaining arches 40, 40′, 40″.


The annular collar 50 may constitute at least one flared and/or tapered section of the frame for improving fixation of the frame 1 in the position of the diseased valve of the patient and for preventing antegrade migration of the frame having a prosthetic valve affixed thereto. The embodiment shown in FIGS. 1 and 2 particularly shows that the struts 51 of the annular collar 50 are flared outwardly, so as to constitute a flared section of the frame 1. Another preferred alternative, however, is to construct the annular collar 50 in a substantial pear-shape. In more detail, the pear-shape is represented by a flared upper portion of the annular collar 50, which is connected to the cell structure 30 and the retaining arches 40, 40′, 40″ respectively, and a lower tapered section, which forms the inflow end 2 of the frame 1. In this way, the inflow end 2 of the frame 1 provides the stability of a flared section and is tapered inwardly in order to prevent forth stimulation of the nerves of the heart conduction system.


The particular flared and/or tapered shape of the annular collar 50 is preferably only visible in the expanded state of the frame 1, as can be derived from a comparison of FIGS. 2 and 3. Preferably, the flared or tapered section of the frame has a circular shape. However, according to anther embodiment, the annular collar 50 may only have flared or tapered sections provided near the location of the retaining arches and no flared or tapered sections near the regions in between the two arms of neighboring retaining arches 40, 40′, 40″. The annular collar 50 shown in FIGS. 1 and 2 is constructed of a plurality of struts formed in a rhomboidal shape.



FIG. 3 is a flat roll out view of the frame 1 according to the embodiment depicted in FIGS. 1 and 2. From FIG. 3 it is readily apparent that the frame 1 preferably exhibits a structure, which is integrally cut from a portion of a tube, in particular from a small metal tube. The small metal tube is preferably made of a shape memory material such as Nitinol. Of course, other shape memory materials are equivalently feasibly. FIG. 3 shows the flat roll out view of the frame 1 in its first collapsed mode. Of course, when the frame 1 is being introduced into the patient's body, it is transferred to its second expanded mode, which is illustrated by FIGS. 1 and 2. That is, the frame consists of a shape memory material such that the frame can transform from a temporary shape into a permanent shape under influence of an external stimulus. The temporary shape of the frame corresponds to the first compressed mode of the frame 1 (FIG. 3) and the permanent shape of the frame corresponds to the second expanded mode of the frame 1 (FIGS. 1 and 2).


The external stimulus can be a definable switching temperate bridge, which is preferably in the range of between room temperature and body temperature of the patient, so as to enable the frame 1 to expand as soon as the frame 1 gets in contact with the blood of the patient.


The present invention further relates to a method for manufacturing the radially collapsible frame 1. This method shall be described in more detail with reference to FIG. 3. Firstly a hollow tube made of shape memory material is provided and cut into the stent pattern shown in FIG. 3 by scanning a beam of laser radiation over the desired regions of the hollow tube. The cut out stent pattern of FIG. 3 shows a particularly important aspect, namely that the positioning arches 20, 20′, 20″ are formed above the cell structure 30, the commissure attachment regions 10, 10′, 10″ and the retaining arches 40, 40′, 40″ during the step for laser cutting. This is because, otherwise the positioning arches 20, 20′, 20″ could not be produced at the same time as the first cell region 31, 31′, 31″ of the cell structure 30.


After cutting the stent pattern by means of laser radiation, a shape-setting process is carried out in order to rearrange the direction of the anchoring/positioning arches 20, 20′, 20″. In this way, the final structure of the radially collapsible frame 1, shown in FIGS. 1 and 2 can be produced from a single piece of hollow tube. The shape-setting process includes a step for bending the anchoring/positioning arches 20, 20′, 20″ such that the at least one anchoring/positioning arch 20, 20′, 20″ extends in the same direction as the plurality of cells of the cell structure 30 or the retaining arches 40, 40′, 40″ respectively. In the depicted embodiment, the shape-setting process comprises a step for bending the anchoring/positioning arches 20, 20′, 20″ downward towards the inflow end 2 of the frame 1.


Bending the anchoring/positioning arches 20, 20′, 20″ downward towards the inflow 2 of the inventive frame may be implemented by applying a heat treatment process to the stent pattern. To this end, the stent pattern shown in FIG. 3 is deformed and fixed into the desired shape shown in FIGS. 1 and 2 of the present invention. Subsequently, the shaped stent pattern is heated to temperatures between 400° and 600° C. for several minutes and rapidly cooled down via water quenching or by means of rapid air cooling, for example. In this way, the frame 1 obtains a permanent mode, which is represented by FIGS. 1 and 2 of the present invention, and a temporary mode, which relates to the collapsed mode of the frame. Depending on the time and temperature of the heat treatment, the switching temperature between the temporary and the permanent mode of the frame 1 can be adjusted. According to the present invention, it is preferred to set the shifting temperature to a temperature between room temperature and body temperature of the patient, preferably about 22° C.


A second embodiment of the inventive radially collapsible frame can be derived from FIGS. 4a to 4c. The radially collapsible frame 100 according to the second embodiment is shown in a flat roll-out view in FIG. 4c. Similar to the first embodiment, the second embodiment of the inventive radially collapsible frame 100 comprises an outflow end region 103 at a proximal end of the frame 100 and inflow end region 102 at a distal end of the frame 100, opposite the outflow end region 103. The depicted radially collapsible frame 100 further comprises at least two radially space commissure region 110, 110′, 110″ located at the out flow end region 103 of the frame 100. In particular, the depicted frame 100 comprises three commissure regions 110, 110′, 110″. The commissure attachment regions 110, 110′, 110″ each comprise a commissure attachment portion 112, 112′, 112″ which is configured to receive commissure edges of prosthetic valve leaflet of a valve prosthesis.


The radially commissure attachment regions 110, 110′, 110″ are connected to each other by means of a cell structure which is composed of a plurality of lattice cells which are arranged around a flow axis (not shown) of the frame 100. As shown, the cell structure 130 is located between the radially spaced attachment regions 110, 110′, 110″ and attached with the lower end of the commissure attachment portions 112, 112′, 112″. The commissure attachment portions 112, 112′, 112″ comprise a plurality of fastening holes 113, providing a means for suturing the valvular prosthesis to frame 100. According to the second embodiment, the retaining portions 111, 111′, 111″ are not directly attached to the commissure attachment regions 110, 110′, 110″. Instead, as will be described in more detail below, the retaining portions 111, 111′, 111″ are attached to the anchoring/positioning arches 120, 120′, 120″ of the second embodiment.


Unlike the first embodiment, the inventive frame 100 according to the second embodiment does not comprise any retaining arches. For this reason, the cell structure 130 is used in order to attach the cusp edges of a valvular prosthesis to the frame 100. At the same time, the cell structure 130 of the second embodiment functions in order to protect the leaflets of the valvular prosthesis from any contact with the natural heart valve leaflets. That is, the cell structure 130 may be used as an attachment means and as a leaflet guard at the same time.


Further to the cell structure 130 and the radially spaced commissure attachment regions 110, 110′, 110″, the inventive frame 100 comprises at least one, in particular three, anchoring/positioning arches 120, 120′, 120″. The anchoring/positioning arches 120, 120′, 120″ radially overlap the cell structure 30 at least partially. In other words, the anchoring/positioning arches 120, 120′, 120″ are positioned at a radial distance at a flow axis, which is further than the radial distance of the cell structure 130 from the flow axis. That is, the anchoring/positioning arches 120, 120′, 120″ expand radially outwards relative to the cell structure 130. Each of the three anchoring/position arches 120, 120′, 120″ comprises two arms 120a, 120b, 120a′, 120b′, 120a″, 120b″ which are connected to each other at the inflow end 102 of the frame 100. In general, the anchoring/positioning arches exhibit the same features as the anchoring/positioning arches according to the first embodiment of the frame.


In contrast to the first embodiment, however, the positioning arches 120, 120′, 120″ of the second embodiment are not integrally formed together with the rest of the stent frame, such as the cell structure 130 and the commissure attachment region 110, 110′, 110″, shown in FIG. 4a. Rather, the anchoring/positioning arches 120, 120′, 120″ are manufactured as a separate piece, a roll-out view of which is shown in FIG. 4b. After producing the stent pattern of FIG. 4a and the anchoring/positioning arches 120, 120′, 120″ of FIG. 4b separately, the two parts are connected by means of welding, suturing, gluing or riveting. As can be derived from FIG. 4b, the anchoring/positioning arches 120, 120′, 120″ are most preferably welded to the edges of the commissure attachment regions 110, 110′, 110″ of the frame 100 according to second embodiment.


At the proximal end of the anchoring/positioning arches 120, 120′, 120″, retaining portions 111, 111′, 111″ are provided. The retaining portions 111, 111′, 111″ may comprise eyelets (not shown) which can be used in order to temporarily attach the inventive frame 100 to a medical insertion device. Alternatively, the retaining portions 111, 111′, 111″ could be received by grooves of a retaining element attached to the insertion device. The retaining portions 111, 111′, 111″ may comprise the depicted round shape. However, it is also conceivable to form the retaining portions 111, 111′, 111″ in any other shape, such as rectangular or polygonal shapes.


In order to manufacture the radially collapsible frame 100 of the second embodiment, it is not necessary to bend the anchoring/positioning arches 120, 120′, 120″ downward in a shape-setting process, after the stent pattern has been cut out of a hollow tube. Rather, the anchoring/positioning arches 120, 120′, 120″ are produced individually and attached in a separate manufacturing process step. This alternative manufacturing method has the advantage that no bending processes are introduced into the anchoring/positioning arches 120, 120′, 120″ during the shape setting process.


Finally it should be noted that the inventive frame 100 according to the second embodiment does not comprise a particular annular collar. Instead, the second embodiment of the inventive collapsible frame 100 comprises three additional support structures 140, 140′, 140″ as can be derived from FIGS. 4a and c. The additional support structures 140, 140′, 140″ are located at the inflow end region 102 of the radially collapsible frame 100 according to the second embodiment. Each of the three additional structures 140, 140′, 140″ is attached to a lower end of one of the plurality of the respective cells of the cell structure 130. Preferably, the additional support structure 140, 140′, 140″ are disposed radially around a flow axis of the frame 100 with an angle of about 120° in between two of the additional support structures 140, 140′, 140″. Furthermore, it can be derived from FIGS. 4a and 4c that the additional support structures 140, 140′, 140″ comprise a small rounded shape, so as to contact small areas of the heart valve ventricle below the natural heart valve annulus. Furthermore, the additional support structures 140, 140′, 140″ are preferably flared outward so as to achieve an effect, similar to the effect of the annular collar 40.


A third embodiment of the inventive radially collapsible frame is shown in FIG. 5. In more detail, FIG. 5 shows a flat roll-out view of the third embodiment of the inventive frame 200. The radially collapsible frame 200 according to the third embodiment mostly corresponds to the radially collapsible frame 100 of the second embodiment. The main difference between the frame 100 of the second embodiment and the frame 200 of the third embodiment is the construction of the cell structure 240. Unless stated otherwise, the parts of the frame 200 according to the third embodiment correspond identically to the parts of the frame 100 of the second embodiment. Similar parts were denoted with the reference signs of the second embodiment, wherein the factor “100” was added.


Compared to the cell structure 130 of the second embodiment, the cell structure 230 of the third embodiment comprises a smaller amount of lattice cells in the longitudinal direction of frame 200. In particular, the third embodiment shown in FIG. 5 does not comprise the uppermost row of cells of the cell structure 130 shown in FIG. 4c. Consequently, the frame 200 of the third embodiment has a smaller cell structure 130 which is compensated by a plurality of commissure attachment arms 215a, 215b, 215a′, 215b′, 215a″, 215b″. The commissure attachment arms 215a, 215b, 215a′, 215b′, 215a″, 215b″ are part of the commissure attachment regions 210, 210′, 210″ and configured to attach the commissure attachment portions 212, 112′, 212′ to the upper end of the cell structure 230. In particular, each of the commissure attachment portions 212, 212′, 212″ is attached to the cell structure 230 by means of two respective commissure attachment arms 215a, 215b, 215a′, 215b′, 215a″, 215b″.


Each of the commissure attachment arms 215a, 215b, 215a′, 215b′, 215a″, 215b″ comprises a plurality of notches 241, which have already been described with respect to the embodiment shown in FIGS. 1 to 3. Similar to the arms of the retaining arches according to the first embodiment, the commissure attachment arms 215a, 215b, 215a′, 215b′, 215a″, 215b″ are configured to assist with attaching the cusp edges of a valvular prosthesis to the collapsible frame 200. In particular, the cusp edges of the valvular prosthesis may be sutured to the notches 241 of the commissure attachment arches 215a, 215b, 215a′, 215b′, 215a″, 215b″.


All above mentioned and described embodiments and preferred embodiments will be appreciated by the skilled person to be workable also in other combinations of the features not explicitly described and such combinations will also be within the scope and disclosure of the invention. In particular, the frame of the first embodiment only optionally comprises retaining arches as depicted by the figures. Similar to the second and third embodiment, these retaining arches could be completely replaced by the cell structure, which could be used in order to attach the valvular prosthesis. Furthermore, the inventive frame could comprise more or fewer flared or tapered portions in its longitudinal direction. Finally, it should be noted that the frame is not restricted to the shape memory material Nitinol. Of course, any other suitable shape memory material is feasible especially in view of the bending stresses during the manufacturing as described above.


LIST OF REFERENCES




  • 1, 100, 200 collapsible frame


  • 2, 102, 202 inflow end region


  • 3, 103, 203 outflow end region


  • 10, 10′, 10″ commissure attachment regions


  • 110, 110′, 110


  • 210, 210′, 210


  • 11, 11′, 11″ retaining portions


  • 111, 111′, 111


  • 211, 211′, 211


  • 12, 12′, 12″ commissure attachment portion


  • 112, 112′, 112


  • 212, 212′, 212


  • 20, 20′, 20″ anchoring/positioning arch


  • 120, 120′, 120


  • 20, 220′, 220


  • 20
    a, 20a′, 20a″ first arm of anchoring/positioning arch


  • 120
    a, 120a′, 120a″


  • 220
    a, 220a′, 220a″


  • 20
    b, 20b′, 20b″ second arm of anchoring/positioning arch


  • 120
    b, 120b′, 120b″


  • 220
    b, 220b′, 220b″


  • 21, 121, 221 eyelet of positioning arches


  • 30, 130, 230 cell structure


  • 31, 31′, 31″ first cell region


  • 32, 32′, 32″ second cell region


  • 40, 40′, 40″ retaining arch


  • 40
    a, 40a′, 40a″ first arm of retaining arch


  • 40
    b, 40b′, 40b″ second arm of retaining arch


  • 41, 241 notches


  • 50 annular collar


  • 51 struts of annular collar


  • 113 fastening holes


  • 140, 140′, 140″ additional support structure


  • 240, 240′, 240


  • 215
    a, 215a′, 215a″ first commissure attachment arm


  • 215
    b, 215b′, 215b″ second commissure attachment arm


  • 311 struts of first cell region


  • 321 struts of second cell region


Claims
  • 1. An endoprosthesis comprising: a frame including: at least two commissure regions at an outflow end region of the frame;a plurality of first arches, each first arch including a first arm joined to a second arm;a plurality of second arches; andlattice cells proximal to an outflow end of each first arch and each second arch, the lattice cells comprising a plurality of first cells between the first arm and the second arm of each first arch, and a plurality of second cells between adjacent first arches, wherein the plurality of second arches is radially outward of at least a portion of the plurality of first cells; anda valve prosthesis coupled to the frame.
  • 2. The endoprosthesis of claim 1, wherein the frame includes three commissure regions.
  • 3. The endoprosthesis of claim 1, wherein the frame includes three first arches and three second arches.
  • 4. The endoprosthesis of claim 1, wherein the plurality of first cells is integrally connected to the plurality of second cells.
  • 5. The endoprosthesis of claim 1, wherein the first arm and the second arm of each first arch are joined to one another forming a U-shaped or V-shaped structure.
  • 6. The endoprosthesis of claim 1, wherein a first arch joins an adjacent first arch at one of the at least two commissure regions.
  • 7. The endoprosthesis of claim 1, wherein each of the first arches and each of the second arches has a closed end, and the closed end of each first arch is circumferentially aligned with the closed end of a corresponding second arch.
  • 8. The endoprosthesis of claim 1, wherein at least one first arch of the plurality of first arches includes apertures configured to receive a suture.
  • 9. An endoprosthesis comprising: a frame including: three commissure regions at an outflow end region of the frame;a plurality of first arches, each first arch including a first arm joined to a second arm in a U-shaped or V-shaped structure;a plurality of second arches; andlattice cells comprising a plurality of first cells between the first arm and the second arm of each first arch, and a plurality of second cells between adjacent first arches; anda valve prosthesis coupled to the frame;wherein at least one second arch of the plurality of second arches is radially outward of at least a portion of the plurality of first cells and circumferentially aligned with one of the first arches.
  • 10. The endoprosthesis of claim 9, wherein the plurality of second arches includes exactly three second arches.
  • 11. The endoprosthesis of claim 9, wherein the valve prosthesis is attached to an inner surf ace of the frame via sutures.
  • 12. The endoprosthesis of claim 9, wherein the endoprosthesis has a compressed configuration and an expanded configuration, and an outer diameter of the endoprosthesis in the compressed configuration ranges from 5.0 mm to 7.0 mm.
  • 13. The endoprosthesis of claim 9, wherein the frame includes an annular collar at an inflow end region of the frame.
  • 14. The endoprosthesis of claim 9, wherein the lattice cells are integrally connected to the plurality of first arches and the plurality of second arches.
  • 15. An endoprosthesis comprising: a frame having a compressed configuration and an expanded configuration, the frame including: three commissure regions at an outflow end region of the frame;three first arches, each first arch including a first arm joined to a second arm;three second arches; andlattice cells comprising a plurality of first cells between the first arm and the second arm of each first arch, and a plurality of second cells between adjacent first arches; anda valve prosthesis coupled to an inner surface of the frame;wherein each first arch and each second arch has a closed end, and the closed end of each first arch is circumferentially aligned with the closed end of a corresponding second arch.
  • 16. The endoprosthesis of claim 15, wherein an outer diameter of the frame in the compressed configuration ranges from 5.0 mm to 7.0 mm.
  • 17. The endoprosthesis of claim 15, wherein the frame includes an annular collar at an inflow end region of the frame.
  • 18. The endoprosthesis of claim 15, wherein each first arch joins an adjacent first arch at one of the three commissure regions.
  • 19. The endoprosthesis of claim 15, wherein at least one second arch is radially outward of at least a portion of the plurality of first cells.
  • 20. The endoprosthesis of claim 15, wherein at least one first arch includes apertures.
Priority Claims (1)
Number Date Country Kind
13182346 Aug 2013 EP regional
Parent Case Info

This application is a continuation of U.S. application Ser. No. 15/834,376, filed on Dec. 7, 2017, which is a continuation of U.S. application Ser. No. 14/914,313, filed on Feb. 25, 2016, now U.S. Pat. No. 9,867,694, which is a U.S. national stage filing under 35 U.S.C. § 371 of International Application No. PCT/EP2014/065817, filed on Jul. 23, 2014, which claims the benefit of priority to European Patent Application No. 13182346.0, filed on Aug. 30, 2013. Each of U.S. application Ser. Nos. 14/914,313 and 15/834,376, and International Application No. PCT/EP2014/065817, is incorporated by reference herein in its entirety.

US Referenced Citations (2763)
Number Name Date Kind
15192 Peale Jun 1856 A
388776 Hall Aug 1888 A
944214 Rydquist Dec 1909 A
2121182 Benjamin Jun 1938 A
2669896 Clough Feb 1954 A
2682057 Lord Jun 1954 A
2701559 Cooper Feb 1955 A
2832078 Williams Apr 1958 A
3029819 Edward et al. Apr 1962 A
3099016 Lowell et al. Jul 1963 A
3113586 Edmark, Jr. et al. Dec 1963 A
3130418 Head et al. Apr 1964 A
3143742 Cromie Aug 1964 A
3210836 Johanson et al. Oct 1965 A
3221006 Moore et al. Nov 1965 A
3334629 Cohn Aug 1967 A
3365728 Lowell et al. Jan 1968 A
3367364 Cruz, Jr. et al. Feb 1968 A
3409013 Henry et al. Nov 1968 A
3445916 Schulte et al. May 1969 A
3540431 Mobin-Uddin et al. Nov 1970 A
3548417 Kischer et al. Dec 1970 A
3570014 Hancock et al. Mar 1971 A
3574865 Hamaker Apr 1971 A
3587115 Shiley et al. Jun 1971 A
3592184 Watkins et al. Jul 1971 A
3628535 Ostrowsky et al. Dec 1971 A
3642004 Osthagen et al. Feb 1972 A
3657744 Ersek Apr 1972 A
3671979 Moulopoulos Jun 1972 A
3714671 Edwards et al. Feb 1973 A
3725961 Magovern et al. Apr 1973 A
3755823 Hancock Sep 1973 A
3795246 Sturgeon Mar 1974 A
3839741 Haller Oct 1974 A
3868956 Alfidi et al. Mar 1975 A
3874388 King et al. Apr 1975 A
3983581 Angell et al. Oct 1976 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4056854 Boretos et al. Nov 1977 A
4078268 Possis Mar 1978 A
4084268 Ionescu et al. Apr 1978 A
4106126 Traenkle Aug 1978 A
4106129 Carpentier et al. Aug 1978 A
4118806 Porier et al. Oct 1978 A
4164046 Cooley Aug 1979 A
4182446 Penny Jan 1980 A
4191218 Clark et al. Mar 1980 A
4214587 Sakura, Jr. Jul 1980 A
4215871 Hirsch et al. Aug 1980 A
4222126 Boretos et al. Sep 1980 A
4233690 Akins Nov 1980 A
4261342 Aranguren Duo Apr 1981 A
4263680 Reul et al. Apr 1981 A
4265694 Boretos et al. May 1981 A
4291420 Reul Sep 1981 A
4297749 Davis et al. Nov 1981 A
4319831 Matsui et al. Mar 1982 A
RE30912 Hancock Apr 1982 E
4323358 Lentz et al. Apr 1982 A
4326306 Poler Apr 1982 A
4339831 Johnson Jul 1982 A
4343048 Ross et al. Aug 1982 A
4345340 Rosen Aug 1982 A
4350492 Wright et al. Sep 1982 A
4373216 Klawitter Feb 1983 A
4388735 Ionescu et al. Jun 1983 A
4406022 Roy Sep 1983 A
4423809 Mazzocco Jan 1984 A
4425908 Simon Jan 1984 A
4441215 Kaster Apr 1984 A
4441216 Ionescu et al. Apr 1984 A
4470157 Love Sep 1984 A
4484579 Meno et al. Nov 1984 A
4485816 Krumme Dec 1984 A
4491986 Gabbay Jan 1985 A
4501030 Lane Feb 1985 A
4502488 Degironimo et al. Mar 1985 A
4531943 Van Tassel et al. Jul 1985 A
4535483 Klawitter et al. Aug 1985 A
4546499 Possis et al. Oct 1985 A
4562597 Possis et al. Jan 1986 A
4574803 Storz Mar 1986 A
4580568 Gianturco Apr 1986 A
4592340 Boyles Jun 1986 A
4602911 Ahmadi et al. Jul 1986 A
4605407 Black et al. Aug 1986 A
4610688 Silvestrini et al. Sep 1986 A
4612011 Kautzky Sep 1986 A
4617932 Kornberg Oct 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4643732 Pietsch et al. Feb 1987 A
4647283 Carpentier et al. Mar 1987 A
4648881 Carpentier et al. Mar 1987 A
4655218 Kulik et al. Apr 1987 A
4655771 Wallsten Apr 1987 A
4662885 DiPisa, Jr. May 1987 A
4665906 Jervis May 1987 A
4665918 Garza et al. May 1987 A
4680031 Alonso Jul 1987 A
4681908 Broderick et al. Jul 1987 A
4687483 Fisher et al. Aug 1987 A
4692164 Dzemeshkevich et al. Sep 1987 A
4705516 Barone et al. Nov 1987 A
4710192 Liotta et al. Dec 1987 A
4733665 Palmaz Mar 1988 A
4755181 Igoe Jul 1988 A
4759758 Gabbay Jul 1988 A
4769029 Patel Sep 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4787901 Baykut Nov 1988 A
4796629 Grayzel Jan 1989 A
4797901 Goerne et al. Jan 1989 A
4806595 Noishiki et al. Feb 1989 A
4819751 Shimada et al. Apr 1989 A
4829990 Thuroff et al. May 1989 A
4834755 Silvestrini et al. May 1989 A
4846830 Knoch et al. Jul 1989 A
4851001 Taheri Jul 1989 A
4856516 Hillstead Aug 1989 A
4865600 Carpentier et al. Sep 1989 A
4872874 Taheri Oct 1989 A
4873978 Ginsburg Oct 1989 A
4878495 Grayzel Nov 1989 A
4878906 Lindemann et al. Nov 1989 A
4883458 Shiber Nov 1989 A
4885005 Nashef et al. Dec 1989 A
4909252 Goldberger Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922905 Strecker May 1990 A
4927426 Dretler May 1990 A
4950227 Savin et al. Aug 1990 A
4953553 Tremulis Sep 1990 A
4954126 Wallsten Sep 1990 A
4966604 Reiss Oct 1990 A
4969890 Sugita et al. Nov 1990 A
4979939 Shiber Dec 1990 A
4986830 Owens et al. Jan 1991 A
4994077 Dobben Feb 1991 A
5002556 Ishida et al. Mar 1991 A
5002559 Tower Mar 1991 A
5002566 Carpentier et al. Mar 1991 A
5007896 Shiber Apr 1991 A
5026366 Leckrone Jun 1991 A
5026377 Burton et al. Jun 1991 A
5032128 Alonso Jul 1991 A
5035706 Giantureo et al. Jul 1991 A
5037434 Lane Aug 1991 A
5047041 Samuels Sep 1991 A
5053008 Bajaj Oct 1991 A
5059177 Towne et al. Oct 1991 A
5061273 Yock Oct 1991 A
5061277 Carpentier et al. Oct 1991 A
5064435 Porter Nov 1991 A
5078720 Burton et al. Jan 1992 A
5080668 Bolz et al. Jan 1992 A
5085635 Cragg Feb 1992 A
5089015 Ross Feb 1992 A
5094661 Levy et al. Mar 1992 A
5104399 Lazarus Apr 1992 A
5104407 Lam et al. Apr 1992 A
5108425 Hwang Apr 1992 A
5122154 Rhodes Jun 1992 A
5132473 Furutaka et al. Jul 1992 A
5141494 Danforth et al. Aug 1992 A
5143987 Hansel et al. Sep 1992 A
5147388 Yamazaki Sep 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5159937 Tremulis Nov 1992 A
5161547 Tower Nov 1992 A
5163953 Vince Nov 1992 A
5163955 Love et al. Nov 1992 A
5167628 Boyles Dec 1992 A
5178632 Hanson Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5193546 Shaknovich Mar 1993 A
5197979 Quintero et al. Mar 1993 A
5201757 Heyn et al. Apr 1993 A
5207695 Trout, III May 1993 A
5209741 Spaeth May 1993 A
5211183 Wilson May 1993 A
5215541 Nashef et al. Jun 1993 A
5217481 Barbara Jun 1993 A
5217483 Tower Jun 1993 A
5232445 Bonzel Aug 1993 A
5234447 Kaster et al. Aug 1993 A
5234456 Silvestrini Aug 1993 A
5238004 Sahatjian et al. Aug 1993 A
5258008 Wilk Nov 1993 A
5258023 Reger Nov 1993 A
5258042 Mehta Nov 1993 A
5272909 Nguyen et al. Dec 1993 A
5275580 Yamazaki Jan 1994 A
5279612 Eberhardt Jan 1994 A
5282847 Trescony et al. Feb 1994 A
5287861 Wilk Feb 1994 A
5295958 Shturman Mar 1994 A
5327774 Nguyen et al. Jul 1994 A
5330486 Wilk Jul 1994 A
5330500 Song Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5336258 Quintero et al. Aug 1994 A
5342348 Kaplan Aug 1994 A
5344426 Lau et al. Sep 1994 A
5344427 Cottenceau et al. Sep 1994 A
5344442 Deac Sep 1994 A
5350398 Pavcnik et al. Sep 1994 A
5350399 Erlebacher et al. Sep 1994 A
5352240 Ross Oct 1994 A
5354330 Hanson et al. Oct 1994 A
5360444 Kusuhara Nov 1994 A
5368608 Levy et al. Nov 1994 A
5370685 Stevens Dec 1994 A
5380054 Galvis Jan 1995 A
5387235 Chuter Feb 1995 A
5389096 Aita et al. Feb 1995 A
5389106 Tower Feb 1995 A
5397351 Pavcnik et al. Mar 1995 A
5397355 Marin et al. Mar 1995 A
5409019 Wilk Apr 1995 A
5411552 Andersen et al. May 1995 A
5415633 Lazarus et al. May 1995 A
5425739 Jessen Jun 1995 A
5425762 Muller Jun 1995 A
5429144 Wilk Jul 1995 A
5431676 Dubrul et al. Jul 1995 A
5433723 Lindenberg et al. Jul 1995 A
5443446 Shturman Aug 1995 A
5443449 Buelna Aug 1995 A
5443477 Marin et al. Aug 1995 A
5443495 Buscemi et al. Aug 1995 A
5443499 Schmitt Aug 1995 A
5449384 Johnson Sep 1995 A
5456712 Maginot Oct 1995 A
5456713 Chuter Oct 1995 A
5464449 Ryan et al. Nov 1995 A
5469868 Reger Nov 1995 A
5470320 Tiefenbrun et al. Nov 1995 A
5476506 Lunn Dec 1995 A
5476508 Amstrup Dec 1995 A
5476510 Eberhardt et al. Dec 1995 A
5480423 Ravenscroft et al. Jan 1996 A
5480424 Cox Jan 1996 A
5486193 Bourne et al. Jan 1996 A
5487760 Villafana Jan 1996 A
5489294 McVenes et al. Feb 1996 A
5489297 Duran Feb 1996 A
5489298 Love et al. Feb 1996 A
5496346 Horzewski et al. Mar 1996 A
5499995 Teirstein Mar 1996 A
5500014 Quijano et al. Mar 1996 A
5500015 Deac Mar 1996 A
5507767 Maeda et al. Apr 1996 A
5509930 Love Apr 1996 A
5522881 Lentz Jun 1996 A
5527337 Stack et al. Jun 1996 A
5530949 Koda et al. Jun 1996 A
5534007 St. Germain et al. Jul 1996 A
5540712 Kleshinski et al. Jul 1996 A
5545133 Burns et al. Aug 1996 A
5545209 Roberts et al. Aug 1996 A
5545211 An et al. Aug 1996 A
5545214 Stevens Aug 1996 A
5549665 Vesely et al. Aug 1996 A
5549666 Hata et al. Aug 1996 A
5554119 Harrison et al. Sep 1996 A
5554185 Block et al. Sep 1996 A
5569274 Rapacki et al. Oct 1996 A
5571167 Maginot Nov 1996 A
5571174 Love et al. Nov 1996 A
5571175 Vanney et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573520 Schwartz et al. Nov 1996 A
5575818 Pinchuk Nov 1996 A
5580922 Park et al. Dec 1996 A
5591185 Kilmer et al. Jan 1997 A
5591195 Taheri et al. Jan 1997 A
5593434 Williams Jan 1997 A
5595571 Jaffe et al. Jan 1997 A
5596471 Hanlin Jan 1997 A
5607464 Trescony et al. Mar 1997 A
5607465 Camilli Mar 1997 A
5609626 Quijano et al. Mar 1997 A
5613982 Goldstein Mar 1997 A
5618299 Khosravi et al. Apr 1997 A
5626553 Frassica et al. May 1997 A
5628784 Strecker May 1997 A
5632778 Goldstein May 1997 A
5634942 Chevillon et al. Jun 1997 A
5643278 Wijay Jul 1997 A
5645559 Hachtman et al. Jul 1997 A
5653684 Laptewicz et al. Aug 1997 A
5653745 Trescony et al. Aug 1997 A
5653749 Love et al. Aug 1997 A
5655548 Nelson et al. Aug 1997 A
5662124 Wilk Sep 1997 A
5662671 Barbut et al. Sep 1997 A
5662703 Yurek et al. Sep 1997 A
5665115 Cragg Sep 1997 A
5667523 Bynon et al. Sep 1997 A
5674277 Freitag Oct 1997 A
5674298 Levy et al. Oct 1997 A
5679112 Levy et al. Oct 1997 A
5681345 Euteneuer Oct 1997 A
5682906 Sterman et al. Nov 1997 A
5683451 Lenker et al. Nov 1997 A
5690644 Yurek et al. Nov 1997 A
5693083 Baker et al. Dec 1997 A
5693088 Lazarus Dec 1997 A
5693310 Gries et al. Dec 1997 A
5695498 Tower Dec 1997 A
5697972 Kim et al. Dec 1997 A
5700269 Pinchuk et al. Dec 1997 A
5702368 Stevens et al. Dec 1997 A
5709713 Evans et al. Jan 1998 A
5713917 Leonhardt et al. Feb 1998 A
5713950 Cox Feb 1998 A
5713951 Garrison et al. Feb 1998 A
5713953 Vallana et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5716417 Girard et al. Feb 1998 A
5718725 Sterman et al. Feb 1998 A
5720391 Dohm et al. Feb 1998 A
5720776 Chuter et al. Feb 1998 A
5725549 Lam Mar 1998 A
5725550 Nadal Mar 1998 A
5728068 Leone et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5733267 Del Toro Mar 1998 A
5733325 Robinson et al. Mar 1998 A
5735842 Krueger et al. Apr 1998 A
5746476 Novak et al. May 1998 A
5746709 Rom et al. May 1998 A
5746765 Kleshinski et al. May 1998 A
5746775 Levy et al. May 1998 A
5749890 Shaknovich May 1998 A
5749921 Lenker et al. May 1998 A
5755682 Knudson et al. May 1998 A
5755777 Chuter May 1998 A
5755783 Stobie et al. May 1998 A
5756476 Epstein et al. May 1998 A
5758663 Wilk et al. Jun 1998 A
5766151 Valley et al. Jun 1998 A
5769780 Hata et al. Jun 1998 A
5769812 Stevens et al. Jun 1998 A
5769882 Fogarty et al. Jun 1998 A
5769887 Brown et al. Jun 1998 A
5772609 Nguyen et al. Jun 1998 A
5776188 Shepherd et al. Jul 1998 A
5782809 Umeno et al. Jul 1998 A
5782904 White et al. Jul 1998 A
5795331 Cragg et al. Aug 1998 A
5797946 Chin Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5800456 Maeda et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5800531 Cosgrove et al. Sep 1998 A
5807327 Green et al. Sep 1998 A
5807384 Mueller Sep 1998 A
5807405 Vanney et al. Sep 1998 A
5810836 Hussein et al. Sep 1998 A
5814016 Valley et al. Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5817126 Imran Oct 1998 A
5823956 Roth et al. Oct 1998 A
5824037 Fogarty et al. Oct 1998 A
5824038 Wall Oct 1998 A
5824041 Lenker et al. Oct 1998 A
5824043 Cottone, Jr. Oct 1998 A
5824053 Khosravi et al. Oct 1998 A
5824055 Spiridigliozzi et al. Oct 1998 A
5824056 Rosenberg Oct 1998 A
5824061 Quijano et al. Oct 1998 A
5824063 Cox Oct 1998 A
5824064 Taheri Oct 1998 A
5824071 Nelson et al. Oct 1998 A
5824080 Lamuraglia Oct 1998 A
5829447 Stevens et al. Nov 1998 A
5830222 Makower Nov 1998 A
5840081 Andersen et al. Nov 1998 A
5841382 Walden et al. Nov 1998 A
5843158 Lenker et al. Dec 1998 A
5843161 Solovay Dec 1998 A
5843181 Jaffe et al. Dec 1998 A
5851232 Lois Dec 1998 A
5853419 Imran Dec 1998 A
5853420 Chevillon et al. Dec 1998 A
5855210 Sterman et al. Jan 1999 A
5855597 Jayaraman Jan 1999 A
5855600 Alt Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855602 Angell Jan 1999 A
5860966 Tower Jan 1999 A
5860996 Urban et al. Jan 1999 A
5861024 Rashidi Jan 1999 A
5861028 Angell Jan 1999 A
5865723 Love Feb 1999 A
5868783 Tower Feb 1999 A
5873812 Ciana et al. Feb 1999 A
5873906 Lau et al. Feb 1999 A
5876373 Giba et al. Mar 1999 A
5876419 Carpenter et al. Mar 1999 A
5876434 Flomenblit et al. Mar 1999 A
5876448 Thompson et al. Mar 1999 A
5878751 Hussein et al. Mar 1999 A
5880242 Hu et al. Mar 1999 A
5885228 Rosenman et al. Mar 1999 A
5885238 Stevens et al. Mar 1999 A
5885259 Berg Mar 1999 A
5888201 Stinson et al. Mar 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5891191 Stinson Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5895420 Mirsch, II et al. Apr 1999 A
5899936 Goldstein May 1999 A
5906619 Olson et al. May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5908028 Wilk Jun 1999 A
5908029 Knudson et al. Jun 1999 A
5908451 Yeo Jun 1999 A
5908452 Bokros et al. Jun 1999 A
5910144 Hayashi Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5911752 Dustrude et al. Jun 1999 A
5913842 Boyd et al. Jun 1999 A
5916193 Stevens et al. Jun 1999 A
5922022 Nash et al. Jul 1999 A
5924424 Stevens et al. Jul 1999 A
5925012 Murphy-Chutorian et al. Jul 1999 A
5925063 Khosravi Jul 1999 A
5928281 Huynh et al. Jul 1999 A
5931848 Saadat Aug 1999 A
5935119 Guy et al. Aug 1999 A
5935161 Robinson et al. Aug 1999 A
5935163 Gabbay Aug 1999 A
5938632 Ellis Aug 1999 A
5938697 Killion et al. Aug 1999 A
5941908 Goldsteen et al. Aug 1999 A
5944019 Knudson et al. Aug 1999 A
5944738 Amplatz et al. Aug 1999 A
5104407 Lam et al. Sep 1999 B1
5948017 Taheri Sep 1999 A
5954764 Parodi Sep 1999 A
5954766 Zadno-Azizi et al. Sep 1999 A
5957949 Leonhardt et al. Sep 1999 A
5961549 Nguyen et al. Oct 1999 A
5964405 Benary et al. Oct 1999 A
5964798 Imran Oct 1999 A
5968064 Selmon et al. Oct 1999 A
5968068 Dehdashtian et al. Oct 1999 A
5968070 Bley et al. Oct 1999 A
5971993 Hussein et al. Oct 1999 A
5975949 Holliday et al. Nov 1999 A
5976153 Fischell et al. Nov 1999 A
5976155 Foreman et al. Nov 1999 A
5976174 Ruiz Nov 1999 A
5976178 Goldsteen et al. Nov 1999 A
5976192 McIntyre et al. Nov 1999 A
5976650 Campbell et al. Nov 1999 A
5979455 Maginot Nov 1999 A
5980455 Daniel et al. Nov 1999 A
5980533 Holman Nov 1999 A
5980548 Evans et al. Nov 1999 A
5984956 Tweden et al. Nov 1999 A
5984957 Laptewicz, Jr. et al. Nov 1999 A
5984959 Robertson et al. Nov 1999 A
5984964 Roberts et al. Nov 1999 A
5987344 West Nov 1999 A
5989276 Houser et al. Nov 1999 A
5989287 Yang et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5993481 Marcade et al. Nov 1999 A
5997525 March et al. Dec 1999 A
5997557 Barbut et al. Dec 1999 A
5997563 Kretzers Dec 1999 A
5997573 Quijano et al. Dec 1999 A
5999678 Murphy-Chutorian et al. Dec 1999 A
6001123 Lau Dec 1999 A
6001126 Nguyen-Thien-Nhon Dec 1999 A
6004261 Sinofsky et al. Dec 1999 A
6004347 McNamara et al. Dec 1999 A
6004348 Banas et al. Dec 1999 A
6007543 Ellis et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6010522 Barbut et al. Jan 2000 A
6010530 Goicoechea Jan 2000 A
6010531 Donlon et al. Jan 2000 A
6012457 Lesh Jan 2000 A
6013854 Moriuchi Jan 2000 A
6015431 Thornton et al. Jan 2000 A
5061277 Carpentier et al. Feb 2000 B1
6019777 MacKenzie Feb 2000 A
6019778 Wilson et al. Feb 2000 A
6022370 Tower Feb 2000 A
6026814 LaFontaine et al. Feb 2000 A
6027476 Sterman et al. Feb 2000 A
6027520 Tsugita et al. Feb 2000 A
6027525 Suh et al. Feb 2000 A
6029671 Stevens et al. Feb 2000 A
6029672 Vanney et al. Feb 2000 A
6033582 Lee et al. Mar 2000 A
6035856 LaFontaine et al. Mar 2000 A
6036677 Javier, Jr. et al. Mar 2000 A
6036697 DiCaprio Mar 2000 A
6042554 Rosenman et al. Mar 2000 A
6042581 Ryan et al. Mar 2000 A
6042589 Marianne Mar 2000 A
6042598 Tsugita et al. Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6045565 Ellis et al. Apr 2000 A
6051014 Jang Apr 2000 A
6051104 Oriaran et al. Apr 2000 A
6053924 Hussein Apr 2000 A
6053942 Eno et al. Apr 2000 A
6056743 Ellis et al. May 2000 A
6059809 Amor et al. May 2000 A
6059827 Fenton, Jr. May 2000 A
6066160 Colvin et al. May 2000 A
6067988 Mueller May 2000 A
6068638 Makower May 2000 A
6071292 Makower et al. Jun 2000 A
6074416 Berg et al. Jun 2000 A
6074417 Peredo Jun 2000 A
6074418 Buchanan et al. Jun 2000 A
6076529 Vanney et al. Jun 2000 A
6076742 Benary Jun 2000 A
6077297 Robinson et al. Jun 2000 A
6079414 Roth Jun 2000 A
6080163 Hussein et al. Jun 2000 A
6080170 Nash et al. Jun 2000 A
6083257 Taylor et al. Jul 2000 A
6091042 Benary Jul 2000 A
6092526 LaFontaine et al. Jul 2000 A
6092529 Cox Jul 2000 A
6093166 Knudson et al. Jul 2000 A
6093177 Javier, Jr. et al. Jul 2000 A
6093185 Ellis et al. Jul 2000 A
6093203 Uflacker Jul 2000 A
6093530 McIlroy et al. Jul 2000 A
6096074 Pedros Aug 2000 A
6102941 Tweden et al. Aug 2000 A
6102944 Huynh et al. Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110191 Dehdashtian et al. Aug 2000 A
6110198 Fogarty et al. Aug 2000 A
6110201 Quijano et al. Aug 2000 A
6113612 Swanson et al. Sep 2000 A
6113630 Vanney et al. Sep 2000 A
6113823 Eno Sep 2000 A
6117169 Moe Sep 2000 A
6120520 Saadat et al. Sep 2000 A
6120534 Ruiz Sep 2000 A
6123682 Knudson et al. Sep 2000 A
6123723 Konya et al. Sep 2000 A
6125852 Stevens et al. Oct 2000 A
6126649 Vantassel et al. Oct 2000 A
6126654 Giba et al. Oct 2000 A
6126685 Lenker et al. Oct 2000 A
6126686 Badylak et al. Oct 2000 A
6132451 Payne et al. Oct 2000 A
6132473 Williams et al. Oct 2000 A
6132986 Pathak et al. Oct 2000 A
6139510 Palermo Oct 2000 A
6139541 Vanney et al. Oct 2000 A
6142987 Tsugita Nov 2000 A
6143021 Staehle Nov 2000 A
6143987 Makita Nov 2000 A
6146366 Schachar Nov 2000 A
6146415 Fitz Nov 2000 A
6146417 Ischinger Nov 2000 A
6152937 Peterson et al. Nov 2000 A
6152956 Pierce Nov 2000 A
6155264 Ressemann et al. Dec 2000 A
6156031 Aita et al. Dec 2000 A
6156055 Ravenscroft Dec 2000 A
6156531 Pathak et al. Dec 2000 A
6157852 Selmon et al. Dec 2000 A
6159225 Makower Dec 2000 A
6159239 Greenhalgh Dec 2000 A
6162208 Hipps Dec 2000 A
6162245 Jayaraman Dec 2000 A
6165185 Shennib et al. Dec 2000 A
6165188 Saadat et al. Dec 2000 A
6165200 Tsugita et al. Dec 2000 A
6165209 Patterson et al. Dec 2000 A
6167605 Morales Jan 2001 B1
6168579 Tsugita Jan 2001 B1
6168614 Andersen et al. Jan 2001 B1
6168616 Brown, III Jan 2001 B1
6171251 Mueller et al. Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6171335 Wheatley et al. Jan 2001 B1
6177514 Pathak et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6182664 Cosgrove Feb 2001 B1
6182668 Tweden et al. Feb 2001 B1
6183481 Lee et al. Feb 2001 B1
6186972 Nelson et al. Feb 2001 B1
6187016 Hedges et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6190393 Bevier et al. Feb 2001 B1
6190405 Culombo et al. Feb 2001 B1
6193726 Vanney Feb 2001 B1
6193734 Bolduc et al. Feb 2001 B1
6196230 Hall et al. Mar 2001 B1
6197050 Eno et al. Mar 2001 B1
6197053 Cosgrove et al. Mar 2001 B1
6197296 Davies et al. Mar 2001 B1
6197324 Crittenden Mar 2001 B1
6200311 Danek et al. Mar 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6203550 Olson Mar 2001 B1
6203556 Evans et al. Mar 2001 B1
6206888 Bicek et al. Mar 2001 B1
6206911 Milo Mar 2001 B1
6210408 Chandrasekaran et al. Apr 2001 B1
6210957 Carpentier et al. Apr 2001 B1
6213126 LaFontaine et al. Apr 2001 B1
6214036 Letendre et al. Apr 2001 B1
6214041 Tweden et al. Apr 2001 B1
6214054 Cunanan et al. Apr 2001 B1
6214055 Simionescu et al. Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217549 Selmon et al. Apr 2001 B1
6217575 DeVore et al. Apr 2001 B1
6217609 Haverkost Apr 2001 B1
6218662 Tchakarov et al. Apr 2001 B1
6221006 Dubrul et al. Apr 2001 B1
6221049 Selmon et al. Apr 2001 B1
6221091 Khosravi Apr 2001 B1
6221096 Aiba et al. Apr 2001 B1
6221100 Strecker Apr 2001 B1
6223752 Vanney et al. May 2001 B1
6224584 March et al. May 2001 B1
6231544 Tsugita et al. May 2001 B1
6231546 Milo et al. May 2001 B1
6231551 Barbut May 2001 B1
6231587 Makower May 2001 B1
6231602 Carpentier et al. May 2001 B1
6235000 Milo et al. May 2001 B1
6237607 Vanney et al. May 2001 B1
6238406 Ellis et al. May 2001 B1
6241667 Vetter et al. Jun 2001 B1
6241738 Dereume Jun 2001 B1
6241741 Duhaylongsod et al. Jun 2001 B1
6241757 An et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6245103 Stinson Jun 2001 B1
6245105 Nguyen et al. Jun 2001 B1
6248112 Gambale et al. Jun 2001 B1
6248116 Chevillon et al. Jun 2001 B1
6250305 Tweden Jun 2001 B1
6251079 Gambale et al. Jun 2001 B1
6251104 Kesten et al. Jun 2001 B1
6251116 Shennib et al. Jun 2001 B1
6251135 Stinson et al. Jun 2001 B1
6251418 Ahern et al. Jun 2001 B1
6253768 Wilk Jul 2001 B1
6253769 LaFontaine et al. Jul 2001 B1
6254564 Wilk et al. Jul 2001 B1
6254635 Schroeder et al. Jul 2001 B1
6254636 Peredo Jul 2001 B1
6257634 Wei Jul 2001 B1
6258052 Milo Jul 2001 B1
6258087 Edwards et al. Jul 2001 B1
6258114 Konya et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258119 Hussein et al. Jul 2001 B1
6258120 McKenzie et al. Jul 2001 B1
6258129 Dybdal et al. Jul 2001 B1
6258150 MacKellar Jul 2001 B1
6261304 Hall et al. Jul 2001 B1
6267783 Letendre et al. Jul 2001 B1
6269819 Oz et al. Aug 2001 B1
6270513 Tsugita et al. Aug 2001 B1
6270521 Fischell et al. Aug 2001 B1
6270526 Cox Aug 2001 B1
6273876 Klima et al. Aug 2001 B1
6273895 Pinchuk et al. Aug 2001 B1
6276661 Laird Aug 2001 B1
6277555 Duran et al. Aug 2001 B1
6283127 Sterman et al. Sep 2001 B1
6283951 Flaherty et al. Sep 2001 B1
6283983 Makower et al. Sep 2001 B1
6283995 Moe et al. Sep 2001 B1
6285903 Rosenthal et al. Sep 2001 B1
6287317 Makower et al. Sep 2001 B1
6287334 Moll et al. Sep 2001 B1
6287338 Sarnowski et al. Sep 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6290709 Ellis et al. Sep 2001 B1
6290728 Phelps et al. Sep 2001 B1
6296662 Caffey Oct 2001 B1
6299637 Shaolian et al. Oct 2001 B1
6302875 Makower et al. Oct 2001 B1
6302892 Wilk Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6306164 Kujawski Oct 2001 B1
6309382 Garrison et al. Oct 2001 B1
6309417 Spence et al. Oct 2001 B1
6311693 Sterman et al. Nov 2001 B1
6312465 Griffin et al. Nov 2001 B1
6319281 Patel Nov 2001 B1
6322548 Payne et al. Nov 2001 B1
6322593 Pathak et al. Nov 2001 B1
6325067 Sterman et al. Dec 2001 B1
6327772 Zadno-Azizi et al. Dec 2001 B1
6330884 Kim Dec 2001 B1
6331189 Wolinsky et al. Dec 2001 B1
6334873 Lane et al. Jan 2002 B1
6336934 Gilson et al. Jan 2002 B1
6336937 Vonesh et al. Jan 2002 B1
6338735 Stevens Jan 2002 B1
6338740 Carpentier Jan 2002 B1
6342070 Nguyen-Thien-Nhon Jan 2002 B1
6344044 Fulkerson et al. Feb 2002 B1
6346074 Roth Feb 2002 B1
6346116 Brooks et al. Feb 2002 B1
6348063 Yassour et al. Feb 2002 B1
6350248 Knudson et al. Feb 2002 B1
6350277 Kocur Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6352547 Brown et al. Mar 2002 B1
6352554 De Paulis Mar 2002 B2
6352708 Duran et al. Mar 2002 B1
6357104 Myers Mar 2002 B1
6358277 Duran Mar 2002 B1
6361519 Knudson et al. Mar 2002 B1
6361545 Macoviak et al. Mar 2002 B1
6363938 Saadat et al. Apr 2002 B2
6363939 Wilk Apr 2002 B1
6364895 Greenhalgh Apr 2002 B1
6368338 Konya et al. Apr 2002 B1
6371970 Khosravi et al. Apr 2002 B1
6371983 Lane Apr 2002 B1
6375615 Flaherty et al. Apr 2002 B1
6378221 Ekholm, Jr. et al. Apr 2002 B1
6379319 Garibotto et al. Apr 2002 B1
6379365 Diaz Apr 2002 B1
6379372 Dehdashtian et al. Apr 2002 B1
6379383 Palmaz et al. Apr 2002 B1
6379740 Rinaldi et al. Apr 2002 B1
6380457 Yurek et al. Apr 2002 B1
6383193 Cathcart et al. May 2002 B1
6387119 Wolf et al. May 2002 B2
6387122 Cragg May 2002 B1
6390098 LaFontaine et al. May 2002 B1
6391051 Sullivan, III et al. May 2002 B2
6391538 Vyavahare et al. May 2002 B1
6395208 Herweck et al. May 2002 B1
6398807 Chouinard et al. Jun 2002 B1
6401720 Stevens et al. Jun 2002 B1
6402736 Brown et al. Jun 2002 B1
6402740 Ellis et al. Jun 2002 B1
6406488 Tweden et al. Jun 2002 B1
6406491 Vanney Jun 2002 B1
6406493 Tu et al. Jun 2002 B1
6409697 Eno et al. Jun 2002 B2
6409750 Hyodoh et al. Jun 2002 B1
6409751 Hall et al. Jun 2002 B1
6409755 Vrba Jun 2002 B1
6409759 Peredo Jun 2002 B1
6413275 Nguyen et al. Jul 2002 B1
6416490 Ellis et al. Jul 2002 B1
6416510 Altman et al. Jul 2002 B1
6423089 Gingras et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6432119 Saadat Aug 2002 B1
6432126 Gambale et al. Aug 2002 B1
6432127 Kim et al. Aug 2002 B1
6432132 Cottone et al. Aug 2002 B1
6440164 DiMatteo et al. Aug 2002 B1
6443158 LaFontaine et al. Sep 2002 B1
6447522 Gambale et al. Sep 2002 B2
6447539 Nelson et al. Sep 2002 B1
6451025 Jervis Sep 2002 B1
6451054 Stevens Sep 2002 B1
6454760 Vanney Sep 2002 B2
6454794 Knudson et al. Sep 2002 B1
6454799 Schreck Sep 2002 B1
6458092 Gambale et al. Oct 2002 B1
6458140 Akin et al. Oct 2002 B2
6458153 Bailey et al. Oct 2002 B1
6458323 Boekstegers Oct 2002 B1
6461382 Cao Oct 2002 B1
6464709 Shennib et al. Oct 2002 B1
6468303 Amplatz et al. Oct 2002 B1
6468660 Ogle et al. Oct 2002 B2
6471723 Ashworth et al. Oct 2002 B1
6475169 Ferrera Nov 2002 B2
6475226 Belef et al. Nov 2002 B1
6475239 Campbell et al. Nov 2002 B1
6475244 Herweck et al. Nov 2002 B2
6478819 Moe Nov 2002 B2
6479079 Pathak et al. Nov 2002 B1
6482220 Mueller Nov 2002 B1
6482228 Norred Nov 2002 B1
6485501 Green Nov 2002 B1
6485502 Don Michael et al. Nov 2002 B2
6485513 Fan Nov 2002 B1
6485524 Strecker Nov 2002 B2
6487581 Spence et al. Nov 2002 B1
6488704 Connelly et al. Dec 2002 B1
6491689 Ellis et al. Dec 2002 B1
6491707 Makower et al. Dec 2002 B2
6494211 Boyd et al. Dec 2002 B1
6494897 Sterman et al. Dec 2002 B2
6494909 Greenhalgh Dec 2002 B2
6503272 Duerig et al. Jan 2003 B2
6508496 Huang Jan 2003 B1
6508803 Horikawa et al. Jan 2003 B1
6508825 Selmon et al. Jan 2003 B1
6508833 Pavcnik et al. Jan 2003 B2
6509145 Torrianni Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6511491 Grudem et al. Jan 2003 B2
6514217 Selmon et al. Feb 2003 B1
6514271 Evans et al. Feb 2003 B2
6517527 Gambale et al. Feb 2003 B2
6517558 Gittings et al. Feb 2003 B2
6517573 Pollock et al. Feb 2003 B1
6521179 Girardot et al. Feb 2003 B1
6524323 Nash et al. Feb 2003 B1
6524335 Hartley et al. Feb 2003 B1
6527800 McGuckin, Jr. et al. Mar 2003 B1
6530949 Konya et al. Mar 2003 B2
6530952 Vesely Mar 2003 B2
6533807 Wolinsky et al. Mar 2003 B2
6537297 Tsugita et al. Mar 2003 B2
6537310 Palmaz et al. Mar 2003 B1
6540768 Diaz et al. Apr 2003 B1
6540782 Snyders Apr 2003 B1
6544230 Flaherty et al. Apr 2003 B1
6547827 Carpentier et al. Apr 2003 B2
6551303 Van Tassel et al. Apr 2003 B1
6558318 Daniel et al. May 2003 B1
6558417 Peredo May 2003 B2
6558418 Carpentier et al. May 2003 B2
6558429 Taylor May 2003 B2
6559132 Holmer May 2003 B1
6561998 Roth et al. May 2003 B1
6562031 Chandrasekaran et al. May 2003 B2
6562058 Seguin et al. May 2003 B2
6562063 Euteneuer et al. May 2003 B1
6562069 Cai et al. May 2003 B2
6564805 Garrison et al. May 2003 B2
6565528 Mueller May 2003 B1
6565594 Herweck et al. May 2003 B1
6569145 Shmulewitz et al. May 2003 B1
6569147 Evans et al. May 2003 B1
6569196 Vesely May 2003 B1
6572642 Rinaldi et al. Jun 2003 B2
6572643 Gharibadeh Jun 2003 B1
6572652 Shaknovich Jun 2003 B2
6575168 LaFontaine et al. Jun 2003 B2
6579311 Makower Jun 2003 B1
6582444 Wilk Jun 2003 B2
6582460 Cryer Jun 2003 B1
6582462 Andersen et al. Jun 2003 B1
6585756 Strecker Jul 2003 B1
6585758 Chouinard et al. Jul 2003 B1
6585766 Huynh et al. Jul 2003 B1
6589279 Anderson et al. Jul 2003 B1
6592546 Barbut et al. Jul 2003 B1
6592614 Lenker et al. Jul 2003 B2
6599304 Selmon et al. Jul 2003 B1
6600803 Bruder et al. Jul 2003 B2
6605053 Kamm et al. Aug 2003 B1
6605112 Moll et al. Aug 2003 B1
6605113 Wilk Aug 2003 B2
6608040 Lin et al. Aug 2003 B1
6610077 Hancock et al. Aug 2003 B1
6610085 Lazarus Aug 2003 B1
6610100 Phelps et al. Aug 2003 B2
6613069 Boyd et al. Sep 2003 B2
6613077 Gilligan et al. Sep 2003 B2
6613079 Wolinsky et al. Sep 2003 B1
6613081 Kim et al. Sep 2003 B2
6613086 Moe et al. Sep 2003 B1
6616675 Evard et al. Sep 2003 B1
6616682 Joergensen et al. Sep 2003 B2
6622604 Chouinard et al. Sep 2003 B1
6623491 Thompson Sep 2003 B2
6623518 Thompson et al. Sep 2003 B2
6623521 Steinke et al. Sep 2003 B2
6626938 Butaric et al. Sep 2003 B1
6626939 Burnside et al. Sep 2003 B1
6632241 Hancock et al. Oct 2003 B1
6632243 Zadno-Azizi et al. Oct 2003 B1
6632470 Morra et al. Oct 2003 B2
6635068 Dubrul et al. Oct 2003 B1
6635079 Unsworth et al. Oct 2003 B2
6635080 Lauterjung et al. Oct 2003 B1
6635085 Caffey et al. Oct 2003 B1
6638237 Guiles et al. Oct 2003 B1
6638247 Selmon et al. Oct 2003 B1
6638293 Makower et al. Oct 2003 B1
6641610 Wolf et al. Nov 2003 B2
6651670 Rapacki et al. Nov 2003 B2
6651672 Roth Nov 2003 B2
6652540 Cole et al. Nov 2003 B1
6652546 Nash et al. Nov 2003 B1
6652555 Vantassel et al. Nov 2003 B1
6652571 White et al. Nov 2003 B1
6652578 Bailey et al. Nov 2003 B2
6655386 Makower et al. Dec 2003 B1
6656213 Solem Dec 2003 B2
6660003 DeVore et al. Dec 2003 B1
6660024 Flaherty et al. Dec 2003 B1
6663588 DuBois et al. Dec 2003 B2
6663663 Kim et al. Dec 2003 B2
6663667 Dehdashtian et al. Dec 2003 B2
6666863 Wentzel et al. Dec 2003 B2
6669709 Cohn et al. Dec 2003 B1
6669724 Park et al. Dec 2003 B2
6673089 Yassour et al. Jan 2004 B1
6673101 Fitzgerald et al. Jan 2004 B1
6673106 Mitelberg et al. Jan 2004 B2
6673109 Cox Jan 2004 B2
6676668 Mercereau et al. Jan 2004 B2
6676692 Rabkin et al. Jan 2004 B2
6676693 Belding et al. Jan 2004 B1
6676698 McGuckin, Jr. et al. Jan 2004 B2
6679268 Stevens et al. Jan 2004 B2
6682543 Barbut et al. Jan 2004 B2
6682558 Tu et al. Jan 2004 B2
6682559 Myers et al. Jan 2004 B2
6685648 Flaherty et al. Feb 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6689144 Gerberding Feb 2004 B2
6689164 Seguin Feb 2004 B1
6692512 Jang Feb 2004 B2
6692513 Streeter et al. Feb 2004 B2
6694983 Wolf et al. Feb 2004 B2
6695864 Macoviak et al. Feb 2004 B2
6695865 Boyle et al. Feb 2004 B2
6695875 Stelter et al. Feb 2004 B2
6695878 McGuckin, Jr. et al. Feb 2004 B2
6699274 Stinson Mar 2004 B2
6701932 Knudson et al. Mar 2004 B2
6702851 Chinn et al. Mar 2004 B1
6709425 Gambale et al. Mar 2004 B2
6709444 Makower Mar 2004 B1
6712842 Gifford, III et al. Mar 2004 B1
6712843 Elliott Mar 2004 B2
6714842 Ito Mar 2004 B1
6719770 Laufer et al. Apr 2004 B2
6719787 Cox Apr 2004 B2
6719788 Cox Apr 2004 B2
6719789 Cox Apr 2004 B2
6723116 Taheri Apr 2004 B2
6723122 Yang et al. Apr 2004 B2
6726677 Flaherty et al. Apr 2004 B1
6729356 Baker et al. May 2004 B1
6730118 Spenser et al. May 2004 B2
6730121 Ortiz et al. May 2004 B2
6730377 Wang May 2004 B2
6733513 Boyle et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6736827 McAndrew et al. May 2004 B1
6736839 Cummings May 2004 B2
6736845 Marquez et al. May 2004 B2
6736846 Cox May 2004 B2
6743252 Bates et al. Jun 2004 B1
6746464 Makower Jun 2004 B1
6752828 Thornton Jun 2004 B2
6755854 Gillick et al. Jun 2004 B2
6755855 Yurek et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6764503 Ishimaru Jul 2004 B1
6764509 Chinn et al. Jul 2004 B2
6767345 St. Germain et al. Jul 2004 B2
6767362 Schreck Jul 2004 B2
6769434 Liddicoat et al. Aug 2004 B2
6773454 Wholey et al. Aug 2004 B2
6773455 Allen et al. Aug 2004 B2
6773456 Gordon et al. Aug 2004 B1
6774278 Ragheb et al. Aug 2004 B1
6776791 Stallings et al. Aug 2004 B1
6786925 Schoon et al. Sep 2004 B1
6786929 Gambale et al. Sep 2004 B2
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6790237 Stinson Sep 2004 B2
6792979 Konya et al. Sep 2004 B2
6797000 Simpson et al. Sep 2004 B2
6797002 Spence et al. Sep 2004 B2
6802319 Stevens et al. Oct 2004 B2
6802858 Gambale et al. Oct 2004 B2
6805711 Quijano et al. Oct 2004 B2
6808498 Laroya et al. Oct 2004 B2
6808504 Schorgl et al. Oct 2004 B2
6808529 Fulkerson Oct 2004 B2
6814746 Thompson et al. Nov 2004 B2
6814754 Greenhalgh Nov 2004 B2
6820676 Palmaz et al. Nov 2004 B2
6821211 Otten et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824041 Grieder et al. Nov 2004 B2
6824970 Vyavahare et al. Nov 2004 B2
6830568 Kesten et al. Dec 2004 B1
6830575 Stenzel et al. Dec 2004 B2
6830584 Seguin Dec 2004 B1
6830585 Artof et al. Dec 2004 B1
6830586 Quijano et al. Dec 2004 B2
6837901 Rabkin et al. Jan 2005 B2
6837902 Nguyen et al. Jan 2005 B2
6840957 DiMatteo et al. Jan 2005 B2
6843802 Villalobos et al. Jan 2005 B1
6846325 Liddicoat Jan 2005 B2
6849084 Rabkin et al. Feb 2005 B2
6849085 Marton Feb 2005 B2
6854467 Boekstegers Feb 2005 B2
6860898 Stack et al. Mar 2005 B2
6861211 Levy et al. Mar 2005 B2
6863668 Gillespie et al. Mar 2005 B2
6863684 Kim et al. Mar 2005 B2
6863688 Ralph et al. Mar 2005 B2
6866650 Stevens et al. Mar 2005 B2
6866669 Buzzard et al. Mar 2005 B2
6872223 Roberts et al. Mar 2005 B2
6872226 Cali et al. Mar 2005 B2
6875231 Anduiza et al. Apr 2005 B2
6881199 Wilk et al. Apr 2005 B2
6881220 Edwin et al. Apr 2005 B2
6883522 Spence et al. Apr 2005 B2
6887266 Williams et al. May 2005 B2
6890330 Streeter et al. May 2005 B2
6890340 Duane May 2005 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6896690 Lambrecht et al. May 2005 B1
6899704 Sterman et al. May 2005 B2
6905743 Chen et al. Jun 2005 B1
6908481 Cribier Jun 2005 B2
6911036 Douk et al. Jun 2005 B2
6911040 Johnson et al. Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6913021 Knudson et al. Jul 2005 B2
6913600 Valley et al. Jul 2005 B2
6916304 Eno et al. Jul 2005 B2
6920674 Thornton Jul 2005 B2
6920732 Mårtensson Jul 2005 B2
6926690 Renati Aug 2005 B2
6926732 Derus et al. Aug 2005 B2
6929009 Makower et al. Aug 2005 B2
6929011 Knudson et al. Aug 2005 B2
6929653 Strecter Aug 2005 B2
6936058 Forde et al. Aug 2005 B2
6936066 Palmaz et al. Aug 2005 B2
6936067 Buchanan Aug 2005 B2
6939352 Buzzard et al. Sep 2005 B2
6939359 Tu et al. Sep 2005 B2
6939365 Fogarty et al. Sep 2005 B1
6939370 Hartley et al. Sep 2005 B2
6942682 Vrba et al. Sep 2005 B2
6945949 Wilk Sep 2005 B2
6945997 Huynh et al. Sep 2005 B2
6949080 Wolf et al. Sep 2005 B2
6949118 Kohler et al. Sep 2005 B2
6951571 Srivastava Oct 2005 B1
6953332 Kurk et al. Oct 2005 B1
6953481 Phelps et al. Oct 2005 B2
6955175 Stevens et al. Oct 2005 B2
6955681 Evans et al. Oct 2005 B2
6964652 Guiles et al. Nov 2005 B2
6964673 Tsugita et al. Nov 2005 B2
6964676 Gerberding et al. Nov 2005 B1
6969395 Eskuri Nov 2005 B2
6972025 Wasdyke Dec 2005 B2
6972029 Mayrhofer et al. Dec 2005 B2
6974464 Quijano et al. Dec 2005 B2
6974474 Pavcnik et al. Dec 2005 B2
6974476 McGuckin, Jr. et al. Dec 2005 B2
6976990 Mowry Dec 2005 B2
6979350 Moll et al. Dec 2005 B2
6984242 Campbell et al. Jan 2006 B2
6984244 Perez et al. Jan 2006 B2
6986742 Hart et al. Jan 2006 B2
6986784 Weiser et al. Jan 2006 B1
6988949 Wang Jan 2006 B2
6989027 Allen et al. Jan 2006 B2
6989028 Lashinski et al. Jan 2006 B2
6991649 Sievers Jan 2006 B2
7001425 McCullagh et al. Feb 2006 B2
7004176 Lau Feb 2006 B2
7008397 Tweden et al. Mar 2006 B2
7011095 Wolf et al. Mar 2006 B2
7011681 Vesely Mar 2006 B2
7014655 Barbarash et al. Mar 2006 B2
7018401 Hyodoh et al. Mar 2006 B1
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7022134 Quijano et al. Apr 2006 B1
7025773 Gittings et al. Apr 2006 B2
7025780 Gabbay Apr 2006 B2
7025791 Levine et al. Apr 2006 B2
7028692 Sterman et al. Apr 2006 B2
7037331 Mitelberg et al. May 2006 B2
7037333 Myers et al. May 2006 B2
7041128 McGuckin, Jr. et al. May 2006 B2
7041132 Quijano et al. May 2006 B2
7044966 Svanidze et al. May 2006 B2
7048014 Hyodoh et al. May 2006 B2
7048757 Shaknovich May 2006 B2
7050276 Nishiyama May 2006 B2
7074236 Rabkin et al. Jul 2006 B2
7078163 Torrianni Jul 2006 B2
7081132 Cook et al. Jul 2006 B2
7097658 Oktay Aug 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7105016 Shiu et al. Sep 2006 B2
7108715 Lawrence-Brown et al. Sep 2006 B2
7115141 Menz et al. Oct 2006 B2
7118585 Addis Oct 2006 B2
7122020 Mogul Oct 2006 B2
7125418 Duran et al. Oct 2006 B2
7128759 Osborne et al. Oct 2006 B2
7137184 Schreck et al. Nov 2006 B2
7141063 White et al. Nov 2006 B2
7141064 Scott et al. Nov 2006 B2
7143312 Wang et al. Nov 2006 B1
7147662 Pollock et al. Dec 2006 B1
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7160319 Chouinard et al. Jan 2007 B2
7163556 Xie et al. Jan 2007 B2
7166097 Barbut Jan 2007 B2
7175652 Cook et al. Feb 2007 B2
7175653 Gaber Feb 2007 B2
7175654 Bonsignore et al. Feb 2007 B2
7175656 Khairkhahan Feb 2007 B2
7179290 Cao Feb 2007 B2
7186265 Sharkawy et al. Mar 2007 B2
7189258 Johnson et al. Mar 2007 B2
7189259 Simionescu et al. Mar 2007 B2
7191018 Gielen et al. Mar 2007 B2
7191406 Barber et al. Mar 2007 B1
7195641 Palmaz et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201761 Woolfson et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7214344 Carpentier et al. May 2007 B2
7217287 Wilson et al. May 2007 B2
7235092 Banas et al. Jun 2007 B2
7235093 Gregorich Jun 2007 B2
7238200 Lee et al. Jul 2007 B2
7241257 Ainsworth et al. Jul 2007 B1
7252682 Seguin Aug 2007 B2
7258696 Rabkin et al. Aug 2007 B2
7258891 Pacetti et al. Aug 2007 B2
7261732 Justino Aug 2007 B2
7264632 Wright et al. Sep 2007 B2
7267686 DiMatteo et al. Sep 2007 B2
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7285130 Austin Oct 2007 B2
7297150 Cartledge et al. Nov 2007 B2
7300457 Palmaz Nov 2007 B2
7300463 Liddicoat Nov 2007 B2
7311730 Gabbay Dec 2007 B2
7314449 Pfeiffer et al. Jan 2008 B2
7314485 Mathis Jan 2008 B2
7314880 Chang et al. Jan 2008 B2
7316706 Bloom et al. Jan 2008 B2
7316712 Peredo Jan 2008 B2
7317005 Hoekstra et al. Jan 2008 B2
7317942 Brown Jan 2008 B2
7317950 Lee Jan 2008 B2
7318278 Zhang et al. Jan 2008 B2
7318998 Goldstein et al. Jan 2008 B2
7319096 Malm et al. Jan 2008 B2
7320692 Bender et al. Jan 2008 B1
7320704 Lashinski et al. Jan 2008 B2
7320705 Quintessenza Jan 2008 B2
7320706 Al-Najjar Jan 2008 B2
7322932 Xie et al. Jan 2008 B2
7323006 Andreas et al. Jan 2008 B2
7323066 Budron Jan 2008 B1
7326174 Cox et al. Feb 2008 B2
7326219 Mowry et al. Feb 2008 B2
7326236 Andreas et al. Feb 2008 B2
7327862 Murphy et al. Feb 2008 B2
7329278 Seguin et al. Feb 2008 B2
7329279 Haug et al. Feb 2008 B2
7329280 Bolling et al. Feb 2008 B2
7329777 Harter et al. Feb 2008 B2
7331991 Kheradvar et al. Feb 2008 B2
7331993 White Feb 2008 B2
7333643 Murphy et al. Feb 2008 B2
7335158 Taylor Feb 2008 B2
7335213 Hyde et al. Feb 2008 B1
7335218 Wilson et al. Feb 2008 B2
7335490 Van Gilst et al. Feb 2008 B2
7338484 Schoon et al. Mar 2008 B2
7338520 Bailey et al. Mar 2008 B2
7361189 Case et al. Apr 2008 B2
7361190 Shaoulian et al. Apr 2008 B2
7364588 Mathis et al. Apr 2008 B2
7371258 Woo et al. May 2008 B2
7374560 Ressemann et al. May 2008 B2
7374571 Pease et al. May 2008 B2
7377895 Spence et al. May 2008 B2
7377938 Sarac et al. May 2008 B2
7377940 Ryan et al. May 2008 B2
7381210 Zarbatany et al. Jun 2008 B2
7381216 Buzzard et al. Jun 2008 B2
7381218 Schreck Jun 2008 B2
7381219 Salahieh et al. Jun 2008 B2
7381220 Macoviak et al. Jun 2008 B2
7384411 Condado Jun 2008 B1
7387640 Cummings Jun 2008 B2
7389874 Quest et al. Jun 2008 B2
7390325 Wang et al. Jun 2008 B2
7393358 Malewicz Jul 2008 B2
7393360 Spenser et al. Jul 2008 B2
7396364 Moaddeb et al. Jul 2008 B2
7399315 Iobbi Jul 2008 B2
7402171 Osborne et al. Jul 2008 B2
7404792 Spence et al. Jul 2008 B2
7404793 Lau et al. Jul 2008 B2
7405259 Frye et al. Jul 2008 B2
7410499 Bicer Aug 2008 B2
7412274 Mejia Aug 2008 B2
7412290 Janke et al. Aug 2008 B2
7415861 Sokel Aug 2008 B2
7416530 Turner et al. Aug 2008 B2
7422603 Lane Sep 2008 B2
7422606 Ung-Chhun et al. Sep 2008 B2
7423032 Ozaki et al. Sep 2008 B2
7426413 Balczewski et al. Sep 2008 B2
7427279 Frazier et al. Sep 2008 B2
7427287 Turovskiy et al. Sep 2008 B2
7427291 Liddicoat et al. Sep 2008 B2
7429269 Schwammenthal et al. Sep 2008 B2
7430448 Zimmer et al. Sep 2008 B1
7430484 Ohara Sep 2008 B2
7431691 Wilk Oct 2008 B1
7431733 Knight Oct 2008 B2
7435059 Smith et al. Oct 2008 B2
7435257 Lashinski et al. Oct 2008 B2
7442204 Schwammenthal et al. Oct 2008 B2
RE40570 Carpentier et al. Nov 2008 E
7445630 Lashinski et al. Nov 2008 B2
7445631 Salahieh et al. Nov 2008 B2
7445632 McGuckin, Jr. et al. Nov 2008 B2
7452371 Pavcnik et al. Nov 2008 B2
7455689 Johnson Nov 2008 B2
7462156 Mitrev Dec 2008 B2
7462184 Worley et al. Dec 2008 B2
7462191 Spenser et al. Dec 2008 B2
7468050 Kantrowitz Dec 2008 B1
7470284 Lambrecht et al. Dec 2008 B2
7470285 Nugent et al. Dec 2008 B2
7473271 Gunderson Jan 2009 B2
7473275 Marquez Jan 2009 B2
7473417 Zeltinger et al. Jan 2009 B2
7476196 Spence et al. Jan 2009 B2
7476199 Spence et al. Jan 2009 B2
7476200 Tal Jan 2009 B2
7476244 Buzzard et al. Jan 2009 B2
7481838 Carpentier et al. Jan 2009 B2
7485088 Murphy et al. Feb 2009 B2
7485143 Webler et al. Feb 2009 B2
7488346 Navia Feb 2009 B2
7491232 Bolduc et al. Feb 2009 B2
7493869 Foster et al. Feb 2009 B1
7497824 Taylor Mar 2009 B2
7500949 Gottlieb et al. Mar 2009 B2
7500989 Solem et al. Mar 2009 B2
7503929 Johnson et al. Mar 2009 B2
7503930 Sharkawy et al. Mar 2009 B2
7507199 Wang et al. Mar 2009 B2
7510572 Gabbay Mar 2009 B2
7510574 L et al. Mar 2009 B2
7510575 Spenser et al. Mar 2009 B2
7510577 Moaddeb et al. Mar 2009 B2
7513863 Bolling et al. Apr 2009 B2
7513909 Lane et al. Apr 2009 B2
7522950 Fuimaono et al. Apr 2009 B2
7524330 Berreklouw Apr 2009 B2
7530253 Spenser et al. May 2009 B2
7530995 Quijano et al. May 2009 B2
7534261 Friedman May 2009 B2
7544206 Cohn Jun 2009 B2
7547322 Sarac et al. Jun 2009 B2
7553324 Andreas et al. Jun 2009 B2
7556386 Smith Jul 2009 B2
7556646 Yang et al. Jul 2009 B2
7569071 Haverkost et al. Aug 2009 B2
7578828 Gittings et al. Aug 2009 B2
7585321 Cribier Sep 2009 B2
7591848 Allen Sep 2009 B2
7594974 Cali et al. Sep 2009 B2
7601159 Ewers et al. Oct 2009 B2
7601195 Ichikawa Oct 2009 B2
7608099 Johnson et al. Oct 2009 B2
7611534 Kapadia et al. Nov 2009 B2
7618446 Andersen et al. Nov 2009 B2
7622276 Cunanan et al. Nov 2009 B2
7625403 Krivoruchko Dec 2009 B2
7628802 White et al. Dec 2009 B2
7628803 Pavcnik et al. Dec 2009 B2
7632296 Malewicz Dec 2009 B2
7632298 Hijlkema et al. Dec 2009 B2
7635386 Gammie Dec 2009 B1
7641687 Chinn et al. Jan 2010 B2
7651519 Dittman Jan 2010 B2
7655034 Mitchell et al. Feb 2010 B2
7674282 Wu et al. Mar 2010 B2
7682390 Seguin Mar 2010 B2
7704222 Wilk et al. Apr 2010 B2
7704277 Zakay et al. Apr 2010 B2
7712606 Salahieh et al. May 2010 B2
7717955 Lane et al. May 2010 B2
7722638 Deyette, Jr. et al. May 2010 B2
7722662 Steinke et al. May 2010 B2
7722666 LaFontaine May 2010 B2
7722671 Carlyle et al. May 2010 B1
7731742 Schlick et al. Jun 2010 B2
7735493 Van Der Burg et al. Jun 2010 B2
7736327 Wilk et al. Jun 2010 B2
7736388 Goldfarb et al. Jun 2010 B2
7743481 Lafont et al. Jun 2010 B2
7748389 Salahieh et al. Jul 2010 B2
7758625 Wu et al. Jul 2010 B2
7763065 Schmid et al. Jul 2010 B2
7771463 Ton et al. Aug 2010 B2
7771467 Svensson Aug 2010 B2
7776083 Vesely Aug 2010 B2
7780725 Haug et al. Aug 2010 B2
7780726 Seguin Aug 2010 B2
7785360 Freitag Aug 2010 B2
7794487 Majercak et al. Sep 2010 B2
7799046 White et al. Sep 2010 B2
7799065 Pappas Sep 2010 B2
7803185 Gabbay Sep 2010 B2
7806919 Bloom et al. Oct 2010 B2
7823267 Bolduc Nov 2010 B2
7824442 Salahieh et al. Nov 2010 B2
7824443 Salahieh et al. Nov 2010 B2
7833262 McGuckin, Jr. et al. Nov 2010 B2
7837727 Goetz et al. Nov 2010 B2
7846203 Cribier Dec 2010 B2
7846204 Letac et al. Dec 2010 B2
7854758 Taheri Dec 2010 B2
7857845 Stacchino et al. Dec 2010 B2
7862602 Licata et al. Jan 2011 B2
7867274 Hill et al. Jan 2011 B2
7887583 Macoviak Feb 2011 B2
7892276 Stocker et al. Feb 2011 B2
7892292 Stack et al. Feb 2011 B2
7896913 Damm et al. Mar 2011 B2
7896915 Guyenot et al. Mar 2011 B2
7914569 Nguyen et al. Mar 2011 B2
7914574 Schmid et al. Mar 2011 B2
7914575 Guyenot et al. Mar 2011 B2
7918880 Austin Apr 2011 B2
7927363 Perouse Apr 2011 B2
7938851 Olson et al. May 2011 B2
7947071 Schmid et al. May 2011 B2
7947075 Goetz et al. May 2011 B2
7951189 Haverkost et al. May 2011 B2
7959666 Salahieh et al. Jun 2011 B2
7959672 Salahieh et al. Jun 2011 B2
7967853 Eidenschink et al. Jun 2011 B2
7972359 Kreidler Jul 2011 B2
7972376 Dove et al. Jul 2011 B1
7972378 Tabor et al. Jul 2011 B2
7988724 Salahieh et al. Aug 2011 B2
7993386 Elliott Aug 2011 B2
8002824 Jenson et al. Aug 2011 B2
8002825 Letac et al. Aug 2011 B2
8012198 Hill et al. Sep 2011 B2
8021421 Fogarty et al. Sep 2011 B2
RE42818 Cali et al. Oct 2011 E
RE42857 Cali et al. Oct 2011 E
8038704 Sherburne Oct 2011 B2
8038709 Palasis et al. Oct 2011 B2
8043450 Cali et al. Oct 2011 B2
8048153 Salahieh et al. Nov 2011 B2
8052715 Quinn et al. Nov 2011 B2
8052749 Salahieh et al. Nov 2011 B2
8052750 Tuval et al. Nov 2011 B2
8057540 Letac et al. Nov 2011 B2
8062355 Figulla et al. Nov 2011 B2
8062536 Liu et al. Nov 2011 B2
8062537 Tuominen et al. Nov 2011 B2
8062749 Shelestak et al. Nov 2011 B2
8070799 Righini et al. Dec 2011 B2
8075641 Aravanis et al. Dec 2011 B2
8083788 Acosta et al. Dec 2011 B2
8092518 Schreck Jan 2012 B2
8092520 Quadri Jan 2012 B2
8092521 Figulla et al. Jan 2012 B2
8128676 Cummings Mar 2012 B2
8128681 Shoemaker et al. Mar 2012 B2
8133217 Stokes et al. Mar 2012 B2
8133270 Kheradvar et al. Mar 2012 B2
8136659 Salahieh et al. Mar 2012 B2
8137394 Stocker et al. Mar 2012 B2
8137398 Tuval et al. Mar 2012 B2
8147534 Berez et al. Apr 2012 B2
8157853 Laske et al. Apr 2012 B2
8167894 Miles et al. May 2012 B2
8172896 McNamara et al. May 2012 B2
8182528 Salahieh et al. May 2012 B2
8192351 Fishler et al. Jun 2012 B2
8206437 Bonhoeffer et al. Jun 2012 B2
8211107 Parks et al. Jul 2012 B2
8216174 Wilk et al. Jul 2012 B2
8216301 Bonhoeffer et al. Jul 2012 B2
8221493 Boyle et al. Jul 2012 B2
8226707 White Jul 2012 B2
8226710 Nguyen et al. Jul 2012 B2
8231670 Salahieh et al. Jul 2012 B2
8236049 Rowe et al. Aug 2012 B2
8236241 Carpentier et al. Aug 2012 B2
8246675 Zegdi Aug 2012 B2
8246678 Salahieh et al. Aug 2012 B2
8252051 Chau et al. Aug 2012 B2
8252052 Salahieh et al. Aug 2012 B2
8277500 Schmid et al. Oct 2012 B2
8287584 Salahieh et al. Oct 2012 B2
8303653 Bonhoeffer et al. Nov 2012 B2
8308798 Pintor et al. Nov 2012 B2
8317858 Straubinger et al. Nov 2012 B2
8323335 Rowe et al. Dec 2012 B2
8328868 Paul et al. Dec 2012 B2
8343136 Howat et al. Jan 2013 B2
8343213 Salahieh et al. Jan 2013 B2
8348995 Tuval et al. Jan 2013 B2
8348996 Tuval et al. Jan 2013 B2
8348999 Kheradvar et al. Jan 2013 B2
8357387 Dove et al. Jan 2013 B2
8366767 Zhang Feb 2013 B2
8372134 Schlick et al. Feb 2013 B2
8376865 Forster et al. Feb 2013 B2
8377117 Keidar et al. Feb 2013 B2
8382822 Pavcnik et al. Feb 2013 B2
8398704 Straubinger Mar 2013 B2
8398708 Meiri et al. Mar 2013 B2
8403983 Quadri et al. Mar 2013 B2
8414641 Stocker et al. Apr 2013 B2
8414643 Tuval et al. Apr 2013 B2
8414644 Quadri et al. Apr 2013 B2
8414645 Dwork et al. Apr 2013 B2
8439961 Jagger et al. May 2013 B2
8445278 Everaerts et al. May 2013 B2
8460365 Haverkost et al. Jun 2013 B2
8465540 Straubinger Jun 2013 B2
8468667 Straubinger et al. Jun 2013 B2
8470023 Eidenschink et al. Jun 2013 B2
8491650 Wiemeyer et al. Jul 2013 B2
8512394 Schmid et al. Aug 2013 B2
8512399 LaFontaine Aug 2013 B2
8512400 Tran et al. Aug 2013 B2
8512401 Murray, III et al. Aug 2013 B2
8523936 Schmid et al. Sep 2013 B2
8535368 Headley, Jr. et al. Sep 2013 B2
8540762 Schmid et al. Sep 2013 B2
8545547 Schmid et al. Oct 2013 B2
8551160 Figulla et al. Oct 2013 B2
8556880 Freyman et al. Oct 2013 B2
8556966 Jenson Oct 2013 B2
8568475 Nguyen et al. Oct 2013 B2
8579962 Salahieh et al. Nov 2013 B2
8579965 Bonhoeffer et al. Nov 2013 B2
8585756 Bonhoeffer et al. Nov 2013 B2
8585759 Bumbalough Nov 2013 B2
8591570 Revuelta et al. Nov 2013 B2
8597226 Wilk et al. Dec 2013 B2
8603159 Seguin et al. Dec 2013 B2
8603160 Salahieh et al. Dec 2013 B2
8617235 Schmid et al. Dec 2013 B2
8617236 Paul et al. Dec 2013 B2
8623074 Ryan Jan 2014 B2
8623075 Murray, III et al. Jan 2014 B2
8623076 Salahieh et al. Jan 2014 B2
8623078 Salahieh et al. Jan 2014 B2
8628562 Cummings Jan 2014 B2
8628571 Hacohen et al. Jan 2014 B1
8647381 Essinger et al. Feb 2014 B2
8668733 Haug et al. Mar 2014 B2
8672997 Drasler et al. Mar 2014 B2
8679174 Ottma et al. Mar 2014 B2
8685077 Laske et al. Apr 2014 B2
8696743 Holecek et al. Apr 2014 B2
8721713 Tower et al. May 2014 B2
8721717 Shoemaker et al. May 2014 B2
8734508 Hastings et al. May 2014 B2
8758430 Ferrari et al. Jun 2014 B2
8764818 Gregg Jul 2014 B2
8778020 Gregg et al. Jul 2014 B2
8790395 Straubinger Jul 2014 B2
8795305 Martin et al. Aug 2014 B2
8795356 Quadri et al. Aug 2014 B2
8808356 Braido et al. Aug 2014 B2
8808364 Palasis et al. Aug 2014 B2
8828078 Salahieh et al. Sep 2014 B2
8828079 Thielen et al. Sep 2014 B2
8840662 Salahieh et al. Sep 2014 B2
8840663 Salahieh et al. Sep 2014 B2
8845721 Braido et al. Sep 2014 B2
8851286 Chang et al. Oct 2014 B2
8852272 Gross et al. Oct 2014 B2
8858620 Salahieh et al. Oct 2014 B2
8894703 Salahieh et al. Nov 2014 B2
8932349 Jenson et al. Jan 2015 B2
8940014 Gamarra et al. Jan 2015 B2
8951243 Crisostomo et al. Feb 2015 B2
8951299 Paul et al. Feb 2015 B2
8956383 Aklog et al. Feb 2015 B2
8992608 Haug et al. Mar 2015 B2
8998976 Gregg et al. Apr 2015 B2
9005273 Salahieh et al. Apr 2015 B2
9011521 Haug et al. Apr 2015 B2
9028542 Hill et al. May 2015 B2
9039756 White May 2015 B2
9044318 Straubinger et al. Jun 2015 B2
9131926 Crisostomo et al. Sep 2015 B2
9149358 Tabor et al. Oct 2015 B2
9168130 Straubinger et al. Oct 2015 B2
9168131 Yohanan et al. Oct 2015 B2
9168136 Yang et al. Oct 2015 B2
9180005 Lashinski et al. Nov 2015 B1
9186482 Dorn Nov 2015 B2
9211266 Iwazawa et al. Dec 2015 B2
9216082 Von Segesser et al. Dec 2015 B2
9248037 Roeder et al. Feb 2016 B2
9265608 Miller et al. Feb 2016 B2
9277991 Salahieh et al. Mar 2016 B2
9277993 Gamarra et al. Mar 2016 B2
9301840 Nguyen et al. Apr 2016 B2
9301843 Richardson et al. Apr 2016 B2
9308085 Salahieh et al. Apr 2016 B2
9320599 Salahieh et al. Apr 2016 B2
9326853 Olson et al. May 2016 B2
9358106 Salahieh et al. Jun 2016 B2
9358110 Paul et al. Jun 2016 B2
9370419 Hill et al. Jun 2016 B2
9370421 Crisostomo et al. Jun 2016 B2
9387076 Paul et al. Jul 2016 B2
9393094 Salahieh et al. Jul 2016 B2
9393113 Salahieh et al. Jul 2016 B2
9393114 Sutton et al. Jul 2016 B2
9393115 Tabor et al. Jul 2016 B2
9415567 Sogard et al. Aug 2016 B2
9421083 Eidenschink et al. Aug 2016 B2
9439759 Straubinger Sep 2016 B2
9463084 Stinson Oct 2016 B2
9474598 Gregg et al. Oct 2016 B2
9474609 Haverkost et al. Oct 2016 B2
9492276 Lee et al. Nov 2016 B2
9510945 Sutton et al. Dec 2016 B2
9526609 Salahieh et al. Dec 2016 B2
9532872 Salahieh et al. Jan 2017 B2
9539091 Yang et al. Jan 2017 B2
9554924 Schlick et al. Jan 2017 B2
9597432 Nakamura Mar 2017 B2
9649212 Fargahi May 2017 B2
9717593 Alkhatib et al. Aug 2017 B2
D800908 Hariton et al. Oct 2017 S
9775709 Miller et al. Oct 2017 B2
9788945 Ottma et al. Oct 2017 B2
9861476 Salahieh et al. Jan 2018 B2
9867694 Girard Jan 2018 B2
9867699 Straubinger et al. Jan 2018 B2
9872768 Paul et al. Jan 2018 B2
9889002 Bonhoeffer et al. Feb 2018 B2
9901445 Backus et al. Feb 2018 B2
9949824 Bonhoeffer et al. Apr 2018 B2
9956075 Salahieh et al. May 2018 B2
9987133 Straubinger et al. Jun 2018 B2
10092324 Gillespie et al. Oct 2018 B2
10143552 Wallace et al. Dec 2018 B2
10154901 Straubinger et al. Dec 2018 B2
10321987 Wang et al. Jun 2019 B2
10363134 Figulla et al. Jul 2019 B2
10543084 Guyenot et al. Jan 2020 B2
10702382 Straubinger et al. Jul 2020 B2
10709555 Schreck et al. Jul 2020 B2
20010000041 Selmon et al. Mar 2001 A1
20010001314 Davison et al. May 2001 A1
20010002445 Vesely May 2001 A1
20010004683 Gambale et al. Jun 2001 A1
20010004690 Gambale et al. Jun 2001 A1
20010004699 Gittings et al. Jun 2001 A1
20010007956 Letac et al. Jul 2001 A1
20010008969 Evans et al. Jul 2001 A1
20010010017 Letac et al. Jul 2001 A1
20010011187 Pavcnik et al. Aug 2001 A1
20010011189 Drasler et al. Aug 2001 A1
20010012948 Vanney Aug 2001 A1
20010014813 Saadat et al. Aug 2001 A1
20010016700 Eno et al. Aug 2001 A1
20010018596 Selmon et al. Aug 2001 A1
20010020172 Selmon et al. Sep 2001 A1
20010021872 Bailey et al. Sep 2001 A1
20010025196 Chinn et al. Sep 2001 A1
20010025643 Foley Oct 2001 A1
20010027287 Shmulewitz et al. Oct 2001 A1
20010027338 Greenberg Oct 2001 A1
20010027339 Boatman et al. Oct 2001 A1
20010029385 Shennib et al. Oct 2001 A1
20010032013 Marton Oct 2001 A1
20010034547 Hall et al. Oct 2001 A1
20010037117 Gambale et al. Nov 2001 A1
20010037141 Yee et al. Nov 2001 A1
20010037149 Wilk Nov 2001 A1
20010039426 Makower et al. Nov 2001 A1
20010039445 Hall et al. Nov 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20010041902 Lepulu et al. Nov 2001 A1
20010041928 Pavcnik et al. Nov 2001 A1
20010041930 Globerman et al. Nov 2001 A1
20010044631 Akin et al. Nov 2001 A1
20010044634 Don Michael et al. Nov 2001 A1
20010044647 Pinchuk et al. Nov 2001 A1
20010044652 Moore Nov 2001 A1
20010044656 Williamson, IV et al. Nov 2001 A1
20010047165 Makower et al. Nov 2001 A1
20010049523 DeVore et al. Dec 2001 A1
20010051822 Stack et al. Dec 2001 A1
20010053932 Phelps et al. Dec 2001 A1
20020002349 Flaherty et al. Jan 2002 A1
20020002396 Fulkerson Jan 2002 A1
20020002401 McGuckin, Jr. et al. Jan 2002 A1
20020004662 Wilk Jan 2002 A1
20020004663 Gittings et al. Jan 2002 A1
20020007138 Wilk et al. Jan 2002 A1
20020010489 Grayzel et al. Jan 2002 A1
20020010508 Chobotov Jan 2002 A1
20020026233 Shaknovich Feb 2002 A1
20020029014 Jayaraman Mar 2002 A1
20020029079 Kim et al. Mar 2002 A1
20020029981 Nigam Mar 2002 A1
20020032476 Gambale et al. Mar 2002 A1
20020032478 Boekstegers et al. Mar 2002 A1
20020032480 Spence et al. Mar 2002 A1
20020032481 Gabbay Mar 2002 A1
20020035390 Schaldach et al. Mar 2002 A1
20020035396 Heath Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020042651 Liddicoat et al. Apr 2002 A1
20020045846 Kaplon et al. Apr 2002 A1
20020045928 Boekstegers Apr 2002 A1
20020045929 Diaz Apr 2002 A1
20020049486 Knudson et al. Apr 2002 A1
20020052651 Myers et al. May 2002 A1
20020055767 Forde et al. May 2002 A1
20020055769 Wang May 2002 A1
20020055772 McGuckin, Jr. et al. May 2002 A1
20020055774 Liddicoat May 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020058897 Renati May 2002 A1
20020058987 Butaric et al. May 2002 A1
20020058993 Landau et al. May 2002 A1
20020058995 Stevens May 2002 A1
20020062146 Makower et al. May 2002 A1
20020065478 Knudson et al. May 2002 A1
20020065485 DuBois et al. May 2002 A1
20020072699 Knudson et al. Jun 2002 A1
20020072789 Hackett et al. Jun 2002 A1
20020077566 Laroya et al. Jun 2002 A1
20020077654 Javier, Jr. et al. Jun 2002 A1
20020077696 Zadno-Azizi et al. Jun 2002 A1
20020082584 Rosenman et al. Jun 2002 A1
20020082609 Green Jun 2002 A1
20020092535 Wilk Jul 2002 A1
20020092536 LaFontaine et al. Jul 2002 A1
20020095111 Tweden et al. Jul 2002 A1
20020095173 Mazzocchi et al. Jul 2002 A1
20020095206 Addonizio et al. Jul 2002 A1
20020095209 Zadno-Azizi et al. Jul 2002 A1
20020099439 Schwartz et al. Jul 2002 A1
20020100484 Hall et al. Aug 2002 A1
20020103533 Langberg et al. Aug 2002 A1
20020107565 Greenhalgh Aug 2002 A1
20020111627 Vincent-Prestigiacomo Aug 2002 A1
20020111665 Lauterjung Aug 2002 A1
20020111668 Smith Aug 2002 A1
20020111672 Kim et al. Aug 2002 A1
20020111674 Chouinard et al. Aug 2002 A1
20020117789 Childers et al. Aug 2002 A1
20020120322 Thompson et al. Aug 2002 A1
20020120323 Thompson et al. Aug 2002 A1
20020120328 Pathak et al. Aug 2002 A1
20020123698 Garibotto et al. Sep 2002 A1
20020123786 Gittings et al. Sep 2002 A1
20020123790 White et al. Sep 2002 A1
20020123802 Snyders Sep 2002 A1
20020133183 Lentz et al. Sep 2002 A1
20020133226 Marquez et al. Sep 2002 A1
20020138087 Shennib et al. Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020143285 Eno et al. Oct 2002 A1
20020143289 Ellis et al. Oct 2002 A1
20020143387 Soetikno et al. Oct 2002 A1
20020144696 Sharkawy et al. Oct 2002 A1
20020151913 Berg et al. Oct 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020156522 Ivancev et al. Oct 2002 A1
20020161377 Rabkin Oct 2002 A1
20020161383 Akin et al. Oct 2002 A1
20020161390 Mouw Oct 2002 A1
20020161392 Dubrul Oct 2002 A1
20020161394 Macoviak et al. Oct 2002 A1
20020161424 Rapacki et al. Oct 2002 A1
20020161426 Iancea Oct 2002 A1
20020165479 Wilk Nov 2002 A1
20020165576 Boyle et al. Nov 2002 A1
20020165606 Wolf et al. Nov 2002 A1
20020173842 Buchanan Nov 2002 A1
20020177766 Mogul Nov 2002 A1
20020177772 Altman et al. Nov 2002 A1
20020177840 Farnholtz Nov 2002 A1
20020177894 Acosta et al. Nov 2002 A1
20020179098 Makower et al. Dec 2002 A1
20020183716 Herweck et al. Dec 2002 A1
20020183781 Casey et al. Dec 2002 A1
20020186558 Plank et al. Dec 2002 A1
20020188341 Elliott Dec 2002 A1
20020188344 Bolea et al. Dec 2002 A1
20020193782 Ellis et al. Dec 2002 A1
20020193871 Beyersdorf et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030004541 Linder et al. Jan 2003 A1
20030004560 Chobotov et al. Jan 2003 A1
20030009189 Gilson et al. Jan 2003 A1
20030014104 Cribier Jan 2003 A1
20030018377 Berg et al. Jan 2003 A1
20030018379 Knudson et al. Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030027332 Lafrance et al. Feb 2003 A1
20030028213 Thill et al. Feb 2003 A1
20030028247 Cali Feb 2003 A1
20030033001 Igaki Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040736 Stevens et al. Feb 2003 A1
20030040771 Hyodoh et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030040791 Oktay Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030042186 Boyle Mar 2003 A1
20030044315 Boekstegers Mar 2003 A1
20030045828 Wilk Mar 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055371 Wolf et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030057156 Peterson et al. Mar 2003 A1
20030060844 Borillo et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030069492 Abrams et al. Apr 2003 A1
20030069646 Stinson Apr 2003 A1
20030070944 Nigam Apr 2003 A1
20030073973 Evans et al. Apr 2003 A1
20030074058 Sherry Apr 2003 A1
20030078561 Gambale et al. Apr 2003 A1
20030078652 Sutherland Apr 2003 A1
20030083730 Stinson May 2003 A1
20030093145 Lawrence-Brown et al. May 2003 A1
20030100918 Duane May 2003 A1
20030100919 Hopkins et al. May 2003 A1
20030100920 Akin et al. May 2003 A1
20030105514 Phelps et al. Jun 2003 A1
20030109924 Cribier Jun 2003 A1
20030109930 Bluni et al. Jun 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030120195 Milo et al. Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030130726 Thorpe et al. Jul 2003 A1
20030130727 Drasler et al. Jul 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030130746 Ashworth et al. Jul 2003 A1
20030135257 Taheri Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139798 Brown et al. Jul 2003 A1
20030139803 Sequin et al. Jul 2003 A1
20030139804 Hankh et al. Jul 2003 A1
20030144657 Bowe et al. Jul 2003 A1
20030144732 Cosgrove et al. Jul 2003 A1
20030149474 Becker Aug 2003 A1
20030149475 Hyodoh et al. Aug 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030149477 Gabbay Aug 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030153971 Chandrasekaran Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030158573 Gittings et al. Aug 2003 A1
20030158595 Randall et al. Aug 2003 A1
20030163198 Morra et al. Aug 2003 A1
20030165352 Ibrahim et al. Sep 2003 A1
20030171803 Shimon Sep 2003 A1
20030171805 Berg et al. Sep 2003 A1
20030176884 Berrada et al. Sep 2003 A1
20030181850 Diamond et al. Sep 2003 A1
20030181938 Roth et al. Sep 2003 A1
20030181942 Sutton et al. Sep 2003 A1
20030187495 Cully et al. Oct 2003 A1
20030191449 Nash et al. Oct 2003 A1
20030191516 Weldon et al. Oct 2003 A1
20030191519 Lombardi et al. Oct 2003 A1
20030191526 Van Tassel et al. Oct 2003 A1
20030195457 LaFontaine et al. Oct 2003 A1
20030195458 Phelps et al. Oct 2003 A1
20030195609 Berenstein et al. Oct 2003 A1
20030195620 Huynh et al. Oct 2003 A1
20030198722 Johnston, Jr. et al. Oct 2003 A1
20030199759 Richard Oct 2003 A1
20030199913 Dubrul et al. Oct 2003 A1
20030199963 Tower et al. Oct 2003 A1
20030199971 Tower et al. Oct 2003 A1
20030199972 Zadno-Azizi et al. Oct 2003 A1
20030204160 Kamm et al. Oct 2003 A1
20030204249 Letort Oct 2003 A1
20030208224 Broome Nov 2003 A1
20030212410 Stenzel et al. Nov 2003 A1
20030212413 Wilk Nov 2003 A1
20030212429 Keegan et al. Nov 2003 A1
20030212452 Zadno-Azizi et al. Nov 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030216678 March et al. Nov 2003 A1
20030216679 Wolf et al. Nov 2003 A1
20030216774 Larson Nov 2003 A1
20030220661 Mowry et al. Nov 2003 A1
20030220667 Van Der Burg et al. Nov 2003 A1
20030225445 Derus et al. Dec 2003 A1
20030229366 Reggie et al. Dec 2003 A1
20030229390 Ashton et al. Dec 2003 A1
20030233117 Adams et al. Dec 2003 A1
20030236542 Makower Dec 2003 A1
20030236567 Elliot Dec 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20030236570 Cook et al. Dec 2003 A1
20040004926 Maeda Jan 2004 A1
20040006298 Wilk Jan 2004 A1
20040006380 Buck et al. Jan 2004 A1
20040015225 Kim et al. Jan 2004 A1
20040015228 Lombardi et al. Jan 2004 A1
20040018651 Nadeau Jan 2004 A1
20040019348 Stevens et al. Jan 2004 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040026389 Kessler et al. Feb 2004 A1
20040033364 Spiridigliozzi et al. Feb 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040037946 Morra et al. Feb 2004 A1
20040039343 Eppstein et al. Feb 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040044361 Frazier et al. Mar 2004 A1
20040044392 Von Oepen Mar 2004 A1
20040044400 Cheng et al. Mar 2004 A1
20040044402 Jung et al. Mar 2004 A1
20040049204 Harari et al. Mar 2004 A1
20040049207 Goldfarb et al. Mar 2004 A1
20040049224 Buehlmann et al. Mar 2004 A1
20040049226 Keegan et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040049266 Anduiza et al. Mar 2004 A1
20040058097 Weder Mar 2004 A1
20040059280 Makower et al. Mar 2004 A1
20040059407 Escamilla et al. Mar 2004 A1
20040059409 Stenzel Mar 2004 A1
20040059429 Amin et al. Mar 2004 A1
20040073157 Knudson et al. Apr 2004 A1
20040073198 Gilson et al. Apr 2004 A1
20040073238 Makower Apr 2004 A1
20040073289 Hartley et al. Apr 2004 A1
20040077987 Rapacki et al. Apr 2004 A1
20040077988 Tweden et al. Apr 2004 A1
20040077990 Knudson et al. Apr 2004 A1
20040078950 Schreck et al. Apr 2004 A1
20040082904 Houde et al. Apr 2004 A1
20040082967 Broome et al. Apr 2004 A1
20040082989 Cook et al. Apr 2004 A1
20040087982 Eskuri May 2004 A1
20040088042 Kim et al. May 2004 A1
20040088045 Cox May 2004 A1
20040092858 Wilson et al. May 2004 A1
20040092989 Wilson et al. May 2004 A1
20040093005 Durcan May 2004 A1
20040093016 Root et al. May 2004 A1
20040093060 Seguin et al. May 2004 A1
20040093063 Wright et al. May 2004 A1
20040093070 Hojeibane et al. May 2004 A1
20040093075 Kuehne May 2004 A1
20040097788 Mourlas et al. May 2004 A1
20040098022 Barone May 2004 A1
20040098098 McGuckin, Jr. et al. May 2004 A1
20040098099 McCullagh et al. May 2004 A1
20040098112 DiMatteo et al. May 2004 A1
20040102855 Shank May 2004 A1
20040106931 Guiles et al. Jun 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040106990 Spence et al. Jun 2004 A1
20040107004 Levine et al. Jun 2004 A1
20040111096 Tu et al. Jun 2004 A1
20040113306 Rapacki et al. Jun 2004 A1
20040116951 Rosengart Jun 2004 A1
20040116999 Ledergerber Jun 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040118415 Hall et al. Jun 2004 A1
20040122318 Flaherty et al. Jun 2004 A1
20040122347 Knudson et al. Jun 2004 A1
20040122468 Yodfat et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040127847 DuBois et al. Jul 2004 A1
20040127912 Rabkin et al. Jul 2004 A1
20040127936 Salahieh et al. Jul 2004 A1
20040127979 Wilson et al. Jul 2004 A1
20040127982 Machold et al. Jul 2004 A1
20040133154 Flaherty et al. Jul 2004 A1
20040133225 Makower Jul 2004 A1
20040133274 Webler et al. Jul 2004 A1
20040138694 Tran et al. Jul 2004 A1
20040138742 Myers et al. Jul 2004 A1
20040138743 Myers et al. Jul 2004 A1
20040138745 Macoviak et al. Jul 2004 A1
20040147868 Bardsley et al. Jul 2004 A1
20040147869 Wolf et al. Jul 2004 A1
20040148018 Carpentier et al. Jul 2004 A1
20040148021 Cartledge et al. Jul 2004 A1
20040153094 Dunfee et al. Aug 2004 A1
20040153145 Simionescu et al. Aug 2004 A1
20040153146 Lashinski et al. Aug 2004 A1
20040158143 Flaherty et al. Aug 2004 A1
20040158277 Lowe et al. Aug 2004 A1
20040163094 Matsui et al. Aug 2004 A1
20040167444 Laroya et al. Aug 2004 A1
20040167565 Beulke et al. Aug 2004 A1
20040167573 Williamson, IV et al. Aug 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040168691 Sharkawy et al. Sep 2004 A1
20040176791 Lim et al. Sep 2004 A1
20040181140 Falwell et al. Sep 2004 A1
20040186507 Hall et al. Sep 2004 A1
20040186557 Gambale et al. Sep 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040186587 Ahern Sep 2004 A1
20040193180 Buzzard et al. Sep 2004 A1
20040193244 Hartley et al. Sep 2004 A1
20040193252 Perez et al. Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040197695 Aono Oct 2004 A1
20040199245 Lauterjung Oct 2004 A1
20040204683 McGuckin, Jr. et al. Oct 2004 A1
20040204755 Robin Oct 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210104 Lau et al. Oct 2004 A1
20040210190 Kohler et al. Oct 2004 A1
20040210240 Saint Oct 2004 A1
20040210301 Obermiller et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210306 Quijano et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040215317 Cummings Oct 2004 A1
20040215331 Chew et al. Oct 2004 A1
20040215333 Duran et al. Oct 2004 A1
20040215339 Drasler et al. Oct 2004 A1
20040219180 Gambale et al. Nov 2004 A1
20040220598 Bolduc et al. Nov 2004 A1
20040220655 Swanson et al. Nov 2004 A1
20040225321 Krolik et al. Nov 2004 A1
20040225353 McGuckin, Jr. et al. Nov 2004 A1
20040225354 Allen et al. Nov 2004 A1
20040225355 Stevens Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040236418 Stevens Nov 2004 A1
20040243143 Corcoran et al. Dec 2004 A1
20040243221 Fawzi et al. Dec 2004 A1
20040249343 Cioanta Dec 2004 A1
20040254594 Alfaro Dec 2004 A1
20040254636 Flagle et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20040260393 Rahdert et al. Dec 2004 A1
20040260394 Douk et al. Dec 2004 A1
20040267357 Allen et al. Dec 2004 A1
20050000858 Roovers Jan 2005 A1
20050004505 Phelps et al. Jan 2005 A1
20050004558 Gambale et al. Jan 2005 A1
20050004648 Boekstegers Jan 2005 A1
20050008589 Legrand et al. Jan 2005 A1
20050009000 Wilhelm et al. Jan 2005 A1
20050010246 Streeter et al. Jan 2005 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050010287 Macoviak et al. Jan 2005 A1
20050015112 Cohn et al. Jan 2005 A1
20050021136 Xie et al. Jan 2005 A1
20050025857 Schoenherr et al. Feb 2005 A1
20050027305 Shiu et al. Feb 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033220 Wilk et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050033402 Cully et al. Feb 2005 A1
20050038495 Greenan Feb 2005 A1
20050038509 Ashe Feb 2005 A1
20050043585 Datta et al. Feb 2005 A1
20050043711 Corcoran et al. Feb 2005 A1
20050043757 Arad et al. Feb 2005 A1
20050043759 Chanduszko Feb 2005 A1
20050043760 Fogarty et al. Feb 2005 A1
20050043781 Foley Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049674 Berra et al. Mar 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050049696 Siess et al. Mar 2005 A1
20050055088 Liddicoat et al. Mar 2005 A1
20050060016 Wu et al. Mar 2005 A1
20050060018 Dittman Mar 2005 A1
20050060029 Le et al. Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050070794 Deal et al. Mar 2005 A1
20050070957 Das Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075662 Pedersen et al. Apr 2005 A1
20050075712 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050075725 Rowe Apr 2005 A1
20050075726 Svanidze et al. Apr 2005 A1
20050075727 Wheatley Apr 2005 A1
20050075730 Myers et al. Apr 2005 A1
20050075731 Artof et al. Apr 2005 A1
20050075776 Cho Apr 2005 A1
20050084595 Shukla et al. Apr 2005 A1
20050085841 Eversull et al. Apr 2005 A1
20050085842 Eversull et al. Apr 2005 A1
20050085843 Opolski et al. Apr 2005 A1
20050085890 Rasmussen et al. Apr 2005 A1
20050085900 Case et al. Apr 2005 A1
20050090846 Pedersen et al. Apr 2005 A1
20050090890 Wu et al. Apr 2005 A1
20050096568 Kato May 2005 A1
20050096692 Linder et al. May 2005 A1
20050096724 Stenzel et al. May 2005 A1
20050096726 Sequin et al. May 2005 A1
20050096734 Majercak et al. May 2005 A1
20050096735 Hojeibane et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050096738 Cali et al. May 2005 A1
20050096768 Huang et al. May 2005 A1
20050098547 Cali et al. May 2005 A1
20050100580 Osborne et al. May 2005 A1
20050101903 Kohler et al. May 2005 A1
20050101904 Wilk May 2005 A1
20050101968 Dadourian May 2005 A1
20050107822 Wasdyke May 2005 A1
20050107871 Realyvasquez et al. May 2005 A1
20050113902 Geiser et al. May 2005 A1
20050113904 Shank et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119688 Bergheim Jun 2005 A1
20050119728 Sarac Jun 2005 A1
20050119736 Zilla et al. Jun 2005 A1
20050125075 Meade et al. Jun 2005 A1
20050131438 Cohn Jun 2005 A1
20050137499 Sheets et al. Jun 2005 A1
20050137609 Guiraudon Jun 2005 A1
20050137681 Shoemaker et al. Jun 2005 A1
20050137682 Justino Jun 2005 A1
20050137683 Hezi-Yamit et al. Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137689 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137693 Haug et al. Jun 2005 A1
20050137694 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050137696 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137699 Salahieh et al. Jun 2005 A1
20050137701 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050138689 Aukerman Jun 2005 A1
20050143804 Haverkost Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050143809 Salahieh et al. Jun 2005 A1
20050148997 Valley et al. Jul 2005 A1
20050149159 Andreas et al. Jul 2005 A1
20050149166 Schaeffer et al. Jul 2005 A1
20050149181 Eberhardt Jul 2005 A1
20050150775 Zhang et al. Jul 2005 A1
20050159726 Evans et al. Jul 2005 A1
20050165352 Henry et al. Jul 2005 A1
20050165477 Anduiza et al. Jul 2005 A1
20050165479 Drews et al. Jul 2005 A1
20050171597 Boatman et al. Aug 2005 A1
20050171598 Schaeffer Aug 2005 A1
20050177227 Heim et al. Aug 2005 A1
20050182483 Osborne et al. Aug 2005 A1
20050182486 Gabbay Aug 2005 A1
20050186349 Loper et al. Aug 2005 A1
20050187616 Realyvasquez Aug 2005 A1
20050192527 Gharib et al. Sep 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050197694 Pai et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050203549 Realyvasquez Sep 2005 A1
20050203605 Dolan Sep 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203615 Forster et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050203818 Rotman et al. Sep 2005 A9
20050209580 Freyman Sep 2005 A1
20050214342 Tweden et al. Sep 2005 A1
20050222664 Parker Oct 2005 A1
20050222668 Schaeffer et al. Oct 2005 A1
20050222674 Paine Oct 2005 A1
20050228334 Knudson et al. Oct 2005 A1
20050228472 Case et al. Oct 2005 A1
20050228495 Macoviak Oct 2005 A1
20050228496 Mensah et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240200 Bergheim Oct 2005 A1
20050240262 White Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050251243 Seppala et al. Nov 2005 A1
20050251250 Verhoeven et al. Nov 2005 A1
20050251251 Cribier Nov 2005 A1
20050251252 Stobie Nov 2005 A1
20050256532 Nayak et al. Nov 2005 A1
20050261759 Lambrecht et al. Nov 2005 A1
20050267523 Devellian et al. Dec 2005 A1
20050267560 Bates Dec 2005 A1
20050267567 Shalev Dec 2005 A1
20050267573 Macoviak et al. Dec 2005 A9
20050283231 Haug et al. Dec 2005 A1
20050283962 Boudjemline Dec 2005 A1
20050288627 Mogul Dec 2005 A1
20050288685 Gulles et al. Dec 2005 A1
20050288706 Widomski et al. Dec 2005 A1
20060004439 Spenser et al. Jan 2006 A1
20060004442 Spenser et al. Jan 2006 A1
20060004469 Sokel Jan 2006 A1
20060009841 McGuckin, Jr. et al. Jan 2006 A1
20060009842 Huynh et al. Jan 2006 A1
20060015168 Gunderson Jan 2006 A1
20060025855 Lashinski et al. Feb 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060028766 Khizroev Feb 2006 A1
20060041218 Phelps et al. Feb 2006 A1
20060047338 Jenson et al. Mar 2006 A1
20060047343 Oviatt et al. Mar 2006 A1
20060052736 Tweden et al. Mar 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058775 Stevens et al. Mar 2006 A1
20060058864 Schaeffer et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060064151 Guterman et al. Mar 2006 A1
20060069424 Acosta et al. Mar 2006 A1
20060074477 Berthiaume et al. Apr 2006 A1
20060074484 Huber Apr 2006 A1
20060074485 Realyvasquez Apr 2006 A1
20060077447 Sojian et al. Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060089711 Dolan Apr 2006 A1
20060100685 Seguin et al. May 2006 A1
20060111770 Pavcnik et al. May 2006 A1
20060116757 Lashinski et al. Jun 2006 A1
20060122692 Gilad et al. Jun 2006 A1
20060135961 Rosenman et al. Jun 2006 A1
20060135964 Vesely Jun 2006 A1
20060136034 Modesitt et al. Jun 2006 A1
20060142846 Pavcnik et al. Jun 2006 A1
20060142848 Gabbay Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060155312 Levine et al. Jul 2006 A1
20060155363 LaDuca et al. Jul 2006 A1
20060155366 LaDuca et al. Jul 2006 A1
20060161248 Case et al. Jul 2006 A1
20060161249 Realyvasquez et al. Jul 2006 A1
20060161265 Levine et al. Jul 2006 A1
20060167474 Bloom et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060173524 Salahieh et al. Aug 2006 A1
20060178740 Stacchino et al. Aug 2006 A1
20060190070 Dieck et al. Aug 2006 A1
20060193885 Neethling et al. Aug 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195183 Navia et al. Aug 2006 A1
20060195186 Drews et al. Aug 2006 A1
20060206192 Tower et al. Sep 2006 A1
20060206202 Bonhoeffer et al. Sep 2006 A1
20060210597 Hiles Sep 2006 A1
20060212110 Osborne et al. Sep 2006 A1
20060212111 Case et al. Sep 2006 A1
20060217802 Ruiz et al. Sep 2006 A1
20060224183 Freudenthal Oct 2006 A1
20060229561 Huszar Oct 2006 A1
20060229718 Marquez Oct 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060241745 Solem Oct 2006 A1
20060246584 Covelli Nov 2006 A1
20060247570 Pokorney Nov 2006 A1
20060247763 Slater Nov 2006 A1
20060253191 Salahieh et al. Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259135 Navia et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060259137 Artof et al. Nov 2006 A1
20060265043 Mandrusov et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060270958 George Nov 2006 A1
20060271149 Berez et al. Nov 2006 A1
20060271161 Meyer et al. Nov 2006 A1
20060271166 Thill et al. Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060276873 Sato Dec 2006 A1
20060276874 Wilson et al. Dec 2006 A1
20060276882 Case et al. Dec 2006 A1
20060276887 Brady et al. Dec 2006 A1
20060282161 Huynh et al. Dec 2006 A1
20060287668 Fawzi et al. Dec 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20060290027 O'Connor et al. Dec 2006 A1
20060293745 Carpentier et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070005132 Simionescu et al. Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070010878 Rafiee et al. Jan 2007 A1
20070010887 Williams et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070020248 Everaerts et al. Jan 2007 A1
20070021826 Case et al. Jan 2007 A1
20070027518 Case et al. Feb 2007 A1
20070027520 Sherburne Feb 2007 A1
20070027533 Douk Feb 2007 A1
20070027535 Purdy, Jr. et al. Feb 2007 A1
20070032856 Limon Feb 2007 A1
20070038291 Case et al. Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043420 Lostetter Feb 2007 A1
20070043424 Pryor Feb 2007 A1
20070043431 Melsheimer Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070050014 Johnson Mar 2007 A1
20070051377 Douk et al. Mar 2007 A1
20070055340 Pryor Mar 2007 A1
20070056346 Spencer et al. Mar 2007 A1
20070060998 Butterwick et al. Mar 2007 A1
20070061002 Paul, Jr. et al. Mar 2007 A1
20070061008 Salahieh et al. Mar 2007 A1
20070073389 Bolduc et al. Mar 2007 A1
20070073392 Heyninck-Jantz et al. Mar 2007 A1
20070078504 Mialhe Apr 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093869 Bloom et al. Apr 2007 A1
20070093887 Case et al. Apr 2007 A1
20070100427 Perouse May 2007 A1
20070100435 Case et al. May 2007 A1
20070100439 Cangialosi et al. May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070100449 O'Neil et al. May 2007 A1
20070112355 Salahieh et al. May 2007 A1
20070112358 Abbott et al. May 2007 A1
20070112415 Bartlett May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070118214 Salahieh et al. May 2007 A1
20070123700 Ueda et al. May 2007 A1
20070123979 Perier et al. May 2007 A1
20070135889 Moore et al. Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070155010 Farnsworth et al. Jul 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070162102 Ryan et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162113 Sharkawy et al. Jul 2007 A1
20070173918 Dreher et al. Jul 2007 A1
20070173932 Cali et al. Jul 2007 A1
20070179592 Schaeffer Aug 2007 A1
20070179600 Vardi Aug 2007 A1
20070185513 Woolfson et al. Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070185571 Kapadia et al. Aug 2007 A1
20070198078 Berra et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070203391 Bloom et al. Aug 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203560 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070208550 Cao et al. Sep 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070225681 House Sep 2007 A1
20070225802 Forsell Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070233222 Roeder et al. Oct 2007 A1
20070233228 Eberhardt et al. Oct 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070233238 Huynh et al. Oct 2007 A1
20070238979 Huynh et al. Oct 2007 A1
20070239254 Chia et al. Oct 2007 A1
20070239265 Birdsall Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239271 Nguyen Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070244543 Mitchell Oct 2007 A1
20070244544 Birdsall et al. Oct 2007 A1
20070244545 Birdsall et al. Oct 2007 A1
20070244546 Francis Oct 2007 A1
20070244551 Stobie Oct 2007 A1
20070244552 Salahieh et al. Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070244554 Rafiee et al. Oct 2007 A1
20070244555 Rafiee et al. Oct 2007 A1
20070244556 Rafiee et al. Oct 2007 A1
20070244557 Rafiee et al. Oct 2007 A1
20070250151 Pereira Oct 2007 A1
20070250160 Rafiee Oct 2007 A1
20070255386 Tenne Nov 2007 A1
20070255390 Ducke et al. Nov 2007 A1
20070255394 Ryan Nov 2007 A1
20070255396 Douk et al. Nov 2007 A1
20070260301 Chuter et al. Nov 2007 A1
20070260327 Case et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270751 Stangenes et al. Nov 2007 A1
20070270943 Solem et al. Nov 2007 A1
20070273813 Yoshida et al. Nov 2007 A1
20070282436 Pinchuk Dec 2007 A1
20070287717 Fanning et al. Dec 2007 A1
20070288000 Bonan Dec 2007 A1
20070288087 Fearnot et al. Dec 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080004696 Vesely Jan 2008 A1
20080009934 Schneider et al. Jan 2008 A1
20080009940 Cribier Jan 2008 A1
20080015671 Bonhoeffer Jan 2008 A1
20080021546 Patz et al. Jan 2008 A1
20080021552 Gabbay Jan 2008 A1
20080022504 Melsheimer Jan 2008 A1
20080033534 Cook et al. Feb 2008 A1
20080033541 Gelbart et al. Feb 2008 A1
20080039925 Ishimaru et al. Feb 2008 A1
20080039934 Styrc Feb 2008 A1
20080045921 Anderson et al. Feb 2008 A1
20080048656 Tan et al. Feb 2008 A1
20080065001 DiNucci et al. Mar 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080065206 Liddicoat Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080077227 Ouellette et al. Mar 2008 A1
20080077234 Styrc Mar 2008 A1
20080077236 Letac et al. Mar 2008 A1
20080082165 Wilson et al. Apr 2008 A1
20080082166 Styrc et al. Apr 2008 A1
20080086205 Gordy et al. Apr 2008 A1
20080097586 Pavcnik et al. Apr 2008 A1
20080102439 Tian et al. May 2008 A1
20080109070 Wagner et al. May 2008 A1
20080125859 Salahieh et al. May 2008 A1
20080127707 Kokish et al. Jun 2008 A1
20080133002 Gelbart et al. Jun 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140188 Rahdert et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080147105 Wilson et al. Jun 2008 A1
20080147180 Ghione et al. Jun 2008 A1
20080147181 Ghione et al. Jun 2008 A1
20080147182 Righini et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080161909 Kheradvar et al. Jul 2008 A1
20080161910 Revuelta et al. Jul 2008 A1
20080161911 Revuelta et al. Jul 2008 A1
20080172119 Yamasaki et al. Jul 2008 A1
20080177381 Navia et al. Jul 2008 A1
20080183273 Mesana et al. Jul 2008 A1
20080188928 Salahieh et al. Aug 2008 A1
20080195193 Purdy et al. Aug 2008 A1
20080195199 Kheradvar et al. Aug 2008 A1
20080200977 Paul et al. Aug 2008 A1
20080208209 Fischer et al. Aug 2008 A1
20080208327 Rowe Aug 2008 A1
20080208328 Antocci et al. Aug 2008 A1
20080208332 Lamphere et al. Aug 2008 A1
20080215143 Seguin Sep 2008 A1
20080215144 Ryan et al. Sep 2008 A1
20080221672 Lamphere et al. Sep 2008 A1
20080221703 Que et al. Sep 2008 A1
20080228254 Ryan Sep 2008 A1
20080228263 Ryan Sep 2008 A1
20080234443 Kiss et al. Sep 2008 A1
20080234797 Styrc Sep 2008 A1
20080234814 Salahieh et al. Sep 2008 A1
20080243246 Ryan et al. Oct 2008 A1
20080255651 Dwork Oct 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080255661 Straubinger et al. Oct 2008 A1
20080262590 Murray Oct 2008 A1
20080262592 Jordan et al. Oct 2008 A1
20080262593 Ryan et al. Oct 2008 A1
20080262602 Wilk et al. Oct 2008 A1
20080264102 Berra Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20080275549 Rowe Nov 2008 A1
20080275550 Kheradvar et al. Nov 2008 A1
20080288054 Pulnev et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090012356 Dann et al. Jan 2009 A1
20090012600 Styrc et al. Jan 2009 A1
20090030512 Thielen et al. Jan 2009 A1
20090048656 Wen Feb 2009 A1
20090054968 Bonhoeffer et al. Feb 2009 A1
20090054969 Salahieh et al. Feb 2009 A1
20090054976 Tuval et al. Feb 2009 A1
20090062908 Bonhoeffer et al. Mar 2009 A1
20090069886 Suri et al. Mar 2009 A1
20090069887 Righini et al. Mar 2009 A1
20090069889 Suri et al. Mar 2009 A1
20090069890 Suri et al. Mar 2009 A1
20090076598 Salahieh et al. Mar 2009 A1
20090082844 Zacharias et al. Mar 2009 A1
20090082858 Nugent et al. Mar 2009 A1
20090085900 Weiner Apr 2009 A1
20090093876 Nitzan et al. Apr 2009 A1
20090093877 Keidar et al. Apr 2009 A1
20090099640 Weng Apr 2009 A1
20090099641 Wu et al. Apr 2009 A1
20090099643 Hyodoh et al. Apr 2009 A1
20090099653 Suri et al. Apr 2009 A1
20090112309 Jaramillo et al. Apr 2009 A1
20090138079 Tuval et al. May 2009 A1
20090157175 Benichou Jun 2009 A1
20090163951 Simmons et al. Jun 2009 A1
20090164004 Cohn Jun 2009 A1
20090164006 Seguin et al. Jun 2009 A1
20090171432 Von Segesser et al. Jul 2009 A1
20090171447 Von Segesser et al. Jul 2009 A1
20090171456 Kveen et al. Jul 2009 A1
20090182405 Arnault De La Menardiere et al. Jul 2009 A1
20090192585 Bloom et al. Jul 2009 A1
20090192586 Tabor et al. Jul 2009 A1
20090192591 Ryan et al. Jul 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090198316 Laske et al. Aug 2009 A1
20090198323 Johnson et al. Aug 2009 A1
20090210052 Forster et al. Aug 2009 A1
20090216310 Straubinger et al. Aug 2009 A1
20090216312 Straubinger et al. Aug 2009 A1
20090216313 Straubinger et al. Aug 2009 A1
20090222076 Figulla et al. Sep 2009 A1
20090222082 Lock et al. Sep 2009 A1
20090234407 Hastings et al. Sep 2009 A1
20090234443 Ottma et al. Sep 2009 A1
20090240264 Tuval et al. Sep 2009 A1
20090240320 Tuval et al. Sep 2009 A1
20090248143 Laham Oct 2009 A1
20090259306 Rowe Oct 2009 A1
20090264759 Byrd Oct 2009 A1
20090264997 Salahieh et al. Oct 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090287290 MacAulay et al. Nov 2009 A1
20090287296 Manasse Nov 2009 A1
20090287299 Tabor et al. Nov 2009 A1
20090299462 Fawzi et al. Dec 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100004739 Vesely Jan 2010 A1
20100004740 Seguin et al. Jan 2010 A1
20100011564 Millwee et al. Jan 2010 A1
20100030328 Seguin et al. Feb 2010 A1
20100036479 Hill et al. Feb 2010 A1
20100036485 Seguin Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100057051 Howat et al. Mar 2010 A1
20100057185 Melsheimer et al. Mar 2010 A1
20100069852 Kelley Mar 2010 A1
20100069916 Cully et al. Mar 2010 A1
20100070027 Bonhoeffer et al. Mar 2010 A1
20100082089 Quadri et al. Apr 2010 A1
20100082094 Quadri et al. Apr 2010 A1
20100087913 Rabkin et al. Apr 2010 A1
20100094399 Dorn et al. Apr 2010 A1
20100094411 Tuval et al. Apr 2010 A1
20100100167 Bortlein et al. Apr 2010 A1
20100121434 Paul et al. May 2010 A1
20100131054 Tuval et al. May 2010 A1
20100131057 Subramanian et al. May 2010 A1
20100137979 Tuval et al. Jun 2010 A1
20100145439 Seguin et al. Jun 2010 A1
20100152840 Seguin et al. Jun 2010 A1
20100160725 Kiser et al. Jun 2010 A1
20100161045 Righini Jun 2010 A1
20100168839 Braido et al. Jul 2010 A1
20100174362 Straubinger et al. Jul 2010 A1
20100185275 Richter et al. Jul 2010 A1
20100185277 Braido et al. Jul 2010 A1
20100191320 Straubinger et al. Jul 2010 A1
20100191326 Alkhatib Jul 2010 A1
20100198346 Keogh et al. Aug 2010 A1
20100210991 Wilk et al. Aug 2010 A1
20100219092 Salahieh et al. Sep 2010 A1
20100234932 Arbefeuille et al. Sep 2010 A1
20100234940 Dolan Sep 2010 A1
20100239917 Lee et al. Sep 2010 A1
20100249908 Chau et al. Sep 2010 A1
20100249915 Zhang Sep 2010 A1
20100249916 Zhang Sep 2010 A1
20100249917 Zhang Sep 2010 A1
20100249918 Zhang Sep 2010 A1
20100256723 Murray Oct 2010 A1
20100262231 Tuval et al. Oct 2010 A1
20100268332 Tuval et al. Oct 2010 A1
20100280459 Werner Nov 2010 A1
20100280495 Paul et al. Nov 2010 A1
20100286768 Alkhatib Nov 2010 A1
20100292779 Straubinger et al. Nov 2010 A1
20100292780 Straubinger et al. Nov 2010 A1
20100292785 Seguin et al. Nov 2010 A1
20100298931 Quadri et al. Nov 2010 A1
20110004297 Sogard et al. Jan 2011 A1
20110015616 Straubinger et al. Jan 2011 A1
20110022157 Essinger et al. Jan 2011 A1
20110029066 Gilad et al. Feb 2011 A1
20110034852 Hausler et al. Feb 2011 A1
20110040366 Goetz et al. Feb 2011 A1
20110040374 Goetz et al. Feb 2011 A1
20110071613 Wood et al. Mar 2011 A1
20110093007 Abbott et al. Apr 2011 A1
20110098805 Dwork et al. Apr 2011 A1
20110106244 Ferrari et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110166637 Irwin et al. Jul 2011 A1
20110190862 Bashiri et al. Aug 2011 A1
20110190874 Celermajer et al. Aug 2011 A1
20110208290 Straubinger et al. Aug 2011 A1
20110208297 Tuval et al. Aug 2011 A1
20110224780 Tabor et al. Sep 2011 A1
20110238159 Guyenot et al. Sep 2011 A1
20110238167 Dove et al. Sep 2011 A1
20110257729 Spenser et al. Oct 2011 A1
20110257733 Dwork Oct 2011 A1
20110257735 Salahieh et al. Oct 2011 A1
20110264191 Rothstein Oct 2011 A1
20110264196 Savage et al. Oct 2011 A1
20110264203 Dwork et al. Oct 2011 A1
20110276121 Levine Nov 2011 A1
20110276129 Salahieh et al. Nov 2011 A1
20110288626 Straubinger et al. Nov 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110295363 Girard Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20120016469 Salahieh et al. Jan 2012 A1
20120016471 Salahieh et al. Jan 2012 A1
20120022633 Olson et al. Jan 2012 A1
20120022642 Haug et al. Jan 2012 A1
20120029627 Salahieh et al. Feb 2012 A1
20120035719 Forster et al. Feb 2012 A1
20120035720 Cali et al. Feb 2012 A1
20120041547 Duffy et al. Feb 2012 A1
20120041549 Salahieh et al. Feb 2012 A1
20120041550 Salahieh et al. Feb 2012 A1
20120046740 Paul et al. Feb 2012 A1
20120053683 Salahieh et al. Mar 2012 A1
20120059447 Zilla et al. Mar 2012 A1
20120065464 Ellis et al. Mar 2012 A1
20120078347 Braido et al. Mar 2012 A1
20120078357 Conklin Mar 2012 A1
20120078360 Rafiee Mar 2012 A1
20120089224 Haug et al. Apr 2012 A1
20120100182 Mooney et al. Apr 2012 A1
20120101571 Thambar et al. Apr 2012 A1
20120101572 Kovalsky et al. Apr 2012 A1
20120116496 Chuter et al. May 2012 A1
20120123515 Hosford et al. May 2012 A1
20120123529 Levi et al. May 2012 A1
20120130468 Khosravi et al. May 2012 A1
20120132547 Salahieh et al. May 2012 A1
20120136430 Sochman et al. May 2012 A1
20120165957 Everland et al. Jun 2012 A1
20120172982 Stacchino et al. Jul 2012 A1
20120179244 Schankereli et al. Jul 2012 A1
20120185030 Igaki et al. Jul 2012 A1
20120197379 Laske et al. Aug 2012 A1
20120209374 Bonhoeffer et al. Aug 2012 A1
20120209376 Hauser et al. Aug 2012 A1
20120221100 Huber Aug 2012 A1
20120226341 Schreck et al. Sep 2012 A1
20120283715 Mihalik et al. Nov 2012 A1
20120283823 Bonhoeffer et al. Nov 2012 A1
20120303113 Benichou et al. Nov 2012 A1
20120303116 Gorman, III et al. Nov 2012 A1
20120305441 Murray et al. Dec 2012 A1
20120310332 Murray et al. Dec 2012 A1
20120316637 Holm et al. Dec 2012 A1
20120330408 Hillukka et al. Dec 2012 A1
20120330409 Haug et al. Dec 2012 A1
20130013057 Salahieh et al. Jan 2013 A1
20130018457 Gregg et al. Jan 2013 A1
20130030519 Tran et al. Jan 2013 A1
20130030520 Lee et al. Jan 2013 A1
20130046373 Cartledge et al. Feb 2013 A1
20130053949 Pintor et al. Feb 2013 A1
20130066342 Dell et al. Mar 2013 A1
20130066419 Gregg Mar 2013 A1
20130071441 Iwazawa et al. Mar 2013 A1
20130073037 Gregg et al. Mar 2013 A1
20130079867 Hoffman et al. Mar 2013 A1
20130079869 Straubinger et al. Mar 2013 A1
20130089655 Gregg Apr 2013 A1
20130090728 Solem Apr 2013 A1
20130090729 Gregg et al. Apr 2013 A1
20130096664 Goetz et al. Apr 2013 A1
20130116778 Gregg et al. May 2013 A1
20130118949 Chang et al. May 2013 A1
20130123757 Crisostomo et al. May 2013 A1
20130123795 Gamarra et al. May 2013 A1
20130123796 Sutton et al. May 2013 A1
20130123898 Tung et al. May 2013 A1
20130138207 Quadri et al. May 2013 A1
20130144203 Wilk et al. Jun 2013 A1
20130144276 Crisostomo et al. Jun 2013 A1
20130158653 Gamarra et al. Jun 2013 A1
20130158655 Sutton et al. Jun 2013 A1
20130158656 Sutton et al. Jun 2013 A1
20130166017 Cartledge et al. Jun 2013 A1
20130178930 Straubinger et al. Jul 2013 A1
20130184813 Quadri et al. Jul 2013 A1
20130190865 Anderson Jul 2013 A1
20130204359 Thubrikar et al. Aug 2013 A1
20130231735 Deem et al. Sep 2013 A1
20130245752 Goetz et al. Sep 2013 A1
20130253342 Griswold et al. Sep 2013 A1
20130253635 Straubinger et al. Sep 2013 A1
20130253640 Meiri et al. Sep 2013 A1
20130268067 Forster et al. Oct 2013 A1
20130274865 Haverkost et al. Oct 2013 A1
20130274870 Lombardi et al. Oct 2013 A1
20130289698 Wang et al. Oct 2013 A1
20130296999 Burriesci et al. Nov 2013 A1
20130304199 Sutton et al. Nov 2013 A1
20130310917 Richter et al. Nov 2013 A1
20130310923 Kheradvar et al. Nov 2013 A1
20130310928 Morriss et al. Nov 2013 A1
20130325101 Goetz et al. Dec 2013 A1
20130338755 Goetz et al. Dec 2013 A1
20130345799 Lafontaine Dec 2013 A1
20140012368 Sugimoto et al. Jan 2014 A1
20140012370 Bonhoeffer et al. Jan 2014 A1
20140018911 Zhou et al. Jan 2014 A1
20140052239 Kong et al. Feb 2014 A1
20140058501 Bonhoeffer et al. Feb 2014 A1
20140083190 Kaack et al. Mar 2014 A1
20140088680 Costello et al. Mar 2014 A1
20140094904 Salahieh et al. Apr 2014 A1
20140114390 Tobis et al. Apr 2014 A1
20140114405 Paul et al. Apr 2014 A1
20140114406 Salahieh et al. Apr 2014 A1
20140114407 Rajamannan Apr 2014 A1
20140121763 Duffy et al. May 2014 A1
20140121766 Salahieh et al. May 2014 A1
20140128969 Hill et al. May 2014 A1
20140135912 Salahieh et al. May 2014 A1
20140207229 Shoemaker et al. Jul 2014 A1
20140222142 Kovalsky Aug 2014 A1
20140236287 Clague et al. Aug 2014 A1
20140243962 Wilson et al. Aug 2014 A1
20140243963 Sheps et al. Aug 2014 A1
20140243967 Salahieh et al. Aug 2014 A1
20140249621 Eidenschink Sep 2014 A1
20140257473 Rajamannan Sep 2014 A1
20140277414 Kheradvar Sep 2014 A1
20140296962 Cartledge et al. Oct 2014 A1
20140309732 Solem Oct 2014 A1
20140316518 Kheradvar et al. Oct 2014 A1
20140330371 Gloss et al. Nov 2014 A1
20140343669 Lane et al. Nov 2014 A1
20140379068 Thielen et al. Dec 2014 A1
20150012085 Salahieh et al. Jan 2015 A1
20150032056 Okamura et al. Jan 2015 A1
20150073540 Salahieh et al. Mar 2015 A1
20150073541 Salahieh et al. Mar 2015 A1
20150088252 Jenson et al. Mar 2015 A1
20150094804 Bonhoeffer et al. Apr 2015 A1
20150105857 Bonhoeffer et al. Apr 2015 A1
20150127092 Straubinger et al. May 2015 A1
20150127094 Salahieh et al. May 2015 A1
20150142102 Lafontaine et al. May 2015 A1
20150209142 Paul et al. Jul 2015 A1
20150209146 Hill et al. Jul 2015 A1
20150223933 Haug et al. Aug 2015 A1
20150238315 Rabito et al. Aug 2015 A1
20150245909 Salahieh et al. Sep 2015 A1
20150272731 Racchini et al. Oct 2015 A1
20150320557 Sutton et al. Nov 2015 A1
20150335423 Gregg et al. Nov 2015 A1
20150352252 Nakamura et al. Dec 2015 A1
20150359997 Crisostomo et al. Dec 2015 A1
20160022418 Salahieh et al. Jan 2016 A1
20160045306 Agrawal et al. Feb 2016 A1
20160045307 Yohanan et al. Feb 2016 A1
20160051362 Cooper et al. Feb 2016 A1
20160067040 Agrawal et al. Mar 2016 A1
20160120645 Alon May 2016 A1
20160135951 Salahieh et al. May 2016 A1
20160143731 Backus et al. May 2016 A1
20160158003 Wallace Jun 2016 A1
20160166384 Olson Jun 2016 A1
20160199184 Ma et al. Jul 2016 A1
20160206423 O'Connor et al. Jul 2016 A1
20160213467 Backus et al. Jul 2016 A1
20160220359 Backus et al. Aug 2016 A1
20160220360 Lin et al. Aug 2016 A1
20160220365 Backus et al. Aug 2016 A1
20160250024 Hill et al. Sep 2016 A1
20160256271 Backus et al. Sep 2016 A1
20160262878 Backus et al. Sep 2016 A1
20160346107 Matthison-Hansen et al. Dec 2016 A1
20160354203 Tuval et al. Dec 2016 A1
20160374793 Lafontaine et al. Dec 2016 A1
20160376063 Salahieh et al. Dec 2016 A1
20170000609 Gross et al. Jan 2017 A1
20170007400 Sogard et al. Jan 2017 A1
20170027693 Paul et al. Feb 2017 A1
20170049563 Straubinger Feb 2017 A1
20170049568 Straubinger et al. Feb 2017 A1
20170056172 Salahieh et al. Mar 2017 A1
20170065410 Straubinger Mar 2017 A1
20170095595 Nakamura Apr 2017 A1
20170333230 Folan et al. Nov 2017 A1
20170348013 Mottola et al. Dec 2017 A1
20180368976 Bonhoeffer et al. Dec 2018 A1
20190328522 Straubinger et al. Oct 2019 A1
20200054449 Min et al. Feb 2020 A1
Foreign Referenced Citations (923)
Number Date Country
757647 Feb 2003 AU
776895 Sep 2004 AU
777443 Oct 2004 AU
778831 Dec 2004 AU
2004231189 Dec 2004 AU
2004242527 Jan 2005 AU
2001281277 Sep 2005 AU
2006308187 May 2007 AU
2006310681 May 2007 AU
2006328896 Jun 2007 AU
2002329324 Jul 2007 AU
2007294199 Mar 2008 AU
2009200985 Apr 2009 AU
2006328896 Aug 2013 AU
2378589 Feb 2001 CA
2381192 Feb 2001 CA
2385662 Mar 2001 CA
2407987 Nov 2001 CA
2418958 Feb 2002 CA
2435962 Aug 2002 CA
2457755 Feb 2003 CA
2436258 Jan 2005 CA
2848485 Jan 2005 CA
2848490 Jan 2005 CA
2595233 Jul 2006 CA
2627409 May 2007 CA
2627555 May 2007 CA
2634358 Jun 2007 CA
2657839 Mar 2008 CA
2659690 Mar 2008 CA
1338951 Mar 2002 CN
1342443 Apr 2002 CN
1745727 Mar 2006 CN
2762776 Mar 2006 CN
1897892 Jan 2007 CN
2933337 Aug 2007 CN
101011298 Aug 2007 CN
101431963 May 2009 CN
101605509 Dec 2009 CN
101623217 Jan 2010 CN
101700199 May 2010 CN
101720211 Jun 2010 CN
102271626 Dec 2011 CN
102413793 Apr 2012 CN
2815756 Oct 1979 DE
3640745 Jun 1987 DE
3920657 Jan 1991 DE
3640745 Mar 1992 DE
4316971 Nov 1994 DE
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19633901 Feb 1998 DE
20003874 Jun 2000 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
10010073 Sep 2001 DE
10010074 Oct 2001 DE
10034105 Apr 2002 DE
10049812 Apr 2002 DE
10049813 Apr 2002 DE
10049814 Apr 2002 DE
10049815 Apr 2002 DE
10048814 May 2002 DE
101 21 210 Nov 2002 DE
19546692 Nov 2002 DE
10301026 Feb 2004 DE
10048814 Apr 2004 DE
10049812 Jun 2004 DE
10302447 Jul 2004 DE
10335948 Feb 2005 DE
10010074 Apr 2005 DE
19857887 May 2005 DE
10049815 Oct 2005 DE
10010073 Dec 2005 DE
102005003632 Aug 2006 DE
10 2005 051 849 May 2007 DE
10 2005 052628 May 2007 DE
20 2007 005 491 Jul 2007 DE
69937568 Sep 2008 DE
20221871 Oct 2008 DE
1112042 Feb 2008 DK
200800058 Jun 2008 DK
200800058 Jul 2008 DK
1259195 Feb 2009 DK
1281375 May 2012 DK
0084395 Jul 1983 EP
0103546 Mar 1984 EP
0103546 May 1988 EP
0144167 Nov 1989 EP
0402036 Dec 1990 EP
0402036 Dec 1990 EP
0402176 Dec 1990 EP
0402176 Dec 1990 EP
0411118 Feb 1991 EP
0458877 Apr 1991 EP
0458877 Dec 1991 EP
0515324 Nov 1992 EP
0547135 Jun 1993 EP
0547135 Jun 1993 EP
0579523 Jan 1994 EP
0592410 Apr 1994 EP
0597967 May 1994 EP
0597967 Dec 1994 EP
0657147 Jun 1995 EP
0 592 410 Oct 1995 EP
0 592 410 Nov 1995 EP
0696447 Feb 1996 EP
0729364 Sep 1996 EP
0729364 Sep 1996 EP
0732088 Sep 1996 EP
0756498 Feb 1997 EP
0409929 Apr 1997 EP
0756498 May 1997 EP
0778775 Jun 1997 EP
0778775 Jun 1997 EP
0786970 Aug 1997 EP
0792624 Sep 1997 EP
0797957 Oct 1997 EP
0797958 Oct 1997 EP
0799604 Oct 1997 EP
0801928 Oct 1997 EP
0815798 Jan 1998 EP
0826346 Mar 1998 EP
0829239 Mar 1998 EP
0836834 Apr 1998 EP
0850607 Jul 1998 EP
0853921 Jul 1998 EP
0858779 Aug 1998 EP
0871414 Oct 1998 EP
0876796 Nov 1998 EP
0876803 Nov 1998 EP
0888142 Jan 1999 EP
0888750 Jan 1999 EP
0895752 Feb 1999 EP
0896813 Feb 1999 EP
0903122 Mar 1999 EP
0876796 May 1999 EP
0928615 Jul 1999 EP
0657147 Aug 1999 EP
0934728 Aug 1999 EP
0938877 Sep 1999 EP
0943302 Sep 1999 EP
0597967 Dec 1999 EP
0696447 Jan 2000 EP
0971649 Jan 2000 EP
0986348 Mar 2000 EP
0986348 Mar 2000 EP
1000590 May 2000 EP
1011523 Jun 2000 EP
1020166 Jul 2000 EP
1027870 Aug 2000 EP
1 251 805 Oct 2000 EP
1041942 Oct 2000 EP
1041942 Oct 2000 EP
1041943 Oct 2000 EP
1041943 Oct 2000 EP
1051204 Nov 2000 EP
1057459 Dec 2000 EP
1057460 Dec 2000 EP
1078610 Feb 2001 EP
1088529 Apr 2001 EP
1089676 Apr 2001 EP
1093771 Apr 2001 EP
1097676 May 2001 EP
1112042 Jul 2001 EP
1112097 Jul 2001 EP
1117446 Jul 2001 EP
1117446 Jul 2001 EP
1158937 Dec 2001 EP
1164976 Jan 2002 EP
1166721 Jan 2002 EP
1171061 Jan 2002 EP
1 233 731 May 2002 EP
1206179 May 2002 EP
1206179 May 2002 EP
1233731 Aug 2002 EP
1235537 Sep 2002 EP
1248655 Oct 2002 EP
1251804 Oct 2002 EP
1251804 Oct 2002 EP
1251805 Oct 2002 EP
1255510 Nov 2002 EP
1257305 Nov 2002 EP
1259193 Nov 2002 EP
1259195 Nov 2002 EP
0 971 649 Dec 2002 EP
0959815 Dec 2002 EP
1262201 Dec 2002 EP
1264582 Dec 2002 EP
1281357 Feb 2003 EP
1281375 Feb 2003 EP
0888142 May 2003 EP
1112097 Jun 2003 EP
1330213 Jul 2003 EP
1 017 868 Sep 2003 EP
0937439 Sep 2003 EP
1340473 Sep 2003 EP
1347785 Oct 2003 EP
1354569 Oct 2003 EP
1356793 Oct 2003 EP
1281375 Dec 2003 EP
1340473 Feb 2004 EP
1356793 Mar 2004 EP
1395208 Mar 2004 EP
1401359 Mar 2004 EP
0871414 Apr 2004 EP
1406561 Apr 2004 EP
1408882 Apr 2004 EP
1042045 May 2004 EP
1414295 May 2004 EP
0819013 Jun 2004 EP
1430853 Jun 2004 EP
1347785 Jul 2004 EP
1435878 Jul 2004 EP
1435879 Jul 2004 EP
1439800 Jul 2004 EP
1441672 Aug 2004 EP
0954248 Sep 2004 EP
1452153 Sep 2004 EP
0987998 Oct 2004 EP
1469797 Oct 2004 EP
1 087 727 Nov 2004 EP
1115452 Nov 2004 EP
1472996 Nov 2004 EP
1477202 Nov 2004 EP
1107710 Dec 2004 EP
1484081 Dec 2004 EP
1494616 Jan 2005 EP
1499366 Jan 2005 EP
1499366 Jan 2005 EP
1143879 Mar 2005 EP
1516599 Mar 2005 EP
1518518 Mar 2005 EP
1 253 875 Apr 2005 EP
1229864 Apr 2005 EP
1519697 Apr 2005 EP
1521414 Apr 2005 EP
1522278 Apr 2005 EP
1 251 803 Jun 2005 EP
1088529 Jun 2005 EP
1093771 Jun 2005 EP
1430853 Jun 2005 EP
1539047 Jun 2005 EP
1547533 Jun 2005 EP
1059894 Jul 2005 EP
1551274 Jul 2005 EP
1551336 Jul 2005 EP
1000590 Aug 2005 EP
1027013 Aug 2005 EP
1078610 Aug 2005 EP
1560542 Aug 2005 EP
1562515 Aug 2005 EP
1570809 Sep 2005 EP
1576937 Sep 2005 EP
0943302 Oct 2005 EP
1267753 Oct 2005 EP
1582178 Oct 2005 EP
1582179 Oct 2005 EP
1011523 Nov 2005 EP
1067869 Nov 2005 EP
1469797 Nov 2005 EP
1589902 Nov 2005 EP
1598031 Nov 2005 EP
1600110 Nov 2005 EP
1600121 Nov 2005 EP
0786970 Dec 2005 EP
1156757 Dec 2005 EP
1603493 Dec 2005 EP
1605871 Dec 2005 EP
1021141 Jan 2006 EP
1614400 Jan 2006 EP
1616531 Jan 2006 EP
1616536 Jan 2006 EP
1441672 Jun 2006 EP
1663070 Jun 2006 EP
1667614 Jun 2006 EP
1494616 Jul 2006 EP
1 690 515 Aug 2006 EP
1702247 Sep 2006 EP
1051204 Dec 2006 EP
1734902 Dec 2006 EP
1395208 Jan 2007 EP
1 255 510 Mar 2007 EP
1600121 Jul 2007 EP
1835948 Sep 2007 EP
1112042 Nov 2007 EP
1251797 Nov 2007 EP
1616531 Dec 2007 EP
1863545 Dec 2007 EP
1878407 Jan 2008 EP
1886649 Feb 2008 EP
1 900 343 Mar 2008 EP
1406561 Mar 2008 EP
1893132 Mar 2008 EP
1901681 Mar 2008 EP
1435878 Apr 2008 EP
1886649 Apr 2008 EP
1605871 Jul 2008 EP
1968491 Sep 2008 EP
1259195 Oct 2008 EP
1980220 Oct 2008 EP
1994913 Nov 2008 EP
2 000 115 Dec 2008 EP
1994913 Dec 2008 EP
1560542 Jan 2009 EP
1408882 Feb 2009 EP
1255510 Mar 2009 EP
1330213 Mar 2009 EP
2033593 Mar 2009 EP
2047824 Apr 2009 EP
2059192 May 2009 EP
2074964 Jul 2009 EP
1401359 Aug 2009 EP
1968491 Jul 2010 EP
1259193 Nov 2010 EP
2257242 Dec 2010 EP
2266503 Dec 2010 EP
2266504 Dec 2010 EP
1893132 Mar 2011 EP
2266503 Apr 2011 EP
2266504 Apr 2011 EP
2059192 Jul 2011 EP
1441672 Sep 2011 EP
2364669 Sep 2011 EP
2387977 Nov 2011 EP
1603493 Dec 2011 EP
1281375 Feb 2012 EP
2364669 Mar 2012 EP
2047824 May 2012 EP
2474287 Jul 2012 EP
2387977 Nov 2013 EP
1551274 Dec 2014 EP
2874812 May 2015 EP
2749254 Jun 2015 EP
1702247 Aug 2015 EP
2926766 Oct 2015 EP
1519697 Nov 2015 EP
1863545 Nov 2015 EP
1835948 Feb 2016 EP
1734902 Jun 2016 EP
3028668 Jun 2016 EP
1539047 Nov 2016 EP
1667614 Dec 2016 EP
3181096 Jun 2017 EP
2659861 Mar 2019 EP
1667614 Apr 2020 EP
2293734 Mar 2008 ES
2313954 Mar 2009 ES
2353733 Mar 2011 ES
2381337 May 2012 ES
2421438 Sep 2013 ES
8311 May 2009 FI
2432305 Feb 1980 FR
2788217 Jul 2000 FR
2815844 May 2002 FR
2826863 Jan 2003 FR
2828263 Feb 2003 FR
2874812 Mar 2006 FR
2828263 May 2007 FR
2018950 Oct 1979 GB
2056023 Mar 1981 GB
2316322 Feb 1998 GB
2316322 Oct 1998 GB
2398214 Aug 2004 GB
2398245 Aug 2004 GB
2398245 Mar 2007 GB
2433700 Jul 2007 GB
2433700 Dec 2007 GB
2440809 Feb 2008 GB
2440809 Aug 2011 GB
1053600 Jul 2012 HK
52-86296 Jul 1977 JP
S54137896 Sep 1979 JP
62-227352 Oct 1987 JP
1049571 Feb 1989 JP
S6449571 Feb 1989 JP
H0447576 Aug 1992 JP
H04505866 Oct 1992 JP
H06505187 Jun 1994 JP
H06343703 Dec 1994 JP
7-504091 May 1995 JP
H07505803 Jun 1995 JP
H07265339 Oct 1995 JP
H0833715 Feb 1996 JP
H10507673 Jul 1998 JP
2001000460 Jan 2001 JP
2001504016 Mar 2001 JP
2001-526574 Dec 2001 JP
2004-504111 Feb 2002 JP
2002-525168 Aug 2002 JP
2002-525169 Aug 2002 JP
2002-536115 Oct 2002 JP
2003-515386 May 2003 JP
2003518984 Jun 2003 JP
2003-523262 Aug 2003 JP
2003-524504 Aug 2003 JP
2004130068 Apr 2004 JP
2004514467 May 2004 JP
2004255186 Sep 2004 JP
2004267750 Sep 2004 JP
2004-283461 Oct 2004 JP
2005505343 Feb 2005 JP
2005-118585 May 2005 JP
2007-521125 Aug 2007 JP
2007-296375 Nov 2007 JP
2007298375 Nov 2007 JP
2007534381 Nov 2007 JP
2007536003 Dec 2007 JP
2008506497 Mar 2008 JP
2008514345 May 2008 JP
2008535572 Sep 2008 JP
2008-539985 Nov 2008 JP
2008541865 Nov 2008 JP
2009034529 Feb 2009 JP
2009061293 Mar 2009 JP
2009509635 Mar 2009 JP
4246433 Apr 2009 JP
2009520535 May 2009 JP
2009-131397 Jun 2009 JP
4295460 Jul 2009 JP
2009528905 Aug 2009 JP
2009-534157 Sep 2009 JP
2010525896 Jul 2010 JP
2010-526609 Aug 2010 JP
4636794 Feb 2011 JP
2011509805 Mar 2011 JP
4739223 Aug 2011 JP
2012500665 Jan 2012 JP
4904362 Mar 2012 JP
4912395 Apr 2012 JP
2012518446 Aug 2012 JP
2013520260 Jun 2013 JP
2013521884 Jun 2013 JP
2013526388 Jun 2013 JP
5341455 Nov 2013 JP
2013540495 Nov 2013 JP
6144009 Jun 2017 JP
6449571 Jan 2019 JP
1112042 Jan 2008 PT
1259195 Dec 2008 PT
1259193 Jan 2011 PT
1281375 Mar 2012 PT
1994913 Aug 2013 PT
2149037 May 2000 RU
7901667 Oct 1979 SE
1271508 Nov 1986 SU
1371700 Feb 1988 SU
WO 9212690 Aug 1982 WO
WO-8402266 Jun 1984 WO
WO-9009102 Aug 1990 WO
WO-9014804 Dec 1990 WO
WO 9117720 Nov 1991 WO
WO-9203990 Mar 1992 WO
WO-9214419 Sep 1992 WO
WO-9217118 Oct 1992 WO
WO-9301768 Feb 1993 WO
WO-9315693 Aug 1993 WO
WO-9320757 Oct 1993 WO
WO-9504556 Feb 1995 WO
WO 9511055 Apr 1995 WO
WO-9504556 Apr 1995 WO
WO-9524873 Sep 1995 WO
WO-9528183 Oct 1995 WO
WO 9529713 Nov 1995 WO
WO-9528899 Nov 1995 WO
WO-9529640 Nov 1995 WO
WO-9613227 May 1996 WO
WO-9614032 May 1996 WO
WO-9624306 Aug 1996 WO
WO-9630072 Oct 1996 WO
WO-9632972 Oct 1996 WO
WO-9635469 Nov 1996 WO
WO-9639962 Dec 1996 WO
WO-9639964 Dec 1996 WO
WO-9639965 Dec 1996 WO
WO-9640012 Dec 1996 WO
WO-9713463 Apr 1997 WO
WO-9713471 Apr 1997 WO
WO-9724082 Jul 1997 WO
WO 9727893 Aug 1997 WO
WO 9727898 Aug 1997 WO
WO-9727897 Aug 1997 WO
WO-9728839 Aug 1997 WO
WO-9732615 Sep 1997 WO
WO-9732551 Sep 1997 WO
WO-9743961 Nov 1997 WO
WO-9748350 Dec 1997 WO
WO-9803118 Jan 1998 WO
WO-9806356 Feb 1998 WO
WO 9808456 Mar 1998 WO
WO 9811846 Mar 1998 WO
WO-9810714 Mar 1998 WO
WO-9814137 Apr 1998 WO
WO-9816161 Apr 1998 WO
WO 9819633 May 1998 WO
WO-9824373 Jun 1998 WO
WO-9825533 Jun 1998 WO
WO-9825549 Jun 1998 WO
WO-9829057 Jul 1998 WO
WO-9836790 Aug 1998 WO
WO-9838916 Sep 1998 WO
WO-9838925 Sep 1998 WO
WO-9838939 Sep 1998 WO
WO-9838941 Sep 1998 WO
WO-9839038 Sep 1998 WO
WO 9843556 Oct 1998 WO
WO-9846165 Oct 1998 WO
WO-9844869 Oct 1998 WO
WO-9846115 Oct 1998 WO
WO-9846119 Oct 1998 WO
WO-9849964 Nov 1998 WO
WO-9850103 Nov 1998 WO
WO 9853761 Dec 1998 WO
WO-9853759 Dec 1998 WO
WO-9855027 Dec 1998 WO
WO-9855047 Dec 1998 WO
WO-9857590 Dec 1998 WO
WO-9857591 Dec 1998 WO
WO-9857592 Dec 1998 WO
WO-9857599 Dec 1998 WO
WO-9907296 Feb 1999 WO
WO-9908624 Feb 1999 WO
WO-9915112 Apr 1999 WO
WO-9915220 Apr 1999 WO
WO-9917671 Apr 1999 WO
WO-9917683 Apr 1999 WO
WO-9921490 May 1999 WO
WO-9921510 May 1999 WO
WO-9922655 May 1999 WO
WO-9922656 May 1999 WO
WO-9922658 May 1999 WO
WO-9925273 May 1999 WO
WO-9927985 Jun 1999 WO
WO 9936001 Jul 1999 WO
WO-9937337 Jul 1999 WO
WO-9933414 Jul 1999 WO
WO-9935977 Jul 1999 WO
WO-9935979 Jul 1999 WO
WO-9935980 Jul 1999 WO
WO-9936000 Jul 1999 WO
WO 9942058 Aug 1999 WO
WO-9938459 Aug 1999 WO
WO-9940853 Aug 1999 WO
WO-9940868 Aug 1999 WO
WO-9940963 Aug 1999 WO
WO-9940964 Aug 1999 WO
WO-9944524 Sep 1999 WO
WO-9944540 Sep 1999 WO
WO-9944542 Sep 1999 WO
WO-9947071 Sep 1999 WO
WO-9947075 Sep 1999 WO
WO-9948545 Sep 1999 WO
WO-9948549 Sep 1999 WO
WO 9953987 Oct 1999 WO
WO-9949793 Oct 1999 WO
WO-9949910 Oct 1999 WO
WO-9951162 Oct 1999 WO
WO-9951165 Oct 1999 WO
WO-9953863 Oct 1999 WO
WO-9955406 Nov 1999 WO
WO-9966863 Dec 1999 WO
WO-9960941 Dec 1999 WO
WO-9962430 Dec 1999 WO
WO 0002503 Jan 2000 WO
WO-0009059 Feb 2000 WO
WO-0009195 Feb 2000 WO
WO 0015148 Mar 2000 WO
WO-0010623 Mar 2000 WO
WO-0012029 Mar 2000 WO
WO-0013722 Mar 2000 WO
WO-0015146 Mar 2000 WO
WO-0015147 Mar 2000 WO
WO-0015149 Mar 2000 WO
WO-0015275 Mar 2000 WO
WO-0016848 Mar 2000 WO
WO 0018330 Apr 2000 WO
WO 0018333 Apr 2000 WO
WO-0018445 Apr 2000 WO
WO 0021464 Apr 2000 WO
WO-0018302 Apr 2000 WO
WO-0018323 Apr 2000 WO
WO-0018325 Apr 2000 WO
WO-0018326 Apr 2000 WO
WO-0018331 Apr 2000 WO
WO-0018462 Apr 2000 WO
WO-0021436 Apr 2000 WO
WO-0021461 Apr 2000 WO
WO-0021463 Apr 2000 WO
WO 200025702 May 2000 WO
WO-0024449 May 2000 WO
WO-0028922 May 2000 WO
WO-0028924 May 2000 WO
WO-0033725 Jun 2000 WO
WO-0035376 Jun 2000 WO
WO-0036997 Jun 2000 WO
WO-0041632 Jul 2000 WO
WO-0041633 Jul 2000 WO
WO-0041652 Jul 2000 WO
WO-0043051 Jul 2000 WO
WO-0044211 Jul 2000 WO
WO 0047139 Aug 2000 WO
WO-0044308 Aug 2000 WO
WO-0044311 Aug 2000 WO
WO-0044313 Aug 2000 WO
WO-0044331 Aug 2000 WO
WO-0045711 Aug 2000 WO
WO-0045874 Aug 2000 WO
WO-0045886 Aug 2000 WO
WO-0047136 Aug 2000 WO
WO-0048531 Aug 2000 WO
WO-0049952 Aug 2000 WO
WO-0049954 Aug 2000 WO
WO-0049956 Aug 2000 WO
WO-0049970 Aug 2000 WO
WO-0053125 Sep 2000 WO
WO-0053122 Sep 2000 WO
WO-0054660 Sep 2000 WO
WO-0054661 Sep 2000 WO
WO-0056224 Sep 2000 WO
WO-0056225 Sep 2000 WO
WO-0056387 Sep 2000 WO
WO-0062714 Oct 2000 WO
WO-0060995 Oct 2000 WO
WO 0069367 Nov 2000 WO
WO-0066007 Nov 2000 WO
WO-0066009 Nov 2000 WO
WO-0066035 Nov 2000 WO
WO-0067661 Nov 2000 WO
WO-0069345 Nov 2000 WO
WO-0069504 Nov 2000 WO
WO-0071195 Nov 2000 WO
WO 0078226 Dec 2000 WO
WO-0105331 Jan 2001 WO
WO-0110209 Feb 2001 WO
WO-0106959 Feb 2001 WO
WO-0108566 Feb 2001 WO
WO-0108596 Feb 2001 WO
WO-0108602 Feb 2001 WO
WO-0110320 Feb 2001 WO
WO-0110340 Feb 2001 WO
WO-0110341 Feb 2001 WO
WO-0110343 Feb 2001 WO
WO-0110347 Feb 2001 WO
WO-0110348 Feb 2001 WO
WO-0110349 Feb 2001 WO
WO-0110350 Feb 2001 WO
WO-0117440 Mar 2001 WO
WO-0117456 Mar 2001 WO
WO 200135870 May 2001 WO
WO-0135864 May 2001 WO
WO-0136870 May 2001 WO
WO-0141679 Jun 2001 WO
WO 2001039700 Jun 2001 WO
WO 0149213 Jul 2001 WO
WO-0151104 Jul 2001 WO
WO-0149185 Jul 2001 WO
WO-0149187 Jul 2001 WO
WO 0154625 Aug 2001 WO
WO-0158503 Aug 2001 WO
WO 0162189 Aug 2001 WO
WO 0164137 Sep 2001 WO
WO-0047139 Sep 2001 WO
WO-0176510 Oct 2001 WO
WO-0182837 Nov 2001 WO
WO-0197715 Dec 2001 WO
WO-0211647 Feb 2002 WO
WO 0222054 Mar 2002 WO
WO-0219926 Mar 2002 WO
WO-0224118 Mar 2002 WO
WO 200236048 May 2002 WO
WO-0241789 May 2002 WO
WO-0243620 Jun 2002 WO
WO-0247575 Jun 2002 WO
WO-0249540 Jun 2002 WO
WO-02051489 Jul 2002 WO
WO-02056798 Jul 2002 WO
WO-02056955 Jul 2002 WO
WO-02060509 Aug 2002 WO
WO-02067782 Sep 2002 WO
WO-02069842 Sep 2002 WO
WO-02076349 Oct 2002 WO
WO-02058745 Dec 2002 WO
WO-02100301 Dec 2002 WO
WO-02102286 Dec 2002 WO
WO-02100297 Dec 2002 WO
WO 03003949 Jan 2003 WO
WO-03007795 Jan 2003 WO
WO 2003003949 Jan 2003 WO
WO-03003943 Jan 2003 WO
WO-03009785 Feb 2003 WO
WO 03013239 Feb 2003 WO
WO 2003011195 Feb 2003 WO
WO-03015851 Feb 2003 WO
WO 03028592 Apr 2003 WO
WO-03030776 Apr 2003 WO
WO-03032869 Apr 2003 WO
WO-03032870 Apr 2003 WO
WO-03037222 May 2003 WO
WO-03037227 May 2003 WO
WO 03047468 Jun 2003 WO
WO 03051231 Jun 2003 WO
WO-03047460 Jun 2003 WO
WO-03047648 Jun 2003 WO
WO-03063729 Aug 2003 WO
WO-03079928 Oct 2003 WO
WO 03079933 Oct 2003 WO
WO-03079932 Oct 2003 WO
WO-03088873 Oct 2003 WO
WO 03092554 Nov 2003 WO
WO 2003096935 Nov 2003 WO
WO-03015851 Nov 2003 WO
WO-03063729 Nov 2003 WO
WO-03094793 Nov 2003 WO
WO-03094797 Nov 2003 WO
WO-03096932 Nov 2003 WO
WO-03101195 Dec 2003 WO
WO-03103949 Dec 2003 WO
WO 2004004597 Jan 2004 WO
WO-03003949 Jan 2004 WO
WO-2004006803 Jan 2004 WO
WO-2004006804 Jan 2004 WO
WO 2004016200 Feb 2004 WO
WO 2004016201 Feb 2004 WO
WO-2004014256 Feb 2004 WO
WO 2004019825 Mar 2004 WO
WO-2004019811 Mar 2004 WO
WO-2004019817 Mar 2004 WO
WO-2004021922 Mar 2004 WO
WO-2004023980 Mar 2004 WO
WO-2004026117 Apr 2004 WO
WO 2004026173 Apr 2004 WO
WO 2004028399 Apr 2004 WO
WO 2004030515 Apr 2004 WO
WO-2004019811 Apr 2004 WO
WO 2004043301 May 2004 WO
WO-2004041126 May 2004 WO
WO-2004043293 May 2004 WO
WO-2004047681 Jun 2004 WO
WO-2004058106 Jul 2004 WO
WO-2004062980 Jul 2004 WO
WO 2004064671 Aug 2004 WO
WO-2004058106 Aug 2004 WO
WO-2004066876 Aug 2004 WO
WO-2004071352 Aug 2004 WO
WO 2004082527 Sep 2004 WO
WO 2004082528 Sep 2004 WO
WO-2004082536 Sep 2004 WO
WO-2004089250 Oct 2004 WO
WO-2004089253 Oct 2004 WO
WO 2004096100 Nov 2004 WO
WO-2004093728 Nov 2004 WO
WO-2004103162 Dec 2004 WO
WO-2004105651 Dec 2004 WO
WO-2005002466 Jan 2005 WO
WO-2005004753 Jan 2005 WO
WO-2005007343 Jan 2005 WO
WO 2005011534 Feb 2005 WO
WO-2005009285 Feb 2005 WO
WO-2005011535 Feb 2005 WO
WO 2005021063 Mar 2005 WO
WO-2005023155 Mar 2005 WO
WO-2005027790 Mar 2005 WO
WO-2005027797 Mar 2005 WO
WO 2005034812 Apr 2005 WO
WO-2005032622 Apr 2005 WO
WO-2005010215 May 2005 WO
WO-2005046528 May 2005 WO
WO-2005046529 May 2005 WO
WO-2005048883 Jun 2005 WO
WO 2005062980 Jul 2005 WO
WO 2005063980 Jul 2005 WO
WO-2005065585 Jul 2005 WO
WO-2005065594 Jul 2005 WO
WO 2005070343 Aug 2005 WO
WO-2005072654 Aug 2005 WO
WO-2005076890 Aug 2005 WO
WO-2005084595 Sep 2005 WO
WO-2005087140 Sep 2005 WO
WO-2005096993 Oct 2005 WO
WO 2005102015 Nov 2005 WO
WO-2005110240 Nov 2005 WO
WO-2005112779 Dec 2005 WO
WO-2006005015 Jan 2006 WO
WO-2006009690 Jan 2006 WO
WO-2006026371 Mar 2006 WO
WO-2006027499 Mar 2006 WO
WO-2005062980 May 2006 WO
WO 2006066327 Jun 2006 WO
WO-2006066327 Jun 2006 WO
WO-2006058163 Jun 2006 WO
WO-2006065949 Jun 2006 WO
WO-2006068944 Jun 2006 WO
WO 2006070372 Jul 2006 WO
WO 2006076890 Jul 2006 WO
WO 2006089517 Aug 2006 WO
WO-2006083763 Aug 2006 WO
WO-2006086135 Aug 2006 WO
WO-2006086736 Aug 2006 WO
WO-2006102063 Sep 2006 WO
WO-2006093795 Sep 2006 WO
WO 2006108090 Oct 2006 WO
WO 2006124649 Nov 2006 WO
WO-2006124649 Nov 2006 WO
WO 2006127756 Nov 2006 WO
WO 2006127765 Nov 2006 WO
WO-2006118766 Nov 2006 WO
WO 2006129441 Dec 2006 WO
WO-2006132948 Dec 2006 WO
WO 2006133959 Dec 2006 WO
WO-2006138173 Dec 2006 WO
WO-2006138391 Dec 2006 WO
WO-2007009117 Jan 2007 WO
WO-2007009609 Jan 2007 WO
WO-2007013999 Feb 2007 WO
WO-2007033093 Mar 2007 WO
WO-2007035471 Mar 2007 WO
WO 2007047488 Apr 2007 WO
WO 2007047945 Apr 2007 WO
WO-2005102015 Apr 2007 WO
WO-2006138391 Apr 2007 WO
WO-2007044285 Apr 2007 WO
WO-2007048529 May 2007 WO
WO 2007048529 May 2007 WO
WO 2007051620 May 2007 WO
WO 2007059252 May 2007 WO
WO-2007053243 May 2007 WO
WO-2007058847 May 2007 WO
WO-2007071436 Jun 2007 WO
WO-2006086736 Jun 2007 WO
WO 2007098232 Aug 2007 WO
WO-2007092354 Aug 2007 WO
WO-2007097983 Aug 2007 WO
WO-2007053243 Sep 2007 WO
WO 2007120543 Oct 2007 WO
WO 2007123956 Nov 2007 WO
WO-2007071436 Nov 2007 WO
WO-2007123658 Nov 2007 WO
WO-2007033093 Jan 2008 WO
WO-2007071436 Jan 2008 WO
WO-2008028569 Mar 2008 WO
WO 2008031103 Mar 2008 WO
WO 2008035337 Mar 2008 WO
WO 2008045949 Apr 2008 WO
WO-2008040555 Apr 2008 WO
WO-2008047354 Apr 2008 WO
WO 2008051554 May 2008 WO
WO 2008070797 Jun 2008 WO
WO-2008070442 Jun 2008 WO
WO 2008079962 Jul 2008 WO
WO 2008098191 Aug 2008 WO
WO 2008101083 Aug 2008 WO
WO-2008100599 Aug 2008 WO
WO 2008125153 Oct 2008 WO
WO 2008138584 Nov 2008 WO
WO-2008137603 Nov 2008 WO
WO 2008150529 Dec 2008 WO
WO-2009002548 Dec 2008 WO
WO-2009024859 Feb 2009 WO
WO-2009029199 Mar 2009 WO
WO 2009053497 Apr 2009 WO
WO-2009042196 Apr 2009 WO
WO-2009045334 Apr 2009 WO
WO-2009045338 Apr 2009 WO
WO-2009054397 Apr 2009 WO
WO-2007044285 May 2009 WO
WO-2009061389 May 2009 WO
WO 2009094188 Jul 2009 WO
WO-2009085206 Jul 2009 WO
WO-2009091509 Jul 2009 WO
WO-2009094501 Jul 2009 WO
WO-2009100198 Aug 2009 WO
WO 2009106545 Sep 2009 WO
WO-2009108615 Sep 2009 WO
WO-2009111241 Sep 2009 WO
WO 2009149462 Dec 2009 WO
WO-2009155561 Dec 2009 WO
WO-2010022138 Feb 2010 WO
WO-2010042950 Apr 2010 WO
WO-2010043950 Apr 2010 WO
WO-2010044851 Apr 2010 WO
WO-2010045238 Apr 2010 WO
WO-2010045297 Apr 2010 WO
WO-2010049160 May 2010 WO
WO-2010083558 Jul 2010 WO
WO-2010086460 Aug 2010 WO
WO-2010098857 Sep 2010 WO
WO-2010104638 Sep 2010 WO
WO-2010045238 Oct 2010 WO
WO-2010141626 Dec 2010 WO
WO 2011008812 Jan 2011 WO
WO-2011008853 Jan 2011 WO
WO 2011060386 May 2011 WO
WO-2011051043 May 2011 WO
WO-2011057087 May 2011 WO
WO-2011102968 Aug 2011 WO
WO 2011104269 Sep 2011 WO
WO 2011120050 Sep 2011 WO
WO-2011133368 Oct 2011 WO
WO 2011144351 Nov 2011 WO
WO 2011147849 Dec 2011 WO
WO-2012002228 Jan 2012 WO
WO 2012023980 Feb 2012 WO
WO 2012036742 Mar 2012 WO
WO 2012038550 Mar 2012 WO
WO 2012039748 Mar 2012 WO
WO 2012082952 Jun 2012 WO
WO 2012106491 Aug 2012 WO
WO-2012116368 Aug 2012 WO
WO 2012142189 Oct 2012 WO
WO-2012145546 Oct 2012 WO
WO-2012162228 Nov 2012 WO
WO-2013009975 Jan 2013 WO
WO-2013028387 Feb 2013 WO
WO-2013033791 Mar 2013 WO
WO-2013074671 May 2013 WO
WO-2013096545 Jun 2013 WO
WO-2013134214 Sep 2013 WO
WO-2014056644 Apr 2014 WO
WO-2014072439 May 2014 WO
WO-2014072439 Jul 2014 WO
WO-2015028209 Mar 2015 WO
WO-2016093877 Jun 2016 WO
WO-2016126511 Aug 2016 WO
Non-Patent Literature Citations (256)
Entry
US 6,331,185 B1, 12/2001, Gambale et al. (withdrawn)
US 8,062,356 B2, 11/2011, Salahieh et al. (withdrawn)
US 8,062,357 B2, 11/2011, Salahieh et al. (withdrawn)
US 8,075,614 B2, 12/2011, Salahieh et al. (withdrawn)
US 8,133,271 B2, 03/2012, Salahieh et al. (withdrawn)
US 8,211,170 B2, 07/2012, Paul et al. (withdrawn)
Aortenklappenbioprothese erfolgreich in der Entwicklung, May 16, 2003 (1 page).
English translation of Aortenklappenbioprothese erfolgreich in der Entwicklung (2 pages).
Screen shots from http://www.fraunhofer.de/presse/filme/2006/index.jsp, 2006 (2 pages).
Liang, Ma, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” Eur. J. Cardio-Thoracic Surgery, vol. 28, pp. 194-198 (2005) (5 pages).
Huber, Christoph H., et al. “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” Eur. J. Cardio-Thoracic Surgery, vol. 29, pp. 380-385 (2006) (6 pages).
File history for German Patent DE 195 46 692 filed Dec. 14, 1995 and patented Jul. 11, 2002 (111 pages).
Klein, Allan L. et al., “Age-related Prevalence of Valvular Regurgitation in Normal Subjects: A Comprehensive Color Flow Examination of 118 Volunteers,” J. Am. Soc. Echocardiography, vol. 3, No. 1, pp. 54-63 (1990) (10 pages).
Gummert, J.F. et al., “Cardiac Surgery in Germany During 2007: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 56, pp. 328-336 (2008) (9 pages).
Gummert, J.F. et al., “Cardiac Surgery in Germany During 2006: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery,” Thorac. Cardiov. Surg., vol. 55, pp. 343-350 (2007) (8 pages).
Ferrari, M.W. et al., “Transarterial Aortic Valve Replacement with a Self expanding Stent in Pigs,” Heart, vol. 90, No. 11, pp. 1326-1331 (2004).
Ferrari, “Entwicklung eines Verfahrens zum transvaskulären Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultät der Friedrich-Schiller-Universität Jena, pp. 49-52, dated Sep. 2003.
Ferrari, “Entwicklung eines Verfahrens zum transvaskulären Aortenklappenersatz,” Habilitationsschrift, Medizinische Fakultät der Friedrich-Schiller-Universität Jena, pp. 1-159, dated Sep. 2003.
German National Library, bibliographic information for Ferrari, M., “Entwicklung eines Verfahrens zum transvaskulären Aortenklappenersatz,” available at https://www.deutsche-digitale-bibliothek.de/item/U2RQV45RMES4YP6AHEPGN4QPJWAMGROI.
International Search Report for PCT/EP2014/065817, dated Jan. 7, 2015 (5 pages).
Akins C.W., et al., “Risk of Reoperative Valve Replacement for Failed Mitral and Aortic Bioprostheses,” The Annals of Thoracic Surgery, 65:545-1552 (Jan. 1998). Retrieved from the Internet: URL: http://ats.ctsnetjournals.org/cgi/contenUfull/65/6/1545 (Jan. 1998).
Allen et al., “What are the characteristics of the ideal endovascular graft for abdominal aortic aneurysm exclusion?”, J. Endovasc. Surg., vol. 4(2), May 1997, pp. 195-202.
Anabtawi I.N., et al., “Experimental evaluation of myocardial tunnelization as a method of myocardial revascularization,” Journal of Thoracic and Cardiovascular Surgery, 58(5):638-646 (Nov. 1969).
Andersen et al., “Transluminal implantation of artificial heart valves, Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs,” Euro. Heart J., vol. 13, May 1992, pp. 704-708.
Archie J.P., et al., “Intramyocardial Pressure: Effect of Preload on Transmural Distribution of Systolic Coronary Blood Flow,” The American Journal of Cardiology, 35(6):904-911 (Jun. 1975).
Baba H., et al., “Hemodynamic effects of venous valves in aorta-coronary bypass grafts,” The Journal of Thoracic and Cardiovascular Surgery, 71(5):774-778 (May 1976).
Block et al., “Percutaneous Approaches to Valvular Heart Disease,” Current Cardiology Reports, 7(2):108-113 ( Mar. 2005).
Blum et al., “Endoluminal Stent-Grafts for Intrarenal Abdominal Aortic Aneurysms.” New Engl. J. Med., 336:13-20 (Jan. 1997).
Bonhoeffer et al., “Percutaneous Insertion of the Pulmonary Valve,” J. Am. Coll. Cardiol., vol. 39, May 15, 2002, pp. 1664-1669.
Bonhoeffer et al., “Percutaneous Mitral Valve Dilatation with the Multi-Track System,” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiograhy & Interventions, United States (Oct. 1999), pp. 178-183.
Bonhoeffer et al., “Percutaneous replacement of pulmonary valve in a right ventricle to pulmonary-artery prosthetic conduit with valve dysfunction”, The Lancet, Oct. 21, 2000, vol. 356, pp. 1403-1405.
Bonhoeffer et al., “Transcatheter Implantation of a Bovine Valve in Pulmonary Position: A Lamb Study,” Circulation, vol. 102, Aug. 15, 2000, pp. 813-816.
Bonhoeffer P., et al., “Technique and Results of Percutaneous Mitral Valvuloplasty With the Multi-Track System,” Journal of Interventional Cadiology, 13(4):263-268 (Aug. 2000).
Boudjemline et al., “Percutaneous Implantation of a Biological Valve in Aortic Position: Preliminary Results in a Sheep Study,” European Heart Journal, vol. 22, p. 630, Abstract Only (Sep. 2001).
Boudjemline et al., “Percutaneous Implantation of a Biological Valve in the Aorta to Treat Aortic Valve Insufficiency—A Sheep Study.” Med Sci. Monit., 8:4:BR113-116 (Apr. 2002).
Boudjemline et al., “Percutaneous Implantation of a Valve in the Descending Aorta in Lambs.” Euro. Heart J., Jul. 2002, 23, pp. 1045-1049.
Boudjemline et al., “Percutaneous Pulmonary Valve Replacement in a Large Right Ventricular Outflow Tract: An Experimental Study.” Journal of the American College of Cardiology, 43(6):1082-1087 (Mar. 2004).
Boudjemline et al., “Percutaneous Valve Insertion: A New Approach?”, J. of Thoracic and Cardio. Surg, 125(3): 741-743, Mar. 2003.
Boudjemline et al., “Stent Implantation Combined with a Valve Replacement to Treat Degenerated Right Ventricle to Pulmonary Artery Prosthetic Conduits,” European Heart Journal, vol. 22, p. 355, Abstract Only (Sep. 2001).
Boudjemline et al., “Steps Toward Percutaneous Aortic Valve Replacement.” Circulation, Feb. 12, 2002, vol. 105, pp. 775-778.
Boudjemline et al., “The Percutaneous Implantable Heart Valve,” Progress in Pediatric Cardiology, 14:89-93, (Nov. 2001).
Boudjemline Y., et al., “Images in Cardiovascular Medicine, Percutaneous Aortic Valve Replacement in Animals,” Circulation, vol. 109: e161, United States, Mar. 16, 2004, 1 page.
Boudjemline Y., et al., “Is Percutaneous Implantation of a Bovine Venous Valve in the Inferior Vena Cava a Reliable Technique to Treat Chronic Venous Insufficiency Syndrome?” Medical Science Monitor—International Medical Journal of Experimental and Clinical Research, Poland, Mar. 2004, pp. BR61-BR66.
Boudjemline Y., et al, “Off-pump Replacement of the Pulmonary Valve in Large Right Ventricular Outflow Tracts: A Hybrid Approach,” Journal of Thoracic and Cardiovascular Surgery, United States, vol. 129, No. 4, Apr. 2005, pp. 831-837.
Boudjemline Y., et al., “Percutaneous Aortic Valve Replacement: Will We Get There?” Heart, British Cardiac Society, England, Dec. 2001, pp. 705-706.
Boudjemline Y., et al., “Transcatheter Reconstruction of the Right Heart,” Cardiology in the Young, England, Jun. 2003, pp. 308-311.
Bruce C.J., et al., “Right-sided Valve Disease Deserves Little More Respect,” Circulation, 119(2):2726-2734 (May 2009).
Coats L., et al., “The Potential Impact of Percutaneous Pulmonary Valve Stent Implantation on Right Ventricular Outflow Tract Re-Intervention,” European Journal of Cardio-Thoracic Surgery, vol. 27, England, Apr. 2005, pp. 536-543.
Commeau P et al., “Percutaneous Balloon Dilatation of calcific aortic Valve Stenosis: Anatomical and Haemodynamic Evaluation,” British Heart Journal, 59:227-238 (Feb. 1988).
Cribier et al., “Early Experience with Percutaneous Transcatheter Implantation of Heart Valve Prosthesis for the Treatment of End-Stage Inoperable Patients with Calcific Aortic Stenosis”, J. of Am. Coll. of Cardio, Feb. 18, 2004, 43(4), pp. 698-703.
Cribier et al., “Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case”, Circulation, 106(24):3006-3008 (Dec. 2002).
Cribier et al., “Percutaneous Transluminal Valvuloplasty of Acquired Aortic Stenosis in Elderly Patients: An Alternative to Valve Replacement?”, The Lancet, Jan. 11, 1986, pp. 63-67.
Cunanan et al., “Tissue Characterization and Calcification Potential of Commercial Bioprosthetic Heart Valves.” Ann. Thorac. Surg., May 15, 2001, pp. S417-S421.
Cunliffe et al., “Glutaraldehyde Inactivation of Exotic Animal Viruses in Swine Heart Tissue,” Applied and Environmental Microbiology, Greenport, New York, vol. 37, No. 5, May 1979, pp. 1044-1046.
Dake et al., “Transluminal Placement of Endovascular Stent-Grafts for the Treatment of Descending Thoracic Aortic Aneurysms.” New Engl. J. of Med., 331(26):1729-34 (Dec. 1994).
Dalby et al., “Non-Surgical Aortic Valve Replacement” Br. J. Cardiol., 10(6):450-452 (Nov. 2003).
Davidson et al., “Percutaneous therapies for valvular heart disease,” Cardiovascular Pathology 15:123-129 (Jan. 2006).
Dewey et al., “Transapical aortic valve implantation: An Animal Feasibility Study”, The annals of thoracic surgery, 82:110-116 (Feb. 2006).
Dhasmana et al., “Factors Associated With Periprosthetic Leakage Following Primary Mitral Valve Replacement: With Special Consideration of Suture Technique.” Annals of Thorac. Surg., (Feb. 1983), 35(2), pp. 170-178.
Dotter, “Transluminally-Placed Coilspring Endarterial Tube Grafts,” Investigative Radiology, pp. 329-332 (Oct. 1969).
Emery et al., “Replacement of the Aortic Valve in Patients Under 50 Years of Age: Long-Term Follow-Up of the St. Jude Medical Prosthesis.” Ann. Thorac. Surg., 75:1815-1819 (Jun. 2003).
European Search Report dated Aug. 10, 2011 for EP Application No. 06824992.9.
European Search Report for EP Patent Appl. Serial No. 12179049.7 (1257), dated Oct. 30, 2012, 4 pages.
European Search Report for EP Patent Appl. Serial No. 12179075.2 (1257), dated Oct. 29, 2012, 3 pages.
European Search Report for EP Patent Appl. Serial No. 12179141.2 (1257), dated Nov. 2, 2012, 3 pages.
European Search Report for EP Patent Appl. Serial No. 12179146.1 (1257), dated Nov. 7, 2012, 8 pages.
European Search Report for EP Patent Appl. Serial No. 12179330.1 (1257), dated Nov. 22, 2012, 3 pages.
European Search Report for EP Patent Appl. Serial No. 12179338.4 (1257), dated Nov. 2, 2012, 3 pages.
European Search Report for EP Patent Appl. Serial No. 12179339.2 (1257), dated Oct. 29, 2012, 4 pages.
European Search Report for EP Patent Appl. Serial No. 12179914.2 (1257), dated Nov. 7, 2012, 6 pages.
European Search Report for EP Patent Appl. Serial No. 13150337.7 (1257), dated Jul. 9, 2013, 3 pages.
European Search Report for EP Patent Appl. Serial No. 13183134.9 (1651), dated Nov. 19, 2013, 3 pages.
European Search Report for EP Patent Appl. Serial No. 14159630.4 (1651), dated May 22, 2014, 3 pages.
European Search Report for EP Patent Appl. Serial No. 14161991.6 (1651), dated Jun. 3, 2014, 3 pages.
European Search Report for EP Patent Appl. Serial No. 15167832.3 (1651), dated Jul. 23, 2015, 3 pages.
European Search Report for EP Patent Appl. Serial No. 15167847.1 (1651), dated Jul. 23, 2015, 3 pages.
European Search Report for EP Patent Appl. Serial No. 17196833.2, dated Mar. 6, 2018, 4 pages.
European Search Report for EP Patent Appl. Serial No. 18164490.7, dated Sep. 17, 2018 5 pages.
European Search Report from EP Patent Office for EP Application No. 15177718.2, dated Jan. 18, 2016, 4 pages.
European Search Report from EP Patent Office for EP Application No. 15177731.5, dated Apr. 14, 2016, 4 pages.
European Search Report from EP Patent Office for EP Application No. 16151726.3, dated Feb. 25, 2016, 4 pages.
Extended European Search Report dated Apr. 11, 2008 in EP Patent Appl. Serial No. 081630410, 5 pages.
Extended EP Search Report dated Sep. 24, 2020 in EP Patent Appl. Serial No. 20165841.6 (JVT-0280).
Extended European Search Report for Application No. 10183946.2.4-2320 dated Feb. 14, 2012, 7 pages.
Extended European Search Report dated Aug. 9, 2018 in EP Patent Appl. Serial No. 18158901.1 (1113).
Extended European Search Report dated Jun. 12, 2018 in EP Patent Appl. Serial No. 17209326.2 (1113).
Extended European Search Report dated May 16, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257).
Extended European Search Report for Application No. 11178076.3-1257 dated Feb. 29, 2012, 5 pages.
Extended European Search Report from EP Patent Office for EP Application No. 17162616.1, dated Jul. 27, 2017, 7 pages.
Extended European Search Report dated Apr. 9, 2014 in EP Patent Appl. Serial No. 14164683.6.
Extended European Search Report dated May 9, 2013 in EP Patent Appl. Serial No. 130178309.4,4 pages.
Extended European Search Report dated Aug. 19, 2011 in EP Patent Appl. Serial No. 07827132.7.
Extended European Search Report dated Feb. 27, 2017 in EP Patent Appl. Serial No. 16186773,6 pages.
Extended European Search Report dated Sep. 29, 2014 in EP Patent Appl. Serial No. 14164680, 5 pages.
Extended European Search Report for Application No. 07116242.4-2310 dated Mar. 31, 2008, 10 pages.
Extended European Search Report for Application No. 09154935.2, dated May 29, 2009, 7 pages.
Extended European Search Report for Application No. 10012198.7dated Mar. 23, 2011, 7 pages.
Extended European Search Report for Application No. 10168525.3-1257 dated Feb. 3, 2011, 13 pages.
Extended European Search Report for Application No. 11153142.2-1257 dated Aug. 3, 2011, 10 pages.
Extended European Search Report for Application No. 11165093.3-1257 dated Aug. 30, 2011, 6 pages.
Extended European Search Report for Application No. 11178073.0-1257 dated Oct. 14, 2011, 5 pages.
Extended European Search Report for Application No. 11178145.6-1257 dated Feb. 29, 2012, 5 pages.
Extended European Search Report for Application No. 13188858.8-1651 dated Jan. 13, 2014, 6 pages.
Extended European Search Report for Application No. 19195062 dated Jan. 2, 2020, 7 pages.
ExtendedEuropean Search Report for EP Patent Appl. Serial No. 06827630.2 dated Jun. 7, 2010, 5 pages.
Extended European Search Report for EP Patent Appl. Serial No. 07110318.8, dated May 29, 2008, 10 pages.
Extended European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Mar. 22, 2011, 9 pages.
Extended European Search Report for EP Patent Appl. Serial No. 10184842.2, dated Mar. 23, 2011, 7 pages.
Extended European Search Report for EP Patent Appl. Serial No. 11162971.3, dated Jun. 30, 2011, 5 pages.
Extended European Search Report for EP Patent Appl. Serial No. 13163918.9,dated Jul. 24, 2013, 8 pages.
Extended European Search Report for EP Patent Appl. Serial No. 14179639.1, dated Mar. 9, 2015, 7 pages.
Extended European Search Report for EP Patent Appl. Serial No. 16201320.5, dated May 19, 2017, 6 pages.
Extended European Search Report for EP Patent Appl. Serial No. 18200191.7, dated May 6, 2019, 8 pages.
Filsoufi F., et al., “Long-term Outcomes of Tricuspid Valve Replacement in the Current Era,” Ann. Thorac. Surg., 8(3):845-850 (Sep. 2005).
Fluency Vascular Stent Graft Instructions for Use, May 2014, 20 pages.
Greeenberg, “Abdominal Aortic Endografting: Fixation and Sealing.” J. Am. Coll. Surg., 194(1):S79-S87 (Jan. 2002).
Grossi A.E. et al., “Impact of Minimally Invasive Valvular Heart Surgery: A Case-Control Study”, Ann. Thorac. Surg., 71:807-810 (Mar. 2001).
Hanzel et al., “Complications of percutaneous aortic valve replacement: experience with the Criber-Edwards.TM. percutaneous heart valve,” EuroIntervention Supplements I (Supplement A):A3-A8 (May 19, 2006).
Heinrich R.S., et al., “Experimental analysis of fluid mechanical energy losses in aortic valve stenosis: importance of pressure recovery”, Ann Biomed Eng., Nov.-Dec. 1996, vol. 24(6), pp. 685-694.
Hijazi Z.M., “Transcatheter Valve Replacement: A New Era of Percutaneous Cardiac Intervention Begins”, J. of Am. College of Cardio., Nov. 6, 2004, vol. 43, No. 6, pp. 1088-1089.
Hourihan M., et al., “Transcatheter Umbrella Closure of Valvular and Paravalvular Leaks”, JACC, Boston, Massachusetts, 20(6):1371-1377 (Nov. 1992).
Huber H.C., et al., “Direct-Access Valve Replacement: A Novel Approach for Off-Pump Valve Implantation Using Valved Stents”, Journal of the American College of Cardiology, vol. 46, No. 2, Jul. 19, 2005, pp. 366-370.
Huber H.C., et al., “Do Valved Stents Compromise Coronary Flow?”, European Journal of Cardio-thoracic Surgery, Jan. 23, 2004, vol. 25; pp. 754-759.
Ing F., “Stents: What's Available to the Pediatric Interventional Cardiologist?” Catheterization and Cardiovascular Interventions, 57:374-386 (Jun. 2002).
International Search Report dated Dec. 29, 2003 in Intl PCT Patent Appl. U.S. Appl. No. PCT/DE2003/002669.
International Search Report and Written Opinion for PCT Application No. PCT/EP2009/052230 dated Jun. 29, 2009, 12 pages.
International Search Report and Written Opinion for PCT Application No. PCT/EP2010/052429 dated Jun. 14, 2010, 12 pages.
International Search Report and Written Opinion for PCT Application No. PCT/EP2011/002524 dated Apr. 23, 2012, 15 pages.
International Search Report and Written Opinion for PCT Application No. PCT/EP2011/052674 dated Jul. 5, 2011, 12 pages.
International Search Report for PCT Application No. PCT/US1999/020736dated Jan. 28, 2000, 3 pages.
International Search Report and Written Opinion for PCT Application No. PCT/EP2009/050762 dated Jun. 23, 2009, 12 pages.
International Search Report & Written Opiniondated Jul. 18, 2016 for PCT Patent Appl No. PCT/EP2016/059839, 10 pages.
International Search Report and Written Opinion for Appl. No. PCT/EP2016/055783, dated May 30, 2016, 15 pages.
International Search Report and Written Opinion for Application No. PCT/EP2013/057431 dated Jul. 26, 2013, 9 pages.
International Search Report and Written Opinion for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 11 pages.
International Search Report and Written Opinion for International Application No. PCT/EP2010/063306, dated Nov. 17, 2010, 9 pages.
International Search Report and Written Opinion for PCT Application No. PCT/EP2006/010519 dated Mar. 1, 2007, 13 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US06/36286 dated Jul. 9, 2007, 4 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2004/041513 dated Jun. 10, 2005, 4 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2004/043607 dated Mar. 20, 2006, 4 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2005/020947 dated Oct. 6, 2005, 5 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2006/038352 dated May 19, 2008, 4 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2006/043484 dated Jun. 25, 2008, 4 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2007/003992 dated Jan. 10, 2008, 5 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2007/02970 dated Oct. 19, 2007, 7 pages.
International Search Report and Written Opinion for PCT Application No. PCT/US2009/060531 dated May 13, 2010, 6 pages.
International Search Report and Written Opinion for PCT/DE2006/000056 dated Jun. 7, 2006, 11 pages.
International Search Report and Written Opinion for PCT/EP2007/061117 dated May 20, 2008, 16 pages.
International Search Report and Written Opinion for PCT/EP2008/003803 dated Aug. 20, 2008, 10 pages.
International Search Report and Written Opinion for PCT/EP2009/055958 dated Oct. 21, 2009, 8 pages.
International Search Report and Written Opinion for PCT/EP2010/056558 dated Oct. 7, 2010, 14 pages.
International Search Report and Written Opinion for PCT/EP2012/067617 dated Dec. 19, 2012, 10 pages.
International Search Report and Written Opinion for PCT/IL2007/001149 dated May 1, 2008, 4 pages.
International Search Report and Written Opinion for PCT/US2011/027730 dated May 25, 2011, 9 pages.
International Search Report and Written Opinion of the International Search Authority for International Application No. PCT/EP2008/064558, date of completion of report is Mar. 18, 2009, 14 pages.
International Search Report for Application No. PCT/DE2001/000837, dated Aug. 7, 2001, 4 pages.
International Search Report for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 5 pages.
International Search Report for Application No. PCT/EP2010/057798, dated Sep. 12, 2010, 6 pages.
International Search Report for Application No. PCT/EP2011/058506, dated Nov. 3, 2011, 4 pages.
International Search Report for Application No. PCT/EP2011/066677, dated Feb. 17, 2012, 7 pages.
International Search Report for Application No. PCT/EP2012/067617 dated Dec. 19, 2012, 3 pages.
International Search Report for Application No. PCT/EP2012/067714 dated Dec. 18, 2012, 3 pages.
International Search Report for Application No. PCT/EP2013/073318, dated Apr. 17, 2014, 5 pages.
International Search Report for Application No. PCT/EP2016/055783, dated May 30, 2016, 5 pages.
International Search Report for Application No. PCT/EP2016/058532, dated Jul. 11, 2016, 4 pages.
International Search Report for Application No. PCT/IB2008/002180, dated Apr. 15, 2009, 7 pages.
International Search Report for Application No. PCT/IB2018/050438 dated Apr. 12, 2018, 3 pages.
International Search Report for PCT/DE2001/000836 dated Jun. 13, 2001, 6 pages.
International Search Report for PCT/EP2006/010023 dated Mar. 30, 2007, 6 pages.
International Search Report for PCT/EP2007/007413, dated Jan. 28, 2008, 4 pages.
International Search Report for PCT/IB2017/052718, dated Sep. 5, 2017, 4 pages.
Kato et al., “Traumatic Thoracic Aortic Aneurysm: Treatment with Endovascular Stent-Grafts.” Radiol., 205:657-662 (Dec. 1997).
Khambadkone, et al, “Percutaneous Implantation of Pulmonary Valves,” Expert Review of Cardiovascular Therapy (England), Nov. 2003, pp. 541-548.
Khambadkone, “Nonsurgical Pulmonary Valve Replacement: Why, When, and How?” Catheterization and Cardiovascular Interventions—Official Journal of the Society for Cardiac Angiography & Interventions (United States), Jul. 2004, pp. 401-408.
Knudsen et al., “Catheter-implanted prosthetic heart valves”, Intl J. of Art. Organs, 16(5): 253-262, May 1993.
Kort et al., “Minimally Invasive Aortic Valve Replacement: Echocardiographic and Clinical Results.” Am. Heart J., Sep. 2001, vol. 142(3), pp. 476-481.
Kuzela L., et al., “Experimental evaluation of direct transventricular revascularization,” Journal of Thoracic and Cardiovascular Surgery, 57(6):770-773 (Jun. 1969).
Laborde et al., “Percutaneous Implantation of the Corevalve Aortic Valve Prosthesis for Patients Presenting High Risk for Surgical Valve Replacement,” EuroIntervention, 1(4):472-474 (Feb. 2006).
Lawrence et al., “Percutaneous Endovascular Graft: Experimental Evaluation”, Radiology, May 1987, vol. 163(2), pp. 357-360.
Levi et al., “Future of Interventional Cardiology in Pediactrics.” Current Opinion in Cardiol., 18:79-90 (Mar. 2003).
Levy, “Mycobacterium chelonei Infection of Porcine Heart Valves.” The New England Journal of Medicine, Washington DC, 297(12), Sep. 22, 1977, pp. 667-668.
Lichtenstein et al., “Transapical Transcatheter Aortic Valve Implantation in Humans: Initial Clinical Experience”, circulation, American Heart Association vol. 114, Jul. 31, 2006, pp. 591-596.
Lichtenstein, S.V., “Closed heart surgery: Back to the future” The Journal of Thoracic and Cardiovascular Surgery, vol. 131(5), May 2006, pp. 941-943.
Liu et al., “Effect of Fiber Orientation on the Stress Distribution within a Leaflet of a Polymer Composite Heart Valve in be Closed Position”, Journal of Biomechanics, 4:1099-1106 (Jan. 2007).
Lonescu et al., “Prevalence and Clinical Significance of Incidental Paraprosthetic Valvar Regurgitation: A prospective study using transesophageal echocardiography.” Heart, 89:1316-21 (Oct. 2003).
Love S.C. et al., The Autogenous Tissue Heart Valve: Current Status, Journal of Cardiac Surgery, , Mar. 1991, vol. 6(4), pp. 499-507.
Lutter et al., “Percutaneous Aortic Valve Replacement: An Experimental Study. I. Studies on Implantation.” J. of Thoracic and Cardio. Surg., Apr. 2002, vol. 123(4), pp. 768-776.
Lutter et al., “Percutaneous Valve Replacement: Current State and Future Prospects,” Annals of Thoracic Surgery, Netherlands Dec. 2004, pp. 2199-2206.
Ma, et al, “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, vol. 28, No. 2, 2005, pp. 194-199.
Mack, M.J., “Minimally invasive cardiac surgery”, Surg Endosc, 20:S488-S492 (Mar. 2006).
Magovern et al., “Twenty-five-Year Review of the Magovern-Cromie Sutureless Aortic Valve”, Ann. Thorac. Surg., 48:S33-S334 (Jan. 1989).
Maraj et al., Evaluation of Hemolysis in Patients with Prosthetic Heart Valves, Clin. Cardiol. 21:387-392 (Jun. 1998).
Marcus RH et al., “Assessment of small-diameter aortic mechanical prostheses: physiological relevance of the Doppler gradient, utility of flow augmentation, and limitations of orifice area estimation,” Circulation, 98(9):866-872 (Sep. 1998).
Mckay G. R. et al., “The Mansfield Scientific Aortic Valvuloplasty Registry: Overview of Acute Hemodynamic Results and Procedural Complications.” J. Am. Coll. Cardiol., 17(2):485-491 (Feb. 1991).
Mills N.L., et al., “Valvulotomy of valves in the saphenous vein graft before coronary artery bypass,” The Journal of Thoracic and Cardiovascular Surgery, 71(6):878-879 (Jun. 1976).
Mirich et al., “Percutaneously Placed Endovascular Grafts for Aortic Aneurysms: Feasibility Study”, Radiology, 170:1033-1037 (Mar. 1989).
Moazami N et al. “Transluminal Aortic Valve Placement: a Fesibility Study with a Newly Designed Collapsible Aortic Valve”, ASAIO Journal, vol. 42, No. 2, Mar.-Apr. 1996.
Moulopoulos et al., “Catheter-Mounted Aortic Valves,” Annals of Thoracic Surg., vol. 11, No. 5, May 1971, pp. 423-430.
Munro I., et al., “The possibility of myocardial revascularization by creation of a left ventriculocoronary artery fistula,” The Journal of Thoracic and Cardiovascular Surgery, 58(1):25-32 (Jul. 1969).
Nath J., et al., Impact of Tricuspid Regurgitation on Long-term Survival, Journal of the American College of Cardiology, 43(3):405-406 (Feb. 2004).
Nietlispach F., et al., “Current Balloon-Expandable Transcatheter Heart Valve and Delivery Systems”, Catheterization and Cardiovascular Interventions, 75:295-300 (Sep. 2009).
Palacios., “Percutaneous Valve Replacement and Repair, Fiction or Reality?,” Journal of American College of Cardiology, 44(8):1662-1663 (Oct. 2004).
Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents: Early Experience in the Dog,” American Journal of Roentgenology, 145 (4):821-825 (Oct. 1985).
Palmaz J.C., et al., “Expandable Intrahepatic Portacaval Shunt Stents in Dogs with Chronic Portal Hypertension,” American Journal of Roentgenology, 147(6):1251-1254 (Dec. 1986).
Paniagua et al., “Percutaneous Heart Valve in the Chronic in Vitro Testing Model.” Circulation, Sep. 17, 2002, vol. 106: e51-e52.
Parodi J.C., et al., “Transfemoral Intraluminal Graft Implantation for Abdominal Aortic Aneurysms”, Ann. Vasc. Surg., 5(6):491-499 (Nov. 1991).
Partial European Search Report dated Feb. 28, 2012 in EP Patent Appl. Serial No. 11178135.7 (1257).
Partial European Search Report for Application No. 10168525.3-1269 dated Sep. 20, 2010, 5 pages.
Partial European Search Report for Application No. 07116242.4-2310 dated Jan. 14, 2008, 5 pages.
Partial European Search Report for Application No. 11153142.2-1257 dated Apr. 4, 2011, 5 pages.
Partial European Search Report for EP Patent Appl. Serial No. 07110318.8, dated Mar. 10, 2008, 6 pages.
Partial European Search Report for EP Patent Appl. Serial No. 10163478.0, dated Nov. 2, 2010, 6 pages.
Partial International Search Report for International Application No. PCT/EP2014/055044, filed Mar. 13, 2014, 7 pages.
Pavcnik D., et al., “Development and Initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement.” Radiology, 183:151-154 (Apr. 1992).
Pavcnik et al., “Aortic and venous valve for percutaneous insertion,” Min. Invas. Ther. & Allied Technol, 9(3/4):287-292 (Jan. 2000).
Pavcnik et al., “Percutaneous Bioprosthetic Venous Valve: A Long-term Study in Sheep,” Jounal of Vascular Surg., vol. 35, No. 3, Mar. 2002, pp. 598-603.
Pawelec-Wojtalk M., “Closure of left ventricle perforation with the use of muscular VSD occluder,” European Journal of Cardia-Thoracic Surgery, 27(4):714-716 (Apr. 2005).
Pelton A.R., et al., “Medical Uses of Nitinol”, Materials Science Forum, 327-328:63-70 (Jan. 2000).
Phillips et al., “A Temporary Catheter-Tip Aortic Valve: Hemodynamic Effects on Experimental Acute Aortic Insufficiency”, Annals of Thoracic Surg., Feb. 1976, 21(2), pp. 134-136.
Phillips S.J., et al., “Improvement in Forward Coronary Blood Flow by Using a Reversed Saphenous Vein with a Competent Valve,” The Annals of Thoracic Surgery, vol. 21 (1), Jan. 1976, pp. 12-15.
Preliminary Search Report (Rapport De Recherche Preliminaire) dated Jul. 10, 2002 in French Patent Application No. 0110444 (2 pages).
Raillat et al., “Treatment of Iliac Artery Stenosis with the Wallstent Endoprosthesis.” AJR, Mar. 1990, vol. 154(3), pp. 613-616.
Remadi et al., “Preliminary results of 130 aortic valve replacements with a new mechanical bileaflet prosthesis: The Edwards MIRA valve,” Interactive Cardiovasc. and Thorac. Surg., 2:80-83 (Mar. 2003).
Rogers J.H., et al., “The Tricuspid Valve: Current Perspective and Evolving Management of Tricuspid Regurgitation,” Circulation, 119(20):2718-2725 (May 2009).
Ruiz C.E.,“Transcatheter Aortic Valve Implantation and Mitral Valve Repair: State of the Art,” Pediatric Cardiology, 26(3):289-294 (Jun. 2005).
Schurink et al., “Stent Attachment Site—related Endoleakage after Stent Graft Treatment: An in vitro study of the effects of graft size, stent type, and atherosclerotic wall changes”, J. Vasc. Surg., vol. 30(4), Oct. 1999, pp. 658-667.
Search Report dated Oct. 15, 2003 from the European Patent Office for European Patent Application No. EP 02291953.4, 2 pages.
Search Report from the European Patent Office for European Patent Application No. EP 02291954.4, 4 pages.
Sochman et al., “Percutaneous Transcatheter Aortic Disc Valve Prosthesis Implantation: A Feasibility Study.” Cardiovasc. Intervent. Radiol., Sep. 2000, 23: 384-388.
Stanley et al., “Evaluation of Patient Selection Guidelines for Endoluminal AAA Repair With the Zenith Stent Graft: The Australasian Experience.” J. Endovasc. Ther., 8:457-464 (Oct. 2001).
Stassano., “Mid-term Results of the Valve-on-Valve Technique for Bioprosthetic Failure”, European Journal of Cardiothoracic Surgery, Oct. 2000, vol. 18, pp. 453-457.
Stein D.P., et al., “Turbulent blood flow in the ascending aorta of humans with normal and diseased aortic valves”, Circulation Research by American Heart Association, 39:58-65 (Jul. 1976).
Steinhoff et al., “Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits.” Circulation102 [suppl. III], pp. III-50-III-55 (Nov. 2000).
Supplemental Search Report from EP Patent Office for EP Application No. 04813777.2, dated Aug. 19, 2011.
Supplemental Search Report from EP Patent Office for EP Application No. 04815634.3, dated Aug. 19, 2011.
Supplemental Search Report from EP Patent Office for EP Application No. 05758878.2, dated Oct. 24, 2011.
Supplementary European Search Report dated Jan. 2, 2012 in EP Patent Appl. Serial No. 09820051.2.
Thompson et al., “Endoluminal stent grafting of the thoracic aorta: Initial experience with the Gore Excluder,” Journal of Vascular Surgery, Jun. 2002, pp. 1163-1170.
Topol, Eric., Textbook of Interventional Cardiology, 4th Ed; Chapter 24: “Endovascular Options for Peripheral Arterial Occlusive and Aneurysmal Disease,” Saunders, pp. 499-503, 949-953 (Dec. 2003).
Triennial Review of the National Nanotechnology Initiative: “A Matter of Size”, The National Academies Press, Washington DC, V-13, Retrieved from the Internet: URL: http://www.nap.edu/catalog/11752/a-matter-of-size-triennial-review-of-the-national-nanotechnology, 200 pages (Mar. 2006) (Parts 1-5).
Vahanian et al., “Percutaneous Approaches to Valvular Disease”, Circulation, Apr. 6, 2004, 109: 1572-1579.
Van Herwerden et al., “Percutaneous Valve Implantation: Back to the Future?”, Euro. Heart J., Sep. 2002, 23(18): 1415-1416.
Walther et al., “Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results”, European Journal of Cardio-thoracic Surgery 29, 703-708 (May 2006).
Webb et al., “Percutaneous Aortic Valve Implantation Retrograde from the Femoral Artery”, Circulation, American Hea Association, vol. 113, Feb. 6, 2006, pp. 842-850.
Weerasinghe A., et al., “First Redo Heart Valve Replacement: A 10-Year Analysis,” Circulation, 99(5):655-658 (Feb. 1999).
Weyman AB et al., “Aortic Stenosis: Physics and Physiology—What Do the Numbers Really Mean?”, Rev Cardiovasc Med., 6(1):23-32 (Jan. 2005).
White et al., “Endoleak as a Complication of Endoluminal Grafting of Abdominal Aortic Aneurysms: Classification, Incidence, Diagnosis, and Management,” J. Endovasc. Surg., 4:152-168 (May 1997).
Written Opinion for Application No. PCT/EP2006/012455, dated Sep. 27, 2007, 11 pages.
Written Opinion for Application No. PCT/EP2007/007413, dated Jan. 28, 2008, 5 pages.
Written Opinion for Application No. PCT/EP2011/058506, dated Nov. 3, 2011, 5 pages.
Written Opinion for Application No. PCT/EP2014/065817, dated Jan. 7, 2015, 7 pages.
Written Opinion for PCT/EP2006/010023 dated Mar. 30, 2007, 10 Pages.
Written Opinion for PCT/EP2012/067714 dated Dec. 18, 2012, 5 Pages.
Yonga G.O., et al., “Percutaneous Transvenous Mitral Commissurotomy in Juvenile Mitral Stenosis”, East African Medical Journal, 80(4):172-174 (Apr. 2003).
Yoshioka et al., “Self-Expanding Endovascular Graft: An Experimental Study in Dogs.” AJR 151, Oct. 1988, pp. 673-676.
Zhou et al., “Self-expandable Valved Stent of Large Size: Off-Bypass Implantation in Pulmonary Position”, Eur. J. Cardiothorac, Aug. 2003, 24: 212-216.
Related Publications (1)
Number Date Country
20200085572 A1 Mar 2020 US
Continuations (2)
Number Date Country
Parent 15834376 Dec 2017 US
Child 16552176 US
Parent 14914313 US
Child 15834376 US